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Abstract 
 
Stress urinary incontinence (SUI) and pelvic organ prolapse (POP) are diseases related 
to weakness of supportive tissues of the pelvic floor due to altered collagen production 
in middle-aged women and traumatic processes in younger women such as pregnancy 
and vaginal delivery.  
Currently there is no recommended material for use in the surgical management of these 
disorders. Synthetic non-absorbable materials, such as polypropylene mesh produce a 
vigorous inflammatory response followed by dense fibrosis and have been associated 
with serious complications such as exposure. By contrast acellular biological materials 
have a tendency toward rapid absorption with questionable long-term mechanical 
integrity and concerns regarding early failure. 
 
Our approach aims to develop a tissue engineered repair material (TERM) to provide 
the long-term durability of synthetic non-absorbable materials whilst avoiding 
complications such as exposures and pain. The TERM is composed of a scaffold 
designed to degrade slowly whilst the inclusion of autologous cells is anticipated to 
produce a new extracellular matrix (ECM) to remodel fascial tissue for long-term 
restoration of the mechanical properties.  
 
Biodegradable poly-(L)-lactic acid (PLA) scaffolds were identified as the candidate 
material being more cell compatible in vitro than materials currently used to treat SUI 
and POP, and with mechanical properties close to the range of native tissues of the 
pelvic floor.  
A comparison of oral fibroblasts and adipose-derived stem cells (ADSCs) showed 
similar results when these cells were cultured on PLA scaffolds to develop a TERM in 
terms of metabolic activity, ECM production and mechanical properties. Of the two, 
ADSCs were chosen for further experiments since these cells have been shown in the 
literature to have regenerative potential and also to be immunosuppressive and to 
stimulate angiogenesis. The number of cells seeded on the scaffolds, the period of 
culture and culture conditions were optimized for the production of the best TERM 
candidate. On the other hand, no significant effects were found when exploring 
chemical and mechanical stimulation with the aim of increasing ECM production. 
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The host response against the PLA scaffolds implanted cell-free and with ADSCs was 
studied in rats. The acute host response showed that after an inflammatory response, 
new collagen ingrowth and blood vessels were developed in all samples. 
Work was then focussed on the modification of the electrospinning rig to develop a 
variety of PLA scaffolds with different mechanical properties due to different fibre 
configuration. Finally, the potential of ADSCs to develop the TERM was assessed using 
cells from different donors, as well as examining whether this potential was preserved 
when these cells were rapidly isolated from fat using an enclosed system.  
 
In summary, we identified a suitable candidate material, cell candidate and culture 
conditions to develop a TERM designed for pelvic floor repair. Then, an initial animal 
study suggested a host response against our TERM leading to constructive remodelling 
for integration into the native tissues. Finally, a range of PLA scaffolds were produced 
with improved mechanical properties and preliminary data showed the potential to 
rapidly isolate ADSCs which were used to develop a TERM in vitro. 
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1.1 Stress urinary incontinence (SUI)  
 
1.1.1 Epidemiology 
 
Urinary incontinence (UI) is a problem affecting the quality of life of more than 200 
million women in the world (1), exceeding that of other chronic pathologies such as 
arterial hypertension and angina pectoris or diabetes (2). This condition is described as 
urine leakage which occurs when the pressure in the bladder exceeds the pressure within 
the urethra. Micturition is normally regulated by neuromuscular mechanisms and an 
alteration in any of these anatomic and neurologic mechanisms can induce urinary 
incontinence (3).  
 
Stress urinary incontinence (SUI) is the most common type of UI described as a leakage 
on effort or exertion by increased abdominal pressure (4). Intrinsic urethral sphincter 
muscle weakness and anatomical failure of the urethral support are the main problems 
associated with the development of SUI. Insufficient closure pressure in the urethra 
during physical effort may lead to leakage of urine. SUI is defined clinically, by the 
International Continence Society (ICS), as “the involuntary leakage of urine on effort or 
exertion, or sneezing or coughing” (5). 
SUI is in contrast to urgency urinary incontinence (UUI), whereby a sudden compelling 
desire to void occurs which is difficult to defer. UUI is defined as an involuntary loss of 
urine accompanied by or immediately preceded by a sudden, strong desire to void. This 
is explained as result of involuntary bladder contraction, which in turn, has been 
proposed to be due to loss of the viscoelastic features of the bladder. This often shows 
detrusor overactivity during urodynamic testing.  
SUI signs may be reproduced by the clinician on examination; however, if there is 
disparity in symptoms or surgical intervention is contemplated, urodynamics is 
considered beneficial. The urodynamic definition of incontinence proposed by the ICS 
is “the involuntary leakage of urine during increased abdominal pressure, in the absence 
of a detrusor contraction”. 
In addition, while UUI predominates in old women, SUI is most common in young and 
middle age women (6). Occasionally both types of incontinence can occur 
simultaneously. 
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Since definitions for different UI disorders were not established by ICS until 2002, 
reports of the prevalence of SUI are variable. In a meta-analysis of 48 studies, the 
prevalence of UI was reported to be 16% for women younger than 30 years and 29% for 
women aged 30 to 60 years (7). The authors found SUI to be more common than UUI, 
with 78% of women having SUI versus 51% with urge urinary incontinence, and 27% 
of them having mixed urinary incontinence. Each year, an estimated 135,000 women 
undergo surgery for urinary incontinence in the United States alone (8). The estimated 
annual cost to the US economy is approximately $19.5 billion (9). Moreover, it is 
believed that more than half of women suffering from SUI are embarrassed by the 
condition, are unable to mention this to their healthcare provider or may even accept 
some incontinence as a part of the ageing process (10). 
 
SUI can be divided into 3 grades (11): 
1. Leakage on severe stress i.e. Coughing laughing or sneezing. 
2. Leakage on minimal stress e.g. walking, running. 
3. Total incontinence. 
Questionnaires like the Incontinence Impact Questionnaire (12) are used to characterize 
the impact caused by the incontinence symptoms on quality of life. As a measure of 
severity, the most widely used indexes are the Sandvik Severity Index (13) and the 
International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) index 
(14); both have been validated (15). 
 
 
1.1.2 Aetiology 
 
The continence apparatus has been described as the anterior vaginal wall, surrounded by 
muscles and fascial tissues. Levator ani muscles connect to anterior vaginal wall at 
pubovaginalis level, point where muscle contraction retracts anterior vaginal wall to 
support and make pressure on the urethra (16).    
On the other hand, the sphincter unit, including multilayered urethra and alpha-
adrenergically innervated vesical neck, also gives an important continence control. 
Where the urethra crosses the bladder, it is surrounded by the muscle of the trigonal 
ring. This sphincteric unit extends throughout the proximal two-thirds of the urethra and 
is composed of outer striated urogenital sphincter muscle (rhabdosphincter), with a 
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middle circular smooth muscle and an internal longitudinal layer. In 1980 was already 
showed the importance of each urethral layer for urethral closure pressure, and all layers 
were similarly relevant for the contraction of the urethral sphincter including 
submucosal plexus, which is highly vascularised (17). Submucosal vascular plexus is 
also very important for the neural mechanism of the entire complex which is not well 
understood (16). 
In women integrity of the intrinsic urethral sphincteric mechanism is a major factor in 
maintenance of continence. Several researchers agree on “intrinsic sphincter deficiency” 
as a problem of the three different urethral elements which include pudendal 
innervation, striated sphincter mass and function, urethral smooth muscle, mucosa and 
submucosal cushions (18).  
 
Figure 1.1 A view of 
the hammock theory by 
Ulmsten, the supporting 
structures to the 
urethra provide a 
backboard upon which 
the urethral contraction 
may be stabilised 
(Image obtained from 
Wein: Campbell-Walsh 
Urology, 10th ed. 
Chapter 60. Elsevier). 
 
However, the Integral theory of female urinary incontinence, put forward by Petros and 
Ulmsten, proposes that the cause of SUI is connective tissue laxity in the vagina itself, 
or in its anterior and/or posterior supporting ligaments (19). This produces urethra 
mobility, and contraction of pelvic floor muscles is unable to compensate the laxity of 
the connective tissues to give functional support and pressure to the urethra.  
It is believed that both intrinsic sphincter weakness and para-vaginal connective tissue 
(also called para-urethral connective tissues or endopelvic fascia) weakness may co-
exist in some degree in women with SUI (20). 
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For a better understanding of the anatomy of the urethral continence elements Delancey 
described the hammock model (21). The endopelvic fascia, which is found between the 
anterior vaginal wall and the urethra, is attached to both of these structures holding the 
urethra as a hammock (figure 1.1). In addition to this, the endopelvic fascia extends 
from the vaginal apex to perineum and laterally forms the arcus tendinius at both sides. 
Immediately anterior to the proximal urethra are condensations of endopelvic fascia. 
These are dense enough to be recognised and are termed the pubo-urethral ligaments 
(figure 1.2).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Inferior view of the pelvic floor of an elderly female cadaver showing the 
Pubic bone 1, right pubo-urethral ligament 2, lateral endopelvic fascia forming the 
arcus tendinius fascia 3, and central endopelvic fascia 4 (Image obtained from Mostwin 
JL: Current concepts of female pelvic anatomy and physiology. Urol Clin North Am 
1991;18:175-195). 
 
The levator ani muscles run bilaterally from the superior ramus of the pubis to the spine 
of the ischium and coccyx. The middle fibres are attached to the rectal sphincter 
muscles and the anterior fibres descend upon the side of the vagina (figure 1.3). The 
fascial tissue covering the levator ani consists of two leaves: the endopelvic fascia 
(abdominal side) and pubo-cervical fascia (vaginal side). The two leaves fuse to insert 
into the arcus tendinius creating a hammock of support suburethrally (figure 1.1).  
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In summary the posterior urethra is intimately connected to the anterior vaginal wall by 
the endopelvic fascia, which is connected to levator ani muscle complex by the arcus 
tendinius fascia pelvis (ATFP). The levator ani muscles, in combination with the 
endopelvic fascia perform an important part of the continence mechanism in women 
(21). Contraction of the levator ani pulls the vagina against the posterior surface of the 
urethra thus closing it (22).  
 
Figure 1.3 The role of the endopelvic fascia, arcus tendinius and levator ani in support 
of the urethra and bladder (Image obtained from Wein: Campbell-Walsh Urology, 10th 
ed. Chapter 60. Elsevier). 
 
In a series of magnetic resonance imaging (MRI) studies, it has been shown that the 
anterior and posterior walls of the bladder neck are pulled apart due to unequal 
movement of the opposing walls during stress (23, 24). The urethral sphincter is 
connected to the bladder neck by the suburethral complex suggesting that weakness at 
this point may be sufficient to permit distraction of the anterior and posterior urethral 
walls during rotational descent. Women with SUI have shown radiological features 
suggesting impairment of urethral support such as an increased urethrovesical angle, 
bladder neck and urethra hypermobility (25), reduced functional urethral length (26) or 
disruption of periurethral ligaments or defects in endopelvic fascia (27).  
In summary, the essence of urethral support in women is multifaceted and both 
endopelvic fascia and pelvic floor muscle tone acting under neural control are 
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responsible for continence. On the other hand, as above, an intrinsic sphincteric 
deficiency can lead to incomplete sphincter closure thus predisposing to SUI (28, 29). 
 
1.1.3 Risk factors 
 
Risk factors for development of SUI are classified as predisposing factors, obstetric and 
gynaecological factors, and promoting factors. Race (Caucasians are the most affected), 
genetics (other females in the same family with incontinence), congenital factors (i.e. 
ectopic urethra) and neurologic diseases are the main predisposing factors. Pregnancy, 
vaginal delivery (where the weight and number of babies are relevant), pelvic surgery 
and radiation (nerve and/or muscle damage), and pelvic organ prolapse (POP) are the 
most common obstetric factors affecting supportive tissues of the urethra or muscles of 
the urethral sphincter (30). Finally, there are age co-morbidities (i.e. diabetes, vascular 
disease), obesity, constipation (increase in intra-abdominal pressure), menopause, and 
medications which are all promoting factors (31-33).  
 
Since the prevalence of SUI is increased in women over the age of 50 (4), ageing is 
associated with an increased risk of SUI (34). Elderly women may be affected by loss of 
muscle tone and long term effects of denervation injuries sustained during childbirth 
leading to urethral sphincter deficiency; on the other hand, changes in hormonal status 
leading to alterations in collagen of para-vaginal tissues may also disrupt the continence 
apparatus (35, 36).  
However, it has been difficult to prove a link between the natural menopause and 
increasing risk of SUI (37, 38). Also there is no evidence for hormone replacement 
therapy reducing the risk of UI (39-41). 
 
POP itself is considered as a risk factor of SUI (30). The prolapsed organs may give an 
extra tension producing laxity of the para-vaginal connective tissues or innervating the 
urethral sphincter.  
Likewise body mass index (BMI) has been considered to be an important risk factor of 
SUI (42). It is proposed a laxity of support tissues after chronic strain and/or the 
existence of a greater abdominal pressure (34). Women in the highest quartile of BMI 
are 2-4 times more likely to have urinary incontinence than those in the lowest (39). 
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Furthermore, few studies agree with pregnancy and vaginal delivery as major obstetric 
risk factors for SUI. Childbirth leads to SUI due to denervation of sphincter muscles 
which progresses with age (43, 44). Child delivery may loosen para-vaginal connective 
tissues too, affecting the continence apparatus. Some studies demonstrated increased 
risk of SUI after childbirth via caesarean section compared with nulliparous women, but 
even greater comparing last group with women giving birth vaginally (34, 45). Finally, 
epidemiological studies have shown approximately half of all women develop transient 
UI during pregnancy and post partum the prevalence of UI is 9-31% (18).  
 
Additionally medical co-morbidities such as the length of time with type II diabetes 
mellitus have been found to confer increased risk of SUI (31). Other co-morbidities 
presenting risk include neurological disorders and connective tissue disorders (32, 33). 
 
1.1.4 Treatments 
 
Since SUI has a multifactorial aetiology, there is no unified treatment for all patients 
and there is a necessity to adjust treatments to each case.  
Conservative treatments of UI are weight loss, fluid management, and pelvic floor 
muscles exercises. However, in advanced grades of SUI, pharmacological and surgical 
treatments are required. 
Alpha adreno-receptor agonists (ephedrine and norephedrine) and mixed 
pharmacological agents (duloxetine and imipramine) have been used for SUI with the 
aim to stimulate muscle contraction of the urethral sphincter. Also, injection of bulking 
agents into the suburethral tissues and placement of pessaries inside the vagina has been 
used to give urethral support/pressure. 
Surgical treatments for SUI include urethral slings or tapes and retropubic suspensions 
(46) to support the structural continence mechanism of the pelvic floor. 
 
1.1.4.1 Non surgical treatments 
 
Changes in lifestyle such as weight loss together with supervised pelvic floor exercises 
are the first therapies for the treatment of SUI as stated by the National Institute of 
Clinical Excellence. SUI symptoms have been reported to be decreased after weight loss 
(47). Similarly, one study found subjective improvements in a range of 54-58% of SUI 
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patients after treatment with pelvic floor exercises, electrical stimulation or vaginal 
cones (48). Nevertheless, a placebo effect cannot be eliminated as urodynamic studies 
did not show differences between treated and untreated groups.  
Due to the described defects of the supportive tissues of the urethra, it has been shown 
that there are lower resting urethral pressures in SUI patients compared to age matched 
continent women (49, 50). For this reason alpha adreno-receptors agonists have been 
used to maintain urethral muscles tone as a pharmacological treatment of SUI (51). 
Especially ephedrine and norephedrine (18) are used to increased contraction of the 
urethra by release of noradrenaline on alpha adreno-receptors.  
Nevertheless, again, since SUI has a multifactorial aetiology, the urethral pressure 
increased by augmentation of the contraction of the urethral sphincter muscles may not 
be sufficient to improved SUI signs. Therefore, a patient, whose muscle tone is normal, 
but with an erratic continence apparatus due to para-vaginal fascial tissues defects may 
not notice a beneficial effect of alpha adreno-receptors agonists. Consequently, a 
systematic review in 2005 did not find evidence on the clinical benefit of these drugs, 
suggesting, as reported for pelvic floor exercises, a placebo effect improving just 
subjective parameters (52).  
With a similar approach, beta adreno-receptor antagonists have been used to enhance 
alpha adrenoreceptor action by beta adrenoreceptor blockade; however, this has not 
shown any  better effects than alpha adreno-receptors agonists (53).      
 
Duloxetine, a serotonin and noradrenaline reuptake inhibitor was reported to be a very 
promising treatment of SUI as a stimulator of the contractions of the external urethral 
sphincter (rhabdosphincter) (54). Beneficial effects of this drug were observed leading 
to a higher mean urethral pressure profile, maximal urethral closure pressure but not 
functional urethral length (55). High doses significantly decreased the frequency of 
incontinence episodes  in 64% of women; however, 15% of those discontinued the drug 
due to side effects such as nausea (56). More severe side effects such as psychiatric 
disorders have also limited their use (57-59).  
Imipramine, a similar mixed pharmacological agent, has been developed with promising 
results (60); however at present there are no published randomized clinical trials (RCTs) 
with this treatment. Surgery is considered more cost effective than pharmacological 
treatments (61). Drugs may be beneficial in patients with urethral sphincter deficiency 
but may not help in SUI patients with defects of para-vaginal fascial tissues.  
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Estrogen replacement in women increases collagen I and collagen III production in the 
connective tissues of the pelvic floor (62-64). This has been postulated to have a 
positive effect on the maintenance of the urethral pressure since estrogen receptors are 
expressed in the vagina, levator ani muscle, ligaments and fascia (18). However, one 
study showed a decrease in collagen concentration and collagen cross linking in 
urogenital tissues (65), and a recent review described a worsening of SUI, after estrogen 
therapy (66).     
 
Collagen has been injected, as a bulking agent, around the urethra to increase urethral 
pressure. A review reported a short term cure (67), but a multicentre RCT found 19% 
less  success with collagen injections compared to surgery (68). It has been postulated 
that collagen injections may be beneficial after failure of surgery (69), and it has been 
suggested that it should be used just as a follow up treatment (70). Women with SUI 
represent a complex population and for cost effectiveness, treatments have to be well 
established.    
Other urethral bulking agents have been used, ranging from autologous fat, carbon 
particles, calcium hydroxyapetite, ethylene vinyl calcohol copolymer, dextranomer and 
silicone based Macroplastique®. The last one consists of injected cross-linked 
polydimethylsiloxane which is encapsulated by fibrin leaving the fibrous capsule after 
reabsorption of the synthetic material (71). A recent study found better responses when 
using Macroplastique® compared to collagen injection in a blinded RTC with SUI 
women. On the other hand, a higher risk for urinary retention and urethral erosion were 
described in the Macroplastique® group (72). Moreover, its use as a first line treatment 
may complicate a consequent surgical intervention; therefore, again, this urethral 
bulking agent may be used just as a follow up treatment.   
 
Pessaries are commonly used to treat POP. However, they have been also used to treat 
SUI since they are introduced intravaginally to give structural support which may give 
urethral support and pressure as well. On the other hand, they are not commonly used to 
treat SUI since some studies have not found improvements in SUI symptoms when 
using pessaries (73).    
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1.1.4.2 Surgical treatments 
 
The main propose of surgical treatments are to give urethral support, and depending on 
each case, there are 5 categories of surgery treatments which are the main choices for 
most patients suffering SUI, especially for severe cases: 
 
1. Anterior vaginal repair or anterior colporrhaphy is used to treat POP (figure 1.4). 
If this prolapse is associated with incontinence then buttress sutures are placed 
on the bladder. After vaginal incision, the supportive tissue around the bladder, 
endopelvic fascia, is plicated to elevate the bladder neck and urethra giving them 
higher support. A meta-analysis has reported the success rate of this procedure 
to be in a range of 67.8-72% (74). On the other hand a significant decline in the 
continence rates has been reported after 5 years and, nowadays, the procedure is 
not popular anymore (75). 
 
 
 
 
 
 
 
 
 
Figure 1.4 Anterior vaginal repair illustrating sutures plicating endopelvic 
fascia (Image obtained from University of Virginia Health System). 
 
2. Burch Colposuspension is used to fix the vagina into the space behind the pubic 
bone by lifting and suturing the para-vaginal fascial tissues (endopelvic fascia) 
from the anterior vaginal wall (figure 1.5). This surgical treatment is well 
established and continence rates of 83-87% have been reported after 1 year (76). 
Nevertheless, these rates were also reported to decline after 2 years to 51%,  in a 
multicentre randomised trial (77). The same study also reported complications 
with a rate of 39.8% patients developing POP after this procedure and 3.4% of 
patients requiring a second operation due to recurrence of incontinence.  
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Pubic  
bone 
 
Figure 1.5 Colposuspension 
illustrating sutures elevating the 
para-urethral fascia towards pubic 
bone ligaments (Image obtained 
from Dr. Cynthia Hall, 
Urogynecology and Pelvic 
Reconstructive Surgery).  
 
3. A needle suspension procedure is used to fix the bladder neck with sutures to the 
bone anchors of the pubic bone (figure 1.6), and sometimes using patch 
materials as well.  However, these procedures seems to have a very low success 
rates in most studies as reported in a 5 years follow up study with 12% of 
improvements, 5% of subjective success and 83% of failure (78).         
 
 
 
 
Figure 1.6 Needle suspension 
 illustrating  sutures form bladder 
 neck to pubic bone  (Image obtained 
 from Healthbase Online  Inc.).   
 
4. Tension-free tape procedures use synthetic materials as a strip to be placed 
beneath the mid urethra. This procedure is cost-efficient, minimally invasive and 
it takes only a few minutes to be performed. Nowadays, it is the most popular 
technique, with high success in recent years. Long tapes are passed under the 
urethra to the other side and through the retropubic space or through the 
obturator internus muscle and out of the obturator foramen, to be fixed by 
sutures to the anterior abdominal wall (figure 1.7). The last one is termed 
transobturator tape (TOT). Short tapes are equally passed under the urethra and 
attached to the abdominal wall using suspending sutures at each end of the tape 
or to the pubic bones wall attaching same sutures to bone screws (figure 1.7). 
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Cystoscopy is usually conducted after the operation to assess that the surgical 
procedure has not perforated the bladder.  
 
 
 
 
 
 
 
 
 
 
Figure 1.7 Different types of sling/tapes. 
 
5. Pubovaginal slings are biological materials which are implanted by procedures 
very similar to tension-free tapes (figure 1.7). These slings are placed beneath 
the bladder neck applying an adequate amount of tension to reinstate continence. 
A sling which is too tight may lead to urine retention and, conversely, a sling 
that is too loose may lead to recurrence of incontinence. Different materials have 
been used including autologous grafts, allografts and xenografts and different 
success rates are found with each. Cadaveric fascia has been reported to have 
success rates from 33 to 93% (79-81). For autologous rectus fascia, success rates 
are about 80% but depending on the level of patient selection and follow up (82, 
83). After 36 months, porcine dermis showed success rates of 57% (84). 
 
Currently, many companies have brought different tapes to the market. Different 
materials and kits are available resulting in different performance of the procedures. For 
instance, TOT are either placed from inside to out or from outside to in.  
Tension free vaginal tape (TVT- Ethicon®) has being the most used with more than 1.4 
million procedures around the world. In addition, TVT has been shown to have higher 
objective success rates than TOT; although, the subjective cure rates were similar with 
decreased risk of intraoperative complications for TOT (85). Satisfactory success rates 
have been reported after 2 years of TVT implantation being 63% and with an 
improvement noted in another 20% of patients (86). Comparing TVT to porcine dermis 
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pubovaginal slings, success rates are similar, in terms of quality of life, but slings have 
been found to have higher  complication rates (87). 
 
Surgical procedures aim for the well performance of the continence apparatus since 
these treatments give better support to the urethra. If SUI was just related to urethral 
sphincter deficiency all these procedures may not have the elevated improvements 
shown.   
Nevertheless, all surgical treatments have the limitation of variations in success rates 
between clinicians since the procedures involve a subjective interpretation in each 
patient of how much the tissue is plicated or lifted to apply the adequate support of the 
urethra and restore the continence parameters.  
Although its name suggests tapes are holding the urethra without tension, TVTs actually 
apply a small pressure to the urethra. Once the tape is placed and before the vaginal wall 
is closed, the urethra is pushed to loosen the tape and to avoid high pressure which 
could lead to urinary obstruction. But similar to pubovaginal slings, how much the 
clinician pushes the urethra or leaves the whole thing tight depends on a subjective 
interpretation of each clinician and for each patient. 
 
Finally, just to mention that artificial urinary sphincters have been surgically implanted 
for over 30 years in about 100.000 men as a treatment for SUI after prostatectomy. This 
is a fluid-filled and solid silicone elastomer device which simulates normal sphincter 
function by opening and closing the urethra under patient control (88, 89). Although this 
device has shown to be an effective treatment for male, it is not useful for women being 
the main population suffering SUI.   
 
1.1.4.3 Surgical complications  
 
While intraoperative complications are normally associated with the performance of the 
surgery, postoperative complications of SUI surgery are related to the response of the 
patient to the surgery and/or host reaction against the material implanted.  
 
Intraoperative complications may involve injury of pelvic organs such as the urethra, 
bladder, ureter, bowel, but also, blood vessels and nerves.  
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The urethra can be damaged during transvaginal dissection or when passing trocars used 
to assist sling/tape procedures. This rarely occurs but it could lead to urethrovaginal 
fistula and infection and/or erosion of a tape.  
Bladder injury is more likely to occur with colposuspension compared to sling 
procedures (90). 
Uretric injury is also not common. Using mid-urethral tapes is very difficult to get this 
kind of complication; however, during colposuspension the ureter may be kinked. 
Again, bowel injury is very uncommon. Only in case reports has this been reported (91), 
and there may be higher risks during retropubic dissection for colposuspension or 
during trocar passage for tape/sling placement. 
Injury of blood vessels is more common since many vessels pass through the pelvis. 
Care is needed with the obturator fossa and pelvic side walls, and also with the iliac 
vessels and vascular pedicle of the bladder when passing needles and trocars. 
Finally nerve injury may occur during harvest of rectus fascia to use as an autologous 
sling or during the passage of trocars (92, 93). 
 
Postoperative complications include voiding dysfunction, vaginal or urinary tract 
damage and infection. 
Although urgency incontinence may develop after surgical procedures, more cases have 
reported urinary retention. After 4 weeks post-surgery, difficulty in voiding has been 
reported in 4-8% of colposuspensions and 3-11% of sling procedures (94). A maximum 
of 5% women have reported needing an intervention for voiding dysfunction after mid-
urethral tape procedures (91, 95).   
Due to the implantation of a non-degradable material, tape procedures are the ones most 
associated with damage to surrounding tissues after an excessive inflammatory 
response. The presence of a tape in the vagina is called vaginal extrusion. Higher rates 
of this complication have been reported when using multifilament synthetic materials 
compared to monofilament synthetic materials (96, 97), being 5% for the latter (98). 
Erosion occurs when the tape is found in the urinary tract which only occurs in less than 
1% of women treated with mid-urethral tapes (95, 98-100).         
There is always a small risk of infection after a surgical treatment this has been mainly 
reported in case reports of tape/sling procedures to treat SUI. This may be due to the 
inflammatory response against the foreign materials and/or their physical properties 
which may not allow the passage of immune cells to combat bacteria (101-105).  
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1.1.4.4 Surgical outcomes 
 
Outcomes measures used for any kind of treatment must be reliable, valid, interpretable 
and responsive to change.  
An ICIQ questionnaire is widely used and has been derived from other existing well 
validated questionnaires (18). The questionnaire scores symptom modules, quality of 
life modules and optional modules. 
Objective assessments of outcomes after SUI surgical procedures include urodynamics, 
cough stress test, pad tests and bladder diaries.  
Although urodynamics is the gold standard test used to objectively identify SUI, 
urodynamics did not show SUI in 15% of women with primary SUI (106). Moreover, 
this test is not reliable to determine the outcomes of surgical procedures, since 40% of 
women complaining about persistence of SUI after surgical treatment did not show 
leakage during urodynamics (107).  
Since there is no standardized bladder volume and number and force of coughs to 
perform a cough stress test, this may be used to assess cure but not to assess 
improvement in SUI (108). 
With different standardizations and durations of the test, pad tests have been used to 
define cure. Only 1 hour, 24 hours and 72 hours pad tests have been validated (109-
111). 
Also bladder diaries are not well standardized but this test seems to be a reliable 
assessment depending on its duration (112). 
 
 
1.2 Pelvic organ prolapse (POP) 
 
1.2.1 Epidemiology  
 
POP occurs when the female pelvic organs fall from their normal position into or 
through the vagina. 
Similar to SUI, POP is developed after weakness of the different supportive tissues of 
the pelvic floor affecting different vaginal segments including anterior and posterior 
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Rectocele 
Cystocele Uterine prolapse 
vaginal prolapse (cystocele and rectocele, respectively), apical or uterine prolapse, 
enterocele and perineal descent (113).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8 Illustrations of the prolapse of the different compartments (Images obtained 
from Cliveland Clinic). 
 
These are classified in 3 groups of prolapse depending on the compartment affected. 
Anterior prolapse entails the herniation of the bladder, the urethra or both into the 
vagina, resulting in a cystocoele, urethrocele or cystourethrocele respectively (figure 
1.8). Prolapse of the middle compartment refers to herniation of the uterus (figure 1.8). 
Finally, prolapse of the posterior compartment implies the descent of the rectum (figure 
1.8). These were defined by ICS in 2002 (3) leading to the quantification of the degree 
of prolapse, which is called POP quantification system (POPQ): 
Stage 0: no prolapse  
Stage 1: more than 1 cm above the hymen  
Stage 2: within 1 cm proximal or distal to the plane of the hymen  
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Stage 3: more than 1 cm below the plane of the hymen but protrudes no further 
than 2 cm less than the total length of the vagina  
Stage 4: there is complete aversion of the vagina 
 
It is difficult to determine the exact prevalence of POP since few studies have reported 
35% of asymptomatic patients having POPQ stage 2 and between 0.2%-11% having 
vaginal segments at or below the plane of the hymen (114-118). Nevertheless, 
prevalence of symptomatic POP is estimated to be between 3.6%-11.4% (119, 120). 
Recently, in an Australian study, the lifetime risk for a woman of requiring POP surgery 
was reported at 19% (121), and each year, an estimated 225,964 women undergo 
surgery for POP in the United States (122). 
 
1.2.2 Aetiology 
 
Weakness in the supportive connective tissues of the vagina leads to herniation of the 
underlying tissues into the vagina, and consequently, the prolapse of female pelvic 
organs. These include para-vaginal tissues and, as above, their weakness may lead to 
SUI too.  
 
 
 
 
 
 
 
 
 
 
Figure 1.9 DeLancey’s levels of support (Image obtained from DeLancey: The anatomy 
of the pelvic floor. Curr Opin Obstet Gynecol 1994;6(4):313-6). 
 
Conceptually, DeLancey described 3 vaginal supportive levels, which build up the 
support structure of the pelvic floor (123). Level I includes the cardinal-uterosacral 
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ligament complex. At level II, the middle part of the vagina (endopelvic fascia) is 
attached laterally to the ATFP pelvis which attaches to the superior fascia of the levator 
ani muscles. At the third level, the vaginal wall is connected to the perineal membrane 
and perineal body (figure 1.9).  
After an increase in abdominal pressure, the levator ani muscle contracts closing the 
genital hiatus; however, if the supportive tissues are weak, this muscular contraction 
does not prevent pelvic floor organ descent (124).   
 
To find out exactly which supportive structures are altered, several studies have been 
focused on describing alterations on the anatomy of the pelvic floor in women with 
POP. The complexity of this anatomy and different methods and techniques used it 
makes difficult to make a comparison between studies (125-127). These techniques 
include MRI, three-dimensional (3D) imaging and 3D ultrasound.  
Series of fast magnetic resonance images are obtained while voluntary pelvic strain is 
increased. This allows the measurement of the distance between different anatomical 
structures of the pelvic floor to quantify pelvic descent for better understanding of the 
SUI and POP pathophysiology. Imaging studies are not routinely used for clinical 
diagnosis since they are very expensive; however, these should be used in failed 
operations and complex prolapse for better surgical results (23). These methods also 
contributed to introduce the POPQ in 2002. Alternatively, some studies included in this 
thesis using these methods do not contrast between different POP stages since they are 
previous to 2002 (128).  
Electromyography is a technique which can be used during an urodynamic test to 
measure the electrical potential of skeletal muscle cells. This method is has been also 
used to determine functional deficiencies of the pelvic floor muscles; however, these 
studies have not been included in this thesis since they are not within the scope.      
   
The anatomy of the pelvic floor of 37 women with POP and 35 without POP was 
studied by MRI, matching both groups for age, BMI, childbirths, hysterectomy (uterus 
removal) and menopausal status. The study observed the descent of structures from 
level III, which includes the distal vagina, perineal body, apex and external anal 
sphincter, especially for the first two structures. The vagina apex was more ventrally 
displaced demonstrating its descent because of a shorter distance with distal vagina in 
subjects. Posterior vaginal wall showed longer length, such as larger urogenital hiatus 
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and levator ani muscle dimensions with a plate angle of the latest more caudally located 
in subjects. The length of the posterior vaginal wall suggests an alteration of the 
properties of the endopelvic fascia. All these differences were mainly observed in 
patients who belonged to an advanced stage POP (129). In addition, same anatomical 
alterations have been also found in other studies (23, 130).  
Changes of the dimension of the levator ani muscle were also found by 3D imaging in 
women with POP. Muscle was thicker in asymptomatic women than in women with 
POP, which indicates muscle distention in affected women (131). This has been also 
proved in other studies by MRI and ultrasound imaging (132, 133).  
 
DeLancey tried to summarize the association between supportive structures altered and 
the specific types of prolapse (134). While defects of supportive tissues from level III 
would be associated to rectocele (posterior compartment), weakness of endopelvic 
fascia and arcus tendinous, from supportive level II, would be related to cystocele and 
uterine prolapse from anterior compartments. Finally, defects on the uterosacral 
ligaments (supportive level I) would lead to descent of the uterus (middle 
compartment). 
 
1.2.3 Risk factors  
 
Risk factors for development of POP are similar to SUI risk factors affecting similarly 
supportive tissues of the pelvic floor.  
Any incident affecting innervation of the levator ani muscle or anal and urethral 
sphincters, and/or affecting structural properties of pelvic tissues may imply dysfunction 
of the pelvic floor. 
 
Although the interaction between age and hormonal/menopausal status has not been 
associated in the development of POP, ageing has been described as a major risk factor 
when POP was studied in women from different ages (135, 136). As above, ageing may 
affect further deterioration of pelvic floor denervation and may decrease the production 
of collagen of fascial tissues of the vagina (35, 36).  
 
Main injuries of pelvic floor tissues, such as tissue distension and/or denervation, are 
produced by obstetric factors, especially pregnancy and childbirth, which may lead to 
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the development of POP in the same way that affects SUI development. Many studies 
have reported the role of childbirth in the development of POP (137, 138).  
One study classified 120 women according to vaginal delivery or caesarean delivery, 
and 100% and 87.5% of them, respectively, developed POP after 6 weeks postpartum. 
In addition, POP was more advanced in vaginal delivery subjects (139). Another study 
has also stated a partial protection to develop POP when child delivery is performed via 
caesarean (114). Analyzing a database of over 17,000 women, it was found a risk of 
surgery to treat POP of 8.4 in women with a history of 2 or more pregnancies compared 
to nulliparus women (114). In addition, birth weight has been shown to have an effect 
on risk for POP (138, 140). 
 
Again similar to SUI, BMI has been related to the development of POP, as well as a 
family history of POP, heavy lifting at work (>10kg) and constipation (141). 
It has been suggested that excessive weight gain causes severe injury of the pelvic floor 
tissues, in women with POP, since weight loss does not significantly restore the normal 
condition (142).   
A few studies have found high rates of family incidence as an increasing risk for POP 
(143, 144), and genetic variants related to this have been reported (145). 
Finally, neurological disorders and disorders related to alterations of connective tissues, 
such as Ehlers Danlos and Marfan’s syndrome, have been shown to promote POP 
development (33, 146). 
 
1.2.4 Treatments 
 
Pharmacological treatments are not used for POP. Alternatively, again similar to SUI, 
the first treatment recommended in women with an early stage of POP is pelvic floor 
muscle training. If exercises do not improve the pathological condition the use of 
pessaries (mechanical devices such as rings or shelves) or surgical treatment are 
required, in women with more advanced POP stage. 
 
1.2.4.1 Non surgical treatments 
 
It has been described that once POP is detected in patients, exercise of the pelvic floor 
muscles may improve the condition only in a low percentage of these patients, since 
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most of them are not capable of adequate contracting the muscles at this stage (147). A 
systematic review has also summarized the limitations of pelvic floor muscle training 
(148).  
However, these exercises are still being recommended for many patients since they have 
been shown to cause an improvement in objective and subjective symptoms in almost 
50% of patients compared to a control group (149). On the other hand, pelvic floor 
muscle training needs supervision from a specialist, as well as a lifestyle advice to be 
given and this may vary between centres and patients.   
 
Pessaries are placed intra-vaginally to provide structural support. Many different types 
have been developed but normally their shape is similar to the outer ring of a 
diaphragm. They can be placed temporarily or permanently and, although, they are 
more commonly used for prolapse of the uterus, they can be used to treat cystocele, 
rectocele and SUI.  
Pessaries are widely used, and this has been elucidated from a survey in USA describing 
a preference for pessaries to surgical treatment (150). Estrogens can be prescribed, when 
pessaries are placed, to prevent the progression of POP (151).  
Furthermore, a study with 203 women found a 30% of improvement of urinary 
symptoms after pressary treatment (73). 
Nevertheless, success rates of non surgical treatments, such as pelvic floor exercises and 
pressaries, are not significantly relevant and surgical treatments are required in many 
patients with POP, particularly, in severe cases. 
 
1.2.4.2 Surgical treatments 
 
Surgical treatments for POP are classified in 3 types depending on which vaginal tissues 
are repaired: 
 
1. Colporrhaphy or anterior vaginal wall repair, which has been described 
previously for the surgical treatment of SUI (figure 1.4), is also used to treat 
prolapse of the anterior compartment such as cystocele, urethrocele and para-
vaginal defect. Furthermore, when this procedure is performed to treat POP a 
mesh/graft material is used to reinforce the plication of the para-vaginal fascia.   
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When a mesh/graft is used in a colporrhaphy the recurrence of prolapse of the 
anterior compartment is half compared with same procedure when these 
meshes/grafts are not used, being 14% and 30% respectively. Looking at the 
type of mesh/graft used, a higher failure was found when using absorbable 
synthetic meshes (29%), followed by porcine dermis graft (18%) and to a lesser 
extent with non-absorbable meshes (9%). The same trend was observed after 
failure, by recurrence or development of other prolapse in 9% of cases using 
absorbable synthetic meshes, 3% for biological grafts and 1% for non-
absorbable synthetic meshes (152).  
Other people have shown a decreased risk of recurrence of POP 1 year after 
performance of colporrhaphy when using biological or absorbable synthetic 
materials (153), suggesting the relevance of the individual host response against 
these materials in the first months. In addition, similar to tape vs slings used to 
treat SUI, erosion rates were associated with the use of non-absorbable synthetic 
materials compared to the non-absorbable synthetic materials, being 14% and 
2.9% respectively.    
Mesh contraction is another problem which has been reported after colporrhaphy 
procedures which may lead to failure of the structural function of the mesh. 
About 50% of contraction has been observed by ultrasound measurements after 
implantation of non-absorbable polypropylene (PPL) meshes (154). 
 
2. Upper vaginal repair is the term for the surgical repair of the uterine prolapse 
which is associated with defects of the uterosacral ligaments. This type of 
prolapse normally occurs in women above the age of 50, and the main choice of 
surgical treatment is the hysterectomy (uterus removal) with vaginal apex 
fixation, since these women may already be beyond the reproductive age. In the 
USA, hysterectomy is the main recommendation for women over 55 age 
suffering uterine or vaginal prolapse (155).  
 Vaginal sacrospinous colpopexy consists of the suture of the vagina in 
suspension from the sacrospinous ligament to the levator ani muscle, and it is 
used to treat vaginal vault prolapse which is the main complication associated 
with hysterectomy (156). Nevertheless, the incidence of vaginal vault prolapse is 
very low being between 0.2% and 4.3% of women who have had a hysterectomy 
(157). On the other hand, since vaginal sacrospinous colpopexy increases 
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abdominal pressure of the anterior compartment, this procedure has a risk of 
incidence of cystocele between 20% and 30% (158). 
When uterine prolapse happens in younger women, a sacrohysteropexy is 
performed by suturing the uterus to the sacral bone in a tension free fashion. 
Although it has been reported that more complications are associated with 
sacrohysteropexy compared to hysterectomy (159), the first surgical treatment is 
performed in younger women to preserve their fertility.  
Sacrocolpopexy is similar to vaginal sacrospinous colpopexy procedure, which 
is performed after hysterectomy, but consists in using a mesh/graft material to 
suture under suspension the vaginal vault to the ligament of the sacrum (figure 
1.10). Sacrocolpopexy has shown better surgical outcomes, with less risk of 
developing SUI after surgical treatment, compared with vaginal sacrospinous 
colpopexy (160).  
 
 Figure 1.10 Sacrocolpopexy illustrating the mesh/graft material sutured from 
the vaginal vault to the ligament of the sacrum (Images obtained from Cliveland 
Clinic). 
 
Different mesh materials have been used in the sacrocolpopexy procedure such 
as cadaveric fascia lata and non-absorbable PPL mesh. Comparing both meshes, 
none of them have been reported to result in recurrence of vaginal vault 
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prolapse; however a higher incidence of prolapse in other sites has been 
associated with cadaveric fascia lata (161). On the other hand,  when using non-
absorbable materials, erosion has been observed with  rates described to be 
between 2% and 11% (162). Cadaveric fascia lata does not pose a risk of erosion 
but failure and recurrence are more probable because this material can be 
reabsorbed very quickly and this is concluded as there have been no remains of 
this material found at reoperation (79, 163).         
 
3. Posterior vaginal wall is repaired to treat prolapse of the posterior compartment 
of the pelvic floor which basically involves rectocele. Usually a colporrhaphy is 
performed by plication of the connective tissues of the posterior vaginal wall, 
consisting in fascial tissues which are connected to the rectum by the third 
supportive level described by DeLancey, the perineal membrane and perineal 
body.  
Levatorplasty can also be used for same purpose involving plication of the 
levator ani muscles over the rectum.    
Colporrhaphy for the posterior vaginal wall repair can be approached from the 
vagina or anus. Trans-vaginal repair has shown less failure rates and recurrence 
of prolapse, but only when looking at enterocele (prolapse of the intestine) 
development (160), having similar success rates for rectocele repair. 
As for the repair of the anterior vaginal wall, a mesh/graft can be used for the 
treatment of rectocele when performing posterior colporrhaphy to reinforce the 
supportive tissues. Same rectocele recurrence has been reported when comparing 
colporrhaphy with or without an absorbable mesh (158). On the other hand, non-
absorbable synthetic grafts have shown high rates of anatomical cure and 
functional outcomes (164, 165) when used for posterior vaginal wall repair; 
although, again, they are more associated to complications (166). 
 
1.2.4.3 Surgical complications 
 
Surgical complications of POP are classified, as for SUI, as intraoperative and 
postoperative complications. 
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Intraoperative complications are the same as described for SUI which may involve 
direct injury of pelvic organs, blood vessels or nerves, depending on the approach and 
procedure. 
The main postoperative complication is the recurrence of the specific prolapse 
surgically treated, or any other POP derived from the procedure.  
Also SUI has been described to be a complication after surgical treatment of POP; 
although, it has been postulated that SUI may be developed at the same time as the 
prolapse condition, by an excessive distension or displacement of the vaginal wall 
which has an important role on the continence apparatus. Alternatively, a prolapsed 
organ itself may apply pressure on the urethra masking the SUI condition, which would 
only be expressed after the POP repair (167). Nevertheless, since similar surgical 
procedures are performed to treat both disorders, prolapse repair has always been 
considered to reduce the risk for SUI development (168, 169).  
Abdominal sacrocolpopexy has also reported a small risk of ileus and small bowel 
obstruction (170). 
Finally, although synthetic non-absorbable materials have shown better success rates 
than biological and absorbable synthetic materials, the last two types of materials are 
associated to low rates of complications. Non-absorbable materials may lead to erosion 
and extrusion, as well as contraction of these materials has been reported. 
 
1.2.4.4 Surgical outcomes 
 
As for SUI, POP evaluation is divided into subjective measures, including validated 
questionnaires, and objective measures after clinical examinations which are the same 
used to determine the POP stages described above. 
There are 3 main validated questionnaires which assess POP symptoms and quality of 
life (18). 
Anatomical measurements are used to determine the persistence of POP; however, as 
above, this is difficult to interpret since a high percentage of women with some degree 
of prolapse are asymptomatic (171). Furthermore, patients after surgical treatment of 
POP are never going to present POP-stage 0, which is only found in healthy parous 
women (women having given birth to one or more children) (117).           
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1.3 Comparison of SUI and POP 
 
Including both conditions, pelvic floor disorders affect nearly one third of pre-
menopausal women and nearly half of post-menopausal women (172).  
Furthermore, it has been reported that the lifetime risk of undergoing a surgical 
procedure for SUI or POP by age 80 is 11.1%, with 30% of these requiring additional 
surgical procedures for recurrence of the same condition (173). 
 
As above, POP can be a risk factor for the development of SUI. Same anatomical 
structures and tissues affected in the prolapse of the anterior vaginal wall may lead to 
SUI as well. On the other hand, a prolapsed organ itself from another compartment, may 
lead to laxity of the endopelvic fascia and consequent alteration of the continence 
mechanism. So, while the first event may lead to development of both conditions at the 
same time; in the second event, the prolapse occurs first which may cause later the 
incontinence condition. 
   
Two types of prolapse of the anterior vaginal wall have been described (174). 
Distention of the anterior vaginal wall entails weakness of para-vaginal tissues 
supporting the urethra and bladder too. Alternatively, displacement of the anterior 
vaginal wall is attributed to the detachment or elongation of the ATFP. 
As previously described, the continence apparatus is composed by levator ani muscle 
attached by arcus tendinius ligaments to the fascia of the anterior vaginal wall which, in 
turn, is connected to the urethra. Therefore, after levator ani contraction the vaginal wall 
gives urethral support/pressure.  
Both types of prolapse of the anterior vaginal wall may have, as above, a parallel effect 
on SUI condition. And, while the distention of the anterior vaginal wall affects the 
continence mechanism at the supportive level of the urethra made by the para-vaginal 
connective tissues (endopelvic fascia); the displacement of the anterior vaginal wall 
affects the continence apparatus at the level of the arcus tendinius ligaments.   
 
As mentioned previously, any type of POP can mask SUI symptoms by pressure from 
the prolapsed organ on the urethra. That is why SUI has been described after POP 
surgical treatment as a surgical complication.  
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In one study 151 women with POP were analyzed by MRI, and it was found that higher 
levator ani defects were associated with obstructive voiding and smaller SUI symptoms. 
Also, by ultrasound during coughing, same patients did not show SUI symptoms (175).  
Nevertheless, levator ani defects have also been associated with SUI when comparing 
anatomical measurements between primiparous women with or without SUI and 
nulliparous asymptomatic women. By ultrasonography during coughing, vesical neck 
movement, which is associated with a defect of the levator ani, was found only in the 
primiparous group with SUI. Moreover, no differences on urethral closure pressure 
were observed between groups (16). Other studies also found anatomical differences in 
levator ani muscle only in women with SUI who had delivered at least one child (176, 
177), but not in middle age or elderly SUI nulliparous women (178). 
 
On the other hand, urethral closure pressure seems to be the main problem associated 
with SUI. 103 incontinent women and 108 asymptomatic women were analyzed in the 
Research On Stress Incontinence Study (ROSE). After matching BMI and using a 
cough predictor, 61% of the incontinent women  showed significant differences on 
urethral closure pressure, but not on levator defects (179). Furthermore, SUI in aging 
women has been associated with a decrease in the fibres of the circular smooth muscle 
of the external urethral sphincter (rhabdosphincter) when compared with young women 
(180). Another study found the same tendency of a reduction of the urethral function in 
elderly population due to a decrease in the striated muscles cells of their 
rhabdosphincter (181). 
 
Consequently, while anatomical alterations are obviously observed in women with POP 
and these can be also found in women with SUI due to obstetric factors, a decrease of 
urethral closure pressure seems to be the main pathological alteration for development 
of SUI.  
DeLancey postulated after looking at young and old nulliparous populations (16) an 
association between the development of SUI in young women and levator ani muscle 
anatomical defects, due to obstetric factors such as pregnancy and vaginal delivery 
whereas, in the elderly population SUI would be related to a decrease of the urethral 
closure pressure (16). 
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In summary, POP commonly associated to anatomical alterations, may be more likely to 
develop in young women by a traumatic process such as pregnancy and vaginal 
delivery. In addition, either anterior vaginal wall prolapse or overstretching of the para-
vaginal tissues made by a prolapsed organ itself, which in turn are affected by 
anatomical alterations, may be responsible of SUI in primiparous women due to a 
traumatic process.  
Alternatively, SUI is more likely to occur in elderly women with a higher prevalence, 
since the main problem with this condition is a decrease in urethral closure pressure 
which is most likely due to a decrease in the quality of the fascial para-vaginal tissues 
and/or urethral sphincter innervations, attributable to hormonal and aging factors.  
 
Finally, although this section tries to allocate to each aging population different risk 
factors and pathological process for development of SUI and POP, both conditions have 
a multifactorial aetiology. Therefore, traumatic process in young women can also lead 
to a low level of urethral dysfunction, damage of para-vaginal tissues or anatomical 
alterations, which may be worsened by ageing leading to SUI and/or POP in elderly 
women.  
 
 
1.4 Histology of the supportive tissues of the pelvic floor 
 
The histology of the fascial and muscular tissues of the supportive tissues of the pelvic 
floor has been widely investigated to explain differences between women with and 
without SUI and/or POP in terms of quality of these tissues. Similar to anatomical and 
functional differences described in previous sections, the histological differences may 
explain the development of SUI and POP compared to the asymptomatic group and 
differences between young and elderly populations. 
 
When we specify the supportive tissues of the pelvic floor, usually, we are referring to 
the subepithelial connective tissue and a layer of smooth muscle, which together give a 
fibromuscular support, surrounded by loosely connective tissue, adventitia (182). 
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Moreover, the two main risk factors, including ageing and vaginal delivery, for 
development of SUI and POP have shown pathological defects of different connective 
and muscular tissues of the pelvic floor. 
Light and electron microscopy have been the main techniques used to look at the 
pathological alterations of these tissues. 
Using Gibson and Masson’s trichrome staining and electron microscopy, alterations in 
the composition of all these tissues have been described when looking at biopsies from 
the cardinal ligaments of 10 aging women with POP and 10 asymptomatic aging 
women, matching for the same age, gravid number, parity times, number of pelvic 
surgeries and menopausal status. Loose connective tissue was described in POP patients 
as production of less dense extracellular matrix (ECM) with fibroblasts more dispersed, 
and fibres from muscle tissue were packed less regularly and densely and more widely 
spaced (183).  
In rats, after vaginal delivery, the same findings were made in the connective and 
muscular urethral surrounding tissues by histological analyses (184).  
 
1.4.1 Connective/fascial tissue of the pelvic floor 
 
Connective tissue from the pelvic floor is composed mainly of fibroblasts, but also, it 
contains fat and mast cells and a few smooth muscle cells (figure 1.11). Fibroblasts 
synthesize the fibrillar components of the ECM which provide the mechanical 
properties of these tissues. Collagen and elastin are the main fibrillar components of the 
ECM of this tissue, which are embedded in a non-fibrillar ground substance 
(glycoproteins and proteoglycans) and are said to be in a process of constant dynamic 
remodelling (182).  
 
The weakness of fascial supportive tissues of the pelvic floor is central to the 
development of SUI and POP. Histological studies have contributed to determining the 
importance of the quality of suburethral fascial tissues to the development of SUI, or the 
quality of connective tissues from other supportive levels of the pelvic floor for the 
development of the different types of POP.  
In 1986 histological differences in connective tissues between 10 women with POP and 
10 women without POP were described related to laxity of pelvic tissues of the first 
group (128). Not only the synthesis of those structural proteins but also the balance 
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between the activity of the major proteolytic enzymes that degrade them and the 
inhibitors of proteolysis are important components to consider in studies of the 
pathogenesis of the connective tissues of the pelvic floor.     
Figure 1.11 Histological appearance of connective tissue, its cellular and extracellular 
matrix (ECM) components, and synthesis and assembly of the main fibrillar components 
of this ECM and its major proteolytic enzymes and inhibitors of proteolysis.   
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1.4.1.1 Collagen 
 
The synthesis and formation of collagen fibres were described many years ago by 
Ramachandran and Kartha (185). Fibroblasts synthesize a triple helical structure 
(procollagen) inside the endoplasmatic reticulum and then it is secreted into the 
extracellular space. This triple helical structure is the union of 3 collagen molecules 
inside of the fibroblasts which synthesise these. These twist together by numerous 
hydrogen bounds after post-translational modifications of proline and lysine residues. In 
the extracellular space, the triple helices become tropocollagen through covalent cross-
linking by carboxyl- and amino-terminal peptidases action. The tropocollagen 
undergoes self-assembly into collagen fibrils which are finally packed into fibres (figure 
1.11).  
 
In soft tissues there are 3 main kinds of collagen. The relative quantity of them 
determines the strength of the tissue. Collagen I, found in most connective/fascial 
tissues, gives the greatest resistance to tension. Collagen III is predominantly found in 
tissues subjected to periodic stress, as articulations, producing increased flexibility and 
distension (186). Finally, there may be small fibres of collagen IV which have very low 
strength and are normally found around blood vessels. All three collagen types 
copolymerize to form fibrils. The mechanical characteristics of the tissue are influenced 
basically by the ratio of collagen I/III; if it increases there is greater strength; if it is 
decreased then tissue laxity is increased (186). Increases in collagen III and IV generate 
thinner collagen fibres in connective tissues (187). 
 
Two mechanisms of collagen maturation have been described, as well as, how these 
processes are affected by aging. Both involve unions of fibres of collagen, but, while 
one is related to unions made by lysine aldehyde cross-links (188), the other, called the 
Maillard reaction or glycation reaction, binds collagen fibres by the addition of glucose 
leading to a stiffer tissue which is therefore more fragile (188, 189). 
The degradation of collagen is produced by pro-enzymes synthesized in fibroblasts and 
which need to be transformed in active form in the extracellular space through an 
enzymatic action related to growth factors, growth factors binding-proteins, cell surface 
receptors and cell-cell-adhesion molecules (190). The enzymes which influence 
collagen breakdown are known as matrix metalloproteinases (MMP). MMP1, 8 and 13 
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are neutrophil collagenases with the function to degrade fibrillar collagen. The resulting 
denatured peptides are degraded by gelatinases, MMP2 and 9. All these MMPs are 
inhibited by tissue derived inhibitors of metalloproteinases (TIMPs), serum-borne 
inhibitors (191) and also they can suffer spontaneous inhibition by autocatalysis (192) 
(figure 1.11).   
 
Collagen plays an important role in the mechanical properties of the connective tissue of 
the pelvic floor, which has been described in many studies. In elderly and menopausal 
women, the occurrence of POP is increased, at the same time, decreases of tensiometry 
resilience have been found at level I of supportive tissues of the pelvic floor (uterosacral 
ligament) (193). Lower mechanical properties of the endopelvic fascia of the vaginal 
wall from women with POP have also been reported, negatively correlated to age and 
menopausal status (194). 
It is difficult to summarise simply the relationship between the dynamic process of 
collagen synthesis and breakdown and POP development as different studies look at 
patients with different POPQ, or do histological analyses of biopsies taken from 
different places. However, all of these studies include women matched for age, BMI, 
parity, and pre or postmenopausal status. The review of these studies to describe 
changes in connective tissue properties in pelvic diseases is within the scope of this 
thesis, however this has been done in great detail by Kerkhof recently (124).  
Summarizing this and including some new studies, biopsies of fascia of the vaginal wall 
of women with POP and SUI have shown collagen I increase (195) and, in other study, 
collagen III decrease (196). At this anatomical point, a higher collagen concentration, 
probably of collagen I, could suggest more rigid connective tissue with impaired 
mechanical functions.   
It has been shown that uterosacral ligament samples from women with POP 
demonstrated reduced resilience. Only one study found increase of collagen I at this 
level by histological analyses (195). On the other hand, other study found a reduction in 
collagen I (197), and an increase in collagen III was described in another study for the 
cardinal ligament of women with POP (198). Therefore, at level I of vaginal supports, 
the ratio of collagen I/III may be decreased by collagen III augmentation which would 
increase the laxity of these tissues and, at the same time, the strength of the tissue may 
be reduced due to a decrease in collagen I. The ratio of collagen I/III is similarly 
reduced at the ligaments of the level I (ATFP) of women with POP by decrease of 
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collagen I (199), which has been also observed in peri-urethral ligaments of women 
with POP and SUI (200-202).  
Therefore, while in younger women the collagen I/III ratio is decreased in pelvic tissues 
as a result of damage to these tissues in obstetric trauma, in older women the para-
vaginal fascia show an increase in collagen I production as a result of altered 
metabolism leading to dysfunction of the continence apparatus.  
 
Contradictory results have been described for MMP activity. In the uterosacral ligament 
of women with POP the expression of MMP1, 9 (197, 203, 204) and MMP2 (205) is 
increased compared with the asymptomatic group, while other studies have not shown 
any differences for same enzymes or their  inhibitors (205, 206) between the two 
groups. The same occurs for fascial vaginal wall tissues. An increase of MMP2 and 9 
(207) activity in women with POP has been reported compared to the healthy 
population; however, it has been reported no differences for the expression of the same 
MMPs and its inhibitors (TMP2 and 3) in another study (208). 
Alternatively, these studies do not look at the different ages of the patients which may 
explain the differences observed. 
 
1.4.1.2 Elastin 
 
Elastin has an important role in the resilience of the connective tissue of the pelvic floor 
allowing the tissue to come back to its original position after elongation (209). While 
elastin biosynthesis is limited to a brief period of development in some tissues, in 
tissues of the reproductive tract its biosynthesis seems to be constant (210). This may be 
important for overstretching of these tissues during pregnancy and vaginal delivery. 
Lysyl oxidase (LOX) is the enzyme which catalyzes cross-link formation between 
tropo-elastin monomers in elastin assembly. The enzyme fibulin-5 is also responsible 
for assembling elastin fibres, and it has been shown that a decrease in fibulin-5 (211) or 
LOX (212) in women with POP may contribute to the development of this condition. 
Fibulin-5 is decreased in the connective tissue of women with POP obtained from 
uterosacral ligaments (213, 214), anterior vaginal wall (215) and para-urethral tissues 
(216). On the other hand, both enzymes have been demonstrated to be essential for 
recovery of POP. Fibulin-5 is increased in these same ligaments after injury and also in 
an advanced stage of POP (217).  
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Therefore it appears that a decrease in the production of fibulin-5 may contribute to 
developing POP in elderly women while damage of fascial pelvic floor tissues due to 
pregnancy or vaginal delivery leading to advanced POP in young women may lead to 
increased production of fibulin-5 for tissue recovery. 
 
Several studies analyzed women with and without POP, matched for the same 
conditions, looking at elastin production in the connective tissue of the pelvic floor, 
including the major review by Kerkhof (124).  
These studies seem to agree on the alteration in elastin metabolism in cardinal or 
uterosacral ligaments (198, 218, 219), and in anterior vaginal wall or peri-urethral 
fascial tissues (220-223) of women with POP. Some of these studies found a decreased 
expression of mRNA of elastin when culturing fibroblasts isolated from these tissues 
(218), or a decrease in total content of elastin of same tissues (219, 220). Similarly, 
other studies reported a reduction in endogenous inhibitors of elastases (222), or 
augmentation of elastolytic activity (223). 
 
1.4.1.3 Fibroblasts 
 
Fibroblasts from connective tissue of the pelvic floor are responsible for collagen and 
elastin synthesis which will affect the mechanical properties of these tissues.  
 
Endothelin-1 is expressed in fibroblasts with an important role in regulating their 
contractibility. Vaginal myofibroblasts from women with POP showed reduction in both 
their contractibility and the regulator of endothelin-1 expression compared to fibroblasts 
from asymptomatic women (224). Also, higher contraction of cells was observed in 
vaginal myofibroblasts from primiparous young women compared with vaginal 
myofibroblasts from multiparous young and old women with severe POP (225). 
 
Fibroblast proliferation and biosynthesis of the ECM components is thought to be 
regulated by the strength of the tissue. Greater strength found in prolapsed pelvic 
tissues, as previously described for fascial tissues of the vaginal wall, may promote 
fibroblast proliferation, as a healing natural process, in a disorganized manner with an 
altered cytoskeleton architecture (226). 
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Expression of mRNA for p53 protein is decreased in fibroblasts from cardinal ligaments 
of women with POP, and this leads to an inability of cells to enter quiescence (G0 
phase), and therefore, cells keep dividing and do not produce ECM components (218).  
Transforming growth factor-β1 (TGF-β1) is released from fibroblasts and stimulates 
collagen and elastin production. A reduction in TGF-β1 in fibroblasts from the vaginal 
wall has been reported in women with SUI (227). Previous in vitro studies showed 
similar collagen production from fibroblasts isolated from vaginal wall of women with 
and without POP (228) however, this may be explained by POP  being related to 
another pelvic anatomical level.  
 
1.4.1.4 Estrogens 
 
Estrogens have been used to treat SUI and POP by stimulating ECM biosynthesis (229-
232). Since aging is a major risk factor for development of both conditions, how 
estrogens may affect the quality of connective tissues of the pelvic floor has been 
investigated in women after menopause (233). 
 
The importance of the expression of estrogen receptors (ER) for ECM proteins 
production has been described (108 UI). However, while some investigators describe 
ER decreases in women with POP (233, 234), another study found ER increases in 
women with POP (235). 
Estrogen replacement in women leads to an increment in the production of collagen I 
and III (62-64). Estrogen replacement in Macaques with POP also induced increases in 
collagen formation in para-vaginal connective tissue (62). With estrogen replacement, 
an increment in  TIMP and a reduction in MMP was observed in para-urethral vaginal 
wall tissues of women with POP and without SUI, but not for patients with SUI 
associated with muscle dysfunction of the urethral sphincter (236).  
This suggests a positive role of estrogens in collagen metabolism. However, it has been 
postulated that estrogen replacement stimulates collagen synthesis leading to immature 
cross-links which can be easily degraded by MMP, resulting finally, in a reduction of 
the collagen fibres of the ECM (207). This may explain the, previously described, low 
success rates of estrogen replacement in women with SUI (237). On the other hand, this 
low success rate may also be explained by its lack of success in the treatment of women 
with urethral sphincter denervation, who would have normal collagen production.  
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It was postulated that both estrogen and progesterone (P4) are required to reduce MMP 
synthesis in connective tissue of the pelvic floor (238). Administrating 17β-estradiol 
(E2) and P4 in POP rat models and in the medium of fibroblasts isolated from the arcus 
tendinous of pre and postmenopausal women was shown to reduce MMP13 (239). Also 
a decrease of collagen I, and therefore a decrease of the ratio of collagen I/III, was 
found in ATFP of postmenopausal women compared to premenopausal women; 
however, after treatment with both estrogens and progesterone, collagen I and the ratio 
of collagen I/III were increased (199). 
Latent TGF-β1-binding protein-1 (LTBP-1) regulates TGF-β1 activation and 
stimulation of ECM production by fibroblasts. TGF-β1, LTBP-1 and elastin 
microfibrills have been shown to be regulated by hormone therapy due to significantly 
decrease production of LTBP-1 in fibroblasts isolated from women with SUI (237). 
Later, it was found that similar results were obtained by relaxin treatment; a hormone 
secreted during pregnancy. In both, fibroblasts isolated from asymptomatic women and 
women with SUI showed decreased TGF-β1 production at high levels of relaxin (227). 
All this may suggest a regulation of the quality of the ECM of the fascial pelvic tissues 
during pregnancy to allow elongation by loosening these tissues.   
 
Finally, the amount of E2 and follicle stimulation hormone (FSH) in serum was studied 
in 80 patients with SUI, matched for same characteristics and excluding POP. 
Premenopausal patients with SUI had more mobile proximal urethras and higher 
urethral pressures than postmenopausal patients with SUI. Only in postmenopausal 
patients, E2 did have a negative correlation with urethral mobility. In all subjects FSH 
was positively correlated with post void residual volume and flow times (240).     
The role of the female reproductive hormones in connective tissue disorders of the 
pelvic floor is complex and highly regulated and more studies are required for a better 
understanding. 
 
1.4.2 Muscles of the pelvic floor   
 
Muscles of the pelvic floor, such as the anterior vaginal wall, are composed of 
epithelium, lamina propia, muscularis and surrounded by adventitia. The smooth muscle 
fibres of the muscularis allow the attachment to the levator ani muscle (241).  
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Biopsies of the apex of the anterior vaginal wall from 11 women with POP and 8 
controls were analysed looking at smooth muscle alpha actin antibody staining and 
Masson’s trichrome. Vaginal smooth muscles from controls were packed in bundles 
orientated in circular and longitudinal directions. Women with POP showed smaller 
smooth muscles bundles, fewer in number and poorly orientated. Collagen fibres were 
dispersed around the muscularis in women with POP while dense and compact collagen 
was found in women without POP (242). In addition, a decrease in the expression of 
smooth muscle proteins, such as alpha actin, in the anterior vaginal wall of women with 
POP was reported (243).  
Culture of smooth muscle cells under hypoxia leading to cell apoptosis as consequence 
of denervation or trauma of the muscle showed an increase of cell migration and 
decrease of its contractibility capacity (244). Similar study demonstrated that 
myofibroblasts cultured under hypoxia may also modify the synthesis of collagen and 
hence the viscoelastic properties of the vaginal wall (245). On the other way around, it 
is possible that alterations of the collagen and blood vessels which surround muscle may 
have some effect on apoptosis of smooth muscle cells too (246).   
 
Smooth muscle can adapt its contractibility in response to mechanical strength or 
trauma (247).  
Caldesmon protein inhibits actin-activated myosin magnesium adenosine triphosphate 
activity, what is required to generate contractile force. Myosin phosphorylation (248) 
and calcium/calmodulin (249) are the main two mechanisms involved in smooth muscle 
contraction and are regulated by Caldesmon (250). This protein has been reported to be 
reduced in the vaginal wall of women with POP (251).  
A study of the contractile response of the anterior wall muscularis of 6 women with 
POP, at least at stage III (3 of them with posterior wall prolapse too), and 6 controls 
showed an increased contraction in controls compared to women with POP after 
administration of KCl and phenylephrine (adrenergic agonist). These results were also 
consistent with a lower percentage of co-localized alpha-1A-adrenergic receptors and 
smooth muscle alpha actin in muscularis of women with POP (252). A reduction of 
sympathetic regulation may suggest nerve damage of the endopelvic fascia. 
The smooth muscle of biopsies from uterosacral ligaments were studied in 9 women 
with POP and 9 women without POP, without significant differences in age, parity, 
menopausal status or hormone replacement therapy. Contradictory to above, the study 
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concluded there was an increase in mRNA expression of Caldesmon and an increase in 
the staining of Caldesmon associated with  smooth muscle actin protein in women with 
POP (214).  
 
Apoptosis of the cells of the uterosacral ligament has been reported in women with 
POP, what was thought to be due to a decrease in the nanovasculature of the smooth 
muscle (246). Nevertheless, this apoptosis has been attributed to a reduction in the 
mitochondrial genetic material (mtDNA). A decrease in mtDNA and an increase in a 
deletion of the mtDNA (base number 4977) were positively correlated to an advanced 
stage of POP comparing the uterosacral ligaments of 45 women with POP and 38 
controls (253).  
Mitochondrial damage was also found in the levator ani muscle of women with POP. 
Biopsies of levator ani muscle of 3 women with III and 3 women with IV POP stage, 
diagnosed by POPQ, were subjected to histological analyses. Many myofibres from the 
cytoskeleton of smooth muscle cells did not stain for cytochrome c oxidase and succinyl 
dehydrogenase suggesting mitochondrial dysfunction. Also, Gomori and Masson’s 
staining confirmed necrotic cells with loose myofilaments, again, a sign of abnormal 
mitochondrial accumulation (254).  
Oxidative stress may play a role in mitochondrial damage since myogenic or neurogenic 
damage of the levator ani muscle has been also observed after vaginal delivery (255), in 
premenopausal women (256), as well as for women with POP. This suggests that 
apoptosis and mitochondrial damage of muscular cells may happen due to a traumatic 
process, such as vaginal delivery, leading to functional deficiencies of the pelvic floor 
muscles and being a cause of SUI or POP. Nevertheless, this has not been demonstrated 
and, on the other hand, it needs to be considered that the progression of POP may 
damage these tissues leading to this apoptosis and mitochondrial damage.  
Finally, the Homebox A11 (HOXA11) gene for embryogenic development has been 
suggested to be involved in the maintenance of smooth muscle and collagen of the 
uterosacral ligaments, thus defects in this have been described as been a risk factor for 
the development of POP  (257).   
 
In summary, some of the anatomical and functional pathologies among young and 
elderly women with SUI and POP, which were summarized in the previous section, are 
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consistent with abnormal cellular features and changed quality of the ECM of the 
tissues of the pelvic floor.  
As previously described, dysfunction of the continence mechanism or development of 
POP in young women due to a trauma may develop in parallel. This fact is supported by 
injury of the ligaments of the anterior vaginal wall shown by a decrease of collagen I 
leading to higher production of collagen III. Collagen III is the first collagen type to be 
produced after injury, before tissue remodelling happens and stable fibres of collagen I 
are formed. Therefore, this augmentation of collagen III fibres may be associated with 
laxity of the ligaments of supportive level II of the vagina (arcus tendinius) leading to 
displacement of the anterior vaginal wall. In addition, similar results have been 
observed for the supportive ligaments of level I of the vagina leading to uterine 
prolapse. All this suggests that injury of ligaments is more likely to be the responsible in 
young women for the development of SUI and POP, which in turn, is more likely to 
occur due to a trauma in childbirth (table 1). 
On the other hand, dysfunction of the urethral sphincter and/or defective metabolism of 
ECM components of the supportive fascial tissues of the vagina and urethra are more 
common in elderly women. The connective tissue of the vaginal wall, endopelvic fascia, 
has been shown to become rigid due to poor remodelling of this tissue in ageing with 
higher amounts of collagen I (table 1). 
 
 Tissues 
affected 
ECM 
alterations 
Fibroblast 
behaviour 
Explanation 
Elderly 
women 
Endopelvic 
fascia 
Increment of 
collagen I 
due to 
maturation 
process 
Decrease of 
collagen 
production and 
contractibility 
Poor metabolism and 
ECM remodelling 
affecting viscoelastic 
properties (tissue more 
rigid)  
Young 
women 
Uterosacral and 
pubo-urethral 
ligaments and 
ATPF 
Decrease of 
the ratio 
collagen 
I/III  
Normal 
behaviour 
Tissue laxity due to 
collagen III production 
after traumatic process 
Table 1 Summary of connective/fascial tissues of the pelvic floor of women with SUI 
and POP. 
 
Looking at the cellular level, it is again suggested that trauma is likely to lead to the 
development of SUI and POP in young women since fibroblasts isolated from 
connective tissues of this group have shown a normal behaviour in terms of 
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contractibility and collagen production. These same two parameters were reduced when 
were analyzed for same cells isolated from aging women (table 1).  
Also when looking at the menopausal status, especially for women with SUI, 
premenopausal patients showed more mobile proximal urethras and higher urethral 
pressures than postmenopausal patients, suggesting again, higher functional and 
anatomical deficiencies for younger women due to obstetric factors, and pathological 
cellular activity for elder women.  
 
Finally, studies of the muscles of the pelvic floor also agree with previous results when 
comparing women with POP and asymptomatic women (table 2). Muscularis of the 
vaginal wall shows fewer fibres with poorer orientation compared with controls, such as 
less smooth muscle alpha actin and less contractibility of the smooth muscle cells, 
associated with altered metabolism of these tissues in elderly women. Alternatively, 
ligaments of the supportive tissues of the vagina show normal contractility when 
looking at the caldesmon protein, and only apoptosis and mitochondrial damage was 
reported in these tissues, associated with oxidative stress which may be related to a 
traumatic process. Again, tissues/ligaments are more commonly damaged in young 
women by obstetric factors.      
 
 Tissues affected Fibre behaviour Explanation 
Elderly 
women 
Vaginal wall 
muscularis 
Low number of fibres, poor 
orientated and showing low 
contractibility 
Poor cell 
metabolism  
Young 
women 
Uterosacral and 
pubo-urethral 
ligaments and ATPF 
Normal fibre contractibility but 
cell apoptosis and 
mitochondrial damage 
Oxidative stress 
after traumatic 
process 
Table 2 Summary of muscle tissues of the pelvic floor of women with SUI and POP. 
 
We can conclude from last two sections that POP may be more commonly developed in 
young women due to pregnancy and vaginal delivery leading to damage of the 
ligaments of the supportive tissues of the pelvic floor, while SUI is more likely to 
develop in elderly women due to abnormal cellular behaviour and ECM production of 
poor quality. When SUI is developed in young women may be associated with POP due 
to an obstetric process, whereas POP in elderly women may be only related to distention 
of the anterior vaginal wall due to abnormal production of ECM of the para-vaginal 
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connective tissue (endopelvic fascia) with impaired mechanical function. Finally, any 
condition which develops in young women may also become worse with age.  
 
     
1.5 Prostheses used for the surgical treatment of SUI and POP 
 
Although different supportive tissues of the pelvic floor may be affected on the 
development of SUI and POP, the same kind of anatomical, functional or molecular 
abnormalities are responsible for these conditions. Furthermore, these pathological 
alterations seen in different pelvic tissues have same aetiology and risk factors for 
young or elderly women and with SUI or POP. These may explain why similar 
treatments have been successfully used for both conditions.  
 
Pharmacological, hormonal, and bulking agent treatments have not shown good results. 
These treatments are not used for POP where surgical treatments are required since big 
anatomical structures, such as the different pelvic organs, need to be relocated and held 
in place.  
For SUI, pharmacological treatments to stimulate urethral sphincter contraction or 
hormonal and bulking agent treatments to reinforce the urethral support have been 
widely used. Both approaches have shown low success rates. Pharmacological 
treatments used for a woman with SUI due to dysfunction of the continence apparatus 
may not have beneficial effect; in addition there are reported side effects of the drugs 
used. Alternatively, hormonal treatment to simulate collagen production of the para-
urethral connective tissues or a bulking agent to similarly give more support and 
pressure to the urethra may not help those women with SUI due to denervation of the 
urethral sphincter. 
Pessaries have shown very low success rates to treat SUI, but have been widely used to 
treat POP. Surgical treatments for both disorders have demonstrated better results than 
any other type of treatment, particularly in severe cases. 
 
All types of surgical procedures to treat SUI aim for higher pressure and better support 
of the urethra by plicating and/or suturing native supportive tissues to other pelvic 
structures. However, when using native tissues, SUI surgical treatments have shown 
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decreased success rates after a few years follow-up leading to recurrence of the 
condition and requiring a second surgical intervention with an even higher risk of 
failure and recurrence. These procedures may fail due to weakness of the native tissues 
and that may explain why better outcomes have been described when using slings or 
tapes for SUI surgical treatment. Different kits and materials are used to introduce and 
fix the sling/tape, but all of them are placed underneath the urethra to hold and give 
urethral pressure/support.  
Similarly, better outcomes have been described when using synthetic materials in 
surgical treatments to relocate the prolapsed pelvic organs. Different materials and kits 
are used for POP which, are completely different to SUI sling/tapes in terms of 
shape/size. 
 
The same materials are used to treat both conditions. Normally, synthetic non-
absorbable materials have higher initial success rates; however, these materials have 
higher complications, such as erosion and extrusion, compared to degradable synthetic 
materials and biological materials. 
Physical and mechanical properties are described in this section, as well as the host 
response to different materials and how this may explain the outcomes found for all 
these materials.  
Biological materials are classified as autologous grafts, allografts and xenografts. Tissue 
engineered prosthesis, made from a scaffold and a cellular component, and which have 
not yet been tested in clinical trials, are included in this section based on preliminary 
experimental data in animal models.       
  
1.5.1 Non-degradable synthetic prostheses 
 
The use of synthetic meshes was introduced based on efficacy and safety data for their 
use in abdominal wall hernia surgery. In 1995, these materials started to be used for the 
pelvic floor when the concept of TVT through the retropubic space was introduced 
(258). In 1996, transvaginal mesh (Marlex® mesh) was first reported for 
urogynecological POP procedures (259). Later, the first mesh “kit” for POP was 
introduced in 2002 (260).  
The overall estimated percentage of patients with SUI treated with synthetic meshes in 
USA in 2010 was 79% (206,000 patients); while for POP treatment with mesh used in 
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transvaginal repairs from January 2006 to December 2010, estimated by Medicare, was 
45% (96,487 patients) (261). 
In a 2010 survey in UK, practitioners involved in POP surgery (20% urogynecologists, 
52% gynecologists interested in urogynaecology and 21% general gynecologists) were 
asked about the current management of POP (262). With respect to mesh use, 5.5% of 
cases with primary anterior vaginal wall prolapse, 30% of recurrent anterior vaginal 
wall prolapse and 86% of POP with concurrent SUI, would have been treated with 
synthetic meshes in their surgeries. The use of synthetic meshes for primary posterior 
wall prolapse was 5% against 26% in recurrent posterior cases. A similar study in New 
Zealand (263) found an even higher number of synthetic meshes used in primary 
anterior repair (14%), recurrent anterior repair (63%) and recurrent posterior prolapse 
(40%). 
On the other hand there are  rising concerns amongst professional and regulatory bodies 
regarding the long term safety of using synthetic mesh in the pelvic floor (264). Mesh 
erosion, infection, dyspareunia and/or chronic pain, occurs in 4-5% and 14% of SUI and 
POP mesh procedures, respectively (265, 266). 
 
Synthetic meshes can be classified according to the material they are made of, by their 
pore size, their fibre diameter, their knotting or weave configuration (knitted, woven, 
non-woven nor knitted), the nature of the fibres (monofilament or multifilament) and by 
their resistance to degradation (absorbable, non-absorbable or composite). However, the 
majority of the synthetic implants used to treat POP and SUI are made of non-
degradable polymers such as PPL, polyethylene and polytetrafluoroethylene (261). 
They are generally classified according to their porosity as type I – totally macroporous 
(pore size > 75µm), type II – totally microporous (pore size < 15 - 20µm), type III – 
mixture of micro and macro pores and type IV – submicron pore size (267, 268).   
PPL macroporous monofilament type I are the main subtype of these non-degradable 
synthetic meshes used for clinical practices. They can be tailored to have pores large 
enough for macrophages and lymphocytes to pass through, decreasing the risk of 
infection (269), they are have low cost to produce and have good handling 
characteristics (270).  
 
The in vivo host response against PPL meshes indicates little alteration in the 
morphological properties after implantation (table 3) with little changes in their 
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mechanical properties when compared to natural materials (271, 272). New generations 
of PPL meshes tend to be less stiff than precursors, with a view to causing less erosion 
(273). Few studies found that the PPL filament thickness might influence the 
mechanical performance of the prosthesis in vivo. TVT has been found to have the 
lowest stiffness and this might be the reason why it has a higher success rate with lower 
rates of erosion (274, 275).  
A case study based on the use of a silicone-coated PPL mesh reported no tissue 
ingrowth or fibrosis with the removed prosthesis (276). Nevertheless, many animal 
studies agree that PPL meshes provoke a fairly pronounced inflammation, leading to a 
massive cell infiltration into the scaffold and ultimately to new collagen production 
(276-285). 
 
Although PPL meshes is the gold standard material used for the treatment of SUI and 
POP, currently the regulatory bodies are considering these meshes for no longer clinical 
use. The serious complications already mentioned above which have been arisen after 
several years using these materials has led to complaints from many patients. Regulators 
in UK (Medicines and Healthcare products Regulatory Agency, MHRA) and USA 
(Food and Drug Administration, FDA) issued these alerts leading to withdrawal of 
meshes in the USA (286). Furthermore, in March 2014, the European Commission 
requested a scientific opinion from the European Scientific Committee on Emerging and 
Newly Identified Health Risks about 'The safety of surgical meshes used in 
urogynaecological surgery‘; with deadline on January 2015. 
 
1.5.2 Degradable synthetic prostheses 
 
Degradable synthetic prostheses are designed to be absorbed by the body and stimulate 
fibroblast activity leading to long lasting fibrosis. The synthetic material is absorbed by 
macrophages and the material is replaced by new collagen fibres forming a healthy scar 
tissue (287). 
The most commonly used materials are Dexon (polyglycolic acid) and Vicryl 
(polyglactic acid). Vicryl and Dexon are completely absorbed, after 30 and 90 days 
respectively.  
A recent meta-analysis reported absorbable synthetic material to have a lower objective 
recurrence rate at 12 months compared to no mesh procedures (153). In addition, as 
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above, the use of these materials has been reported to cause less erosion or infection  
when compared to the use of non-degradable synthetic materials (153). Nevertheless, 
clinically, absorbable meshes have performed less well for treating prolapse compared 
to non-absorbable meshes as there are higher recurrence rates of prolapse in using these 
(152), and therefore, they have not become popular for surgical treatment of POP (158, 
288). For these reasons the use of degradable materials as sub-urethral tapes for SUI is 
minimal too (289).  
 
1.5.3 Autologous prostheses 
 
Autologous grafts are obtained from the patients themselves. The main autologous 
tissues used for pelvic floor reconstruction are fascia lata, which is the deep fascia of the 
thigh, or rectus fascia, which covers the skeletal muscle of the abdominal wall. 
Autologous grafts are mainly composed of connective tissue, containing packed bundles 
of collagen fibres orientated in parallel, which are synthesized by fibroblasts located 
within the fascia. Fascia functions to surround and bind structures reducing friction 
between them. Once the origin of the fascia that is to be used is decided on, it is 
acquired to be transplanted during the same operation. Autologous grafts are obtained 
by a skin incision to reach the fascia underneath. A desired strip of fascia is harvested 
by pulling it from the underlying muscles. The advantage of using autologous fascia is 
that it is a non-immunogenic material; however, this procedure leads to perioperative 
donor site morbidity which can be further complicated by incisional hernia or 
unsatisfactory cosmetic results (290). 
 
The mechanical properties of autologous grafts commonly used for pelvic floor 
reconstruction were assessed in only 3 studies (table 4), which also assessed the 
mechanical properties of allografts, xenografts and synthetic materials. All these studies 
agree that autologous grafts showed lower values for mechanical properties before 
implantation compared with the others (291-293). Two of these studied the mechanical 
properties of autologous rectus fascia and anterior rectus fascia, respectively, implanted 
in rabbit vagina. Both showed no significant decrease in mechanical properties but the 
grafts showed a 50% decrease in the surface area of implants after 12 weeks 
implantation suggesting a high rate of degradation (292, 293). Following histological 
evaluation, one of these studies observed collagen remodelling with moderate collagen 
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infiltration, but also small fragments which were encapsulated (293), what had been 
described previously (294). The same study also found a minimal inflammatory 
response and minimal neovascularization after implantation of autologous grafts in 
rabbits.  
Autologous grafts implanted under the urethrovesical junction in a SUI rat model after 
laparotomy showed a lower inflammatory response and collagen production compared 
with synthetic materials and xenografts (281). This was supported by a later study 
reporting minimal inflammatory responses and fibrosis after autologous grafts were 
implanted in rabbits (295).  
 In women, histological studies of tranvaginal revision of autologous rectus fascia 
implanted in five patients with SUI (296) showed collagen remodelling, with 
longitudinally-organized connective tissue, in grafts explanted after 4 years, and no 
evidence of inflammatory cell infiltrates or foreign body reaction. Grafts explanted after 
5 and 8 weeks already showed moderate and uniform infiltration of host fibroblasts, as 
well as neovascularization. Similar results were reported by assessing autologous grafts 
implanted in five patients who underwent sling revision (283). Grafts showed a 
moderate and uniform infiltration of host fibroblasts, as well as little neovascularization. 
Collagen fibres were organized longitudinally and samples displayed no evidence of 
encapsulation or infection. Nevertheless, moderate degradation of the grafts was 
reported. 
 
In summary, autologous grafts seem to be well accepted by native tissues due to the 
autologous source of the biological material. This material undergoes moderate 
remodelling, although it can be quickly degraded. On the other hand, the major problem 
associated with autologous grafts is the limited amount of material that can be harvested 
and the risk of donor site morbidity, particularly for treating POP where a bigger 
amount of material is needed.      
 
1.5.4 Allograft prostheses 
 
Allografts are obtained from a donor of the same species. Those used for pelvic floor 
repair are usually from cadaveric origin such as fascia lata, dermis or dura matter. The 
use of allografts avoids the morbidities of perioperative tissues caused by autologous 
grafts, but the disadvantages of these materials are the fact that they can only be sourced 
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via approved tissue banks which are properly regulated (297) and even with well run 
procedures the risk of viral transmission can never be completely eliminated (290). 
Usually, allografts may have all the epithelium and cellular components removed, 
leaving behind an acellular biological matrix. Different companies that manufacture 
allografts have patented processes for optimum cellular removal to render them non-
antigenic. Moreover, other treatments are required to transport and store allografts, such 
as cleaning and drying, that may affect the properties of the graft. 
 
As above, although allografts present higher baseline of mechanical properties than 
autologous grafts (before implantation), significant decreases in these properties have 
been reported for human dermis and fascia lata after implantation in the vagina of 
rabbits (table 5). At 12 weeks post-implantation, mechanical properties were similar to 
autologous grafts after explantation (293, 298). Human cadaveric dermis and fascia 
have been found to be well integrated onto the abdominal wall of different animal 
models by moderate fibroblast infiltration, new collagen production and 
neovascularization (299-303). However, the same materials have shown opposite results 
when implanted in the pelvic floor area of the same animals. Missing and fragmented 
prosthesis were found after 12 weeks implantation on the vaginal wall explaining the, 
already mentioned, drop in mechanical properties. The study describes a higher 
degradation rate for cadaveric fascia compared with autologous and synthetic materials 
(304).  
Other people also found reasonable levels of cell infiltration and angiogenesis when 
human cadaveric dermis and fascia were anchored around the bladder neck of rats; 
however, all samples presented some degree of encapsulation (305).  
Upon re-exploration of failure of allografts in humans, many authors describe allografts 
as being absent (296, 306), or highly degraded with remained portions being acellular 
and encapsulated (283). 
 
In summary, allografts are well integrated by rapid host cell infiltration and remodelling 
of their ECM. However, allografts are quickly degraded and, as seen in animals, the 
pelvic environment	  may increase this degradation.  
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1.5.5 Xenograft prostheses 
 
Xenografts for pelvic floor repair are obtained from other species, particularly from 
porcine origin, either porcine dermis, or small intestinal submucosa (SIS). These tissues 
are de-cellularised and gamma sterilized, as allografts. In addition, they are usually 
cross-linked to make them less likely to be digested by collagenases (307).  
Mechanical properties of porcine dermis have been reported to be a bit lower than 
allografts, but much higher than autologous grafts (293). 
Xenografts implanted in different animals have given different histological results when 
comparing the 2 main grafts used in pelvic floor repair: porcine dermis and SIS (table 
6).  
 
One study assessed 4 porcine dermis xenografts implanted on the abdominal wall and 4 
on vaginal wall of rabbits (293). Two xenografts were absent after explantation from 
vaginal wall, and the other two together with those from the abdominal wall showed a 
decreased of 84.1% of their mechanical properties. Similarly, the mechanical properties 
of cross-linked porcine dermis were assessed in another study before and after 9 months 
implantation on the abdominal and vaginal wall of rabbits (285). They found 36% and 
46% degradation of these materials implanted into abdominal and vaginal walls 
respectively. Fragments of xenografts implanted which were not degraded, presented 
similar mechanical properties post-explantation compared to baseline values, while 
values of degraded materials decreased by more than 50%. Both studies agreed that the 
degradation of biological materials is higher when the inflammatory response against 
them is more vigorous; furthermore, the vaginal environment may accelerate this 
process.  
A chronic inflammatory response has also been described in porcine dermal xenografts 
due to encapsulation leading to minimal neovascularization and collagen ingrowth 
(293). Similar findings were reported in a histological study of porcine dermal 
biomaterial upon explantation from 4 women requiring revision of their sling surgery 
(283). They reported severe graft encapsulation, without fibroblast infiltration or 
neovascularization. In addition, these results are again supported by studies with rats 
(305, 308), rabbits (309), pigs (303) and primates (310).  
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In contrast to porcine dermis, several studies of implanted SIS found high collagen 
ingrowth with a moderate degree of collagen remodelling and orientation, and high 
neovascularization (281, 302, 305, 311-317). In addition, after an initial decrease, 
mechanical properties were shown to be increased to the same or even above baseline 
values (311-313, 315). Only 2 studies reported an absence of host fibroblast infiltration, 
collagen ingrowth and neovascularization for SIS implanted in rats (308) and rabbits 
(304). 
On the other hand, many studies agree with a very rapid degradation of the SIS which is 
replaced by the host tissue (311, 312, 317-320).  
In a recent randomized study, Feldner et al. found significantly higher anatomical cure 
rates (86% Vs 59%) by using a SIS graft compared to a traditional colporrhaphy for 
anterior prolapse, at a 12 months follow up (321). Nevertheless, few clinical cases 
correlate with the 2 main situations observed in animal studies; so while encapsulated 
and acellular SIS was removed due to obstruction (322); a patient with recurrent SUI 
had no longer recognizable SIS, as it had been replaced by host tissues (323, 324). 
 
In summary, xenografts used for the reconstruction of the pelvic floor, porcine dermis 
and SIS, have shown elevated degradation rates, although, SIS seems to be better 
integrated into host tissues with new collagen formation and neovascularization. SIS has 
achieved reasonable success rates when used to treat POP; however, there are many 
cases still reporting recurrence of SUI or POP with both materials due to rapid 
degradation of these materials, or an undesirable chronic inflammatory response due to 
encapsulation.  
 
1.5.6 Tissue engineered prostheses 
 
Tissue engineering has arisen from the necessity to combat tissue damage and organ 
loss caused by degenerative diseases or neoplasia. Organ failure in some instances can 
be treated with donor organ transplantation but life-long immunosuppression is required 
that often results in complications. Therefore, tissue engineering tries to develop more 
compatible biomaterials and, at the same time, studies the mechanisms for regrowth of 
damaged tissues for function restoration.    
Tissue engineering is defined as the use of a combination of cells and materials for the 
development of biological substitutes to restore, maintain or improve tissue functions or 
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a whole organ (325). The fabrication of engineered extracellular matrices (scaffolds) 
from different materials allows one in the laboratory, to growth cells on them producing 
biologically active molecules and obtaining a functional, but also, biomechanically 
stable tissue to be transplanted into a body. Depending on the part of the body injured, 
the success of this procedure will require different cell types, but also, different scaffold 
materials. Also it is important to create a biological environment to stimulate the normal 
development of the engineered tissue in the lab, such as the use of native growth factors 
or hormones, mechanical simulation or the use of bioreactors; besides the logical use of 
the same native temperature, oxygen concentration, humidity, nutrients and osmotic 
pressure maintenance. 
The scaffolds can be produced from biological and synthetic materials. There is a huge 
range of natural polymers used for soft tissue engineering and techniques to construct 
scaffolds of different dimensions and shapes. The matrices also can be harvested from 
autologous, allogeneic or xenogeneic tissues. Then the cellular components are removed 
from matrices for eventual implantation as showed in current treatments of POP and 
SUI.  
 
Anthony Atala performed the first clinical trial with neo-bladders. Bladders of 7 patients 
with myelomeningocele (aged 4-19 years) were reconstructed with degradable synthetic 
materials seeded and cultured previously with autologous urothelial and muscle cells 
from the bladder (table 7). 46 months post-operatively, the mean bladder leak point 
pressure (LLP) decreased, and the volume and compliance increased with recovery of 
bowel function (326).  
In addition, several studies have used successfully mesenchymal stem cells (MSCs) for 
bladder wall regeneration combined with biological matrices (327-330). Adipose-
derived stem cells (ADSCs) have been seeded on a degradable synthetic material and 
cultured with smooth muscle inductive medium to differentiate them into the desired 
cell type. Once the cells started to express smooth muscle specific markers, the 
engineered tissues were implanted into the bladder of rats which previously had been 
partially cystectomized. 12 weeks after, viable ADSCs increased the smooth muscle 
mass of the bladder with higher contractile function (327).   
     
In 2003, urethra reconstruction was firstly approached by tissue engineering using 
decellularized SIS (331).  
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In our group, acellular sterilised donor de-epidermised dermis has been used as a matrix 
to seed buccal keratinocytes and fibroblasts. These cells were isolated from buccal 
mucosa biopsies of same patients who underwent for urethroplasty by implantation of a 
tissue engineered buccal mucosa. After 3 years follow-up, three patients had a patent 
urethra with the engineered tissue in situ, although all three required some form of 
instrumentation (332). Using exactly the same approach, since last few years a product 
called Mukocell® has been commercialized in Germany.  
In 2012, Anthony Atala was the first to develop neo-urethras. He used acellular collagen 
matrices from descellularized porcine bladder tissues which were seeded with epithelial 
and smooth muscle cells from rabbit bladder biopsies. As an autologous approach, the 
tubularized matrices seeded with the cells were implanted in the same rabbits after a 
urethral defect was created. Post-implantation, biopsies of the implanted urethras were 
assessed with organ bath studies and these presented both physiological contractility 
and the presence of neurotransmitters (333). 
 
Again Anthony Atala, in 2003, was the first to develop an engineered soft tissue for 
reconstruction of the pelvic floor (334). A vaginal tissue engineered was developed 
from epithelial and smooth muscle cells isolated from the vagina of rabbits and seeded 
in quick degradable synthetic scaffold.  
Recently, muscle-derived stem cells (MDSCs) have been cultured in SIS for a vaginal 
repair in rats after hysterectomy and partial vaginectomy. MDSCs differentiated into 
smooth muscle cells stimulating vagina tissue repair, with formation of an epithelium 
and preventing fibrosis (335). Later, a tissue engineered fascia has been created from 
vaginal fibroblasts seeded in another biodegradable synthetic material coated with 
collagen for its use to repair connective/supportive injuries of the pelvic floor (336). 
This engineered tissue was assessed by subcutaneous implantation and was well 
integrated in host tissues of mice creating neo-fascia in vivo.  
This year Anthony Atala has published a clinical study after 8 years follow-up of 4 
patients who had an implantation of neo-vaginas. Vulvar biopsies were obtained from 
patients with congenital vaginal aplasia. Epithelial and muscle cells were cultured onto 
biodegradable scaffolds to develop organs which were constructed and allowed to 
mature in an incubator. Vaginal organs developed with autologous cells were surgically 
implanted in each patient. After 8 years, structural and functional vaginal organs were 
found with no post-operative complications. By vaginoscopy, serial tissue biopsies and 
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MRIs, a tri-layered structure was present consisting of an epithelial cell-lined lumen 
surrounded by matrix and muscle (337).  
 
Finally, engineered tissues have been produced to be used as slings to treat SUI animal 
models. Cannon was the first in 2005 using SIS seeded with MDSC and implanting the 
engineered tissue suburethrally by suturing it to the pubic bone. LLP measured by 
urodynamics was improved in rats with urethral sphincter deficiency developed by 
bilateral proximal sciatic nerve transaction (PSNT). However, same LLP values were 
found compared to acellular SIS slings implanted as controls (338). Later, a similar 
study used bone marrow stem cells (BMDSCs) seeded in a silk sling implanted via 
trans-abdominal and sutured to abdominal wall in female rats with PSNT too (339). 
Again same successful rates were found after implantation of the tissue engineered sling 
or the acellular sling. However, in both studies, ligament-like tissue was formed when 
tissue engineered slings were implanted, which was postulated as having potential for 
better integration and long-term retention since higher collagen production and tensile 
strength was assessed for the cell seeded groups.  
 
MSCs have been the main cell type used to develop engineered tissues for the pelvic 
floor, as it can be noticed from above. MSCs have high proliferative potential as well as 
potential for tissue regeneration (340). Particularly ADSCs have shown the capacity to 
release different factors which can stimulate neovascularization, stimulate fibroblast 
proliferation and suppress an inflammatory response (341). All these properties, which 
are further discussed in Chapter 4, make these cells interesting to be used for tissue 
regeneration. 
Therefore, also described in Chapter 4, these cells have been injected into the urethral 
sphincter to treat SUI. In animals, although it has been shown the capacity to use these 
cells as a bulking agent treatment of intrinsic urethral sphincter deficiency (342), 
injected MSCs have also shown the capacity to functionally recover the urethral 
sphincter. However, high number of MSCs is needed since many cells are not retained 
within the injection area. Alternatively, while the urethral sphincter is a well localized 
area, supportive tissues involved in POP may be too large for this approach where 
supportive materials are needed. The introduction of the cells in these tissues could be 
difficult too.     
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Fewer cells are needed if materials previously cultured with cells are implanted and 
which has a similar approach than current surgical treatments but stimulating 
regeneration of native tissues and aiming for a better integration than current materials. 
In addition, this approach has potential to keep the cells in place giving them space to 
proliferate.  
Finally, although MSCs have a regenerative potential, they lose some properties when 
they have been differentiated (340). Undifferentiated and differentiated MSCs have 
been used for urethral sphincter regeneration and in less extent in tissue engineering of 
the pelvic floor. Using already differentiated MSCs has the advantage of driving the cell 
phenotype against the desired tissue-specific cell type. Also, since these differentiated 
cells have lost some properties such as potential for migration they will stay in the 
implanted place. On the other hand, undifferentiated cells will have higher potential to 
proliferate and release growth factors which can, for instance, stimulate 
neovascularization for better regeneration and integration into native tissues. However, 
these cells have the potential to migrate and differentiate into different cell types (340). 
MSCs could produce undesired types of tissues in the implanted place or other places. 
Therefore, many investigations are nowadays going through these issues to assess the 
safety of using these cells and to achieve their approval for clinical use. These issues are 
not within the scope of this thesis but, while these are tackled by other people, we aim 
for the potential of undifferentiated ADSCs based in previous research and which is 
again further discussed in Chapter 4. These cells have fibroblastic behaviour in culture 
and they do not differentiate without the appropriate stimulus (343). ADSCs cultured on 
different materials have shown the potential to proliferate and produce ECM due to their 
fibroblastic behaviour (343). Furthermore, after being implanted into native tissues of 
the pelvic floor, the signals received from the microenvironment may drive these cells 
into the desired tissue-specific cell phenotype. In a recent study with a dog model, 
undifferentiated ADSCs, fibroblasts and ADSCs differentiated into fibroblast-like cells 
using connective growth factor were implanted. They found that the three cell groups 
had a wound healing effect with formation of the same tissue expressing same markers. 
In addition, undifferentiated and differentiated ADSCs had better regenerative effect 
(344).     
       
In summary, degradable synthetic material is not commonly used since it degrades very 
quickly leading to elevated recurrence rates, which are higher than biological and non-
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degradable materials. Fewer complications have been reported with absorbable 
materials, since they produce the lowest inflammatory response compared to the other 
materials (319); however, alternatively, this leads to the lowest production of collagen 
which is necessary for long lasting integration and repair.  
A study proved this concept by higher amount of collagen fibres produced when an 
elevated inflammatory response is developed (319). Compared to biological materials, 
non-degradable synthetic materials cause higher inflammatory response. Only porcine 
materials produce an extensive inflammatory response too, and these 2 groups have 
demonstrated higher fibroblasts infiltration and better collagen formation and 
organization, especially for collagen III (281, 283, 313, 319). Furthermore, these two 
materials have shown the highest success rates when used to treat SUI and POP in 
humans.  
 
All type of prostheses have been shown to present different mechanical properties, but it 
has been already reviewed that mechanical properties do not predict the success of a 
prosthesis (345). However, as shown in this section, the host response against each 
specific material may have an important role on the success of these prostheses. A 
limited inflammatory response seems to be needed for a rapid neovascularization, 
fibroblast infiltration and collagen ingrowth in the implant leading to better integration 
into host tissues, as shown for PPL and SIS. Alternatively, while SIS can be degraded 
very fast leading to recurrence of SUI and POP, such as the other biological materials; 
PPL can evoke a chronic inflammatory response due to the persistence of the non-
degradable synthetic material leading in long-term to erosion, pain or infection. The 
complications reported for these materials are not acceptable and there is a need to look 
for alternative materials to treat pelvic floor disorders. 
 
Tissue engineering may overcome these complications by developing a long-lasting 
repair material with regeneration of its ECM driven by an autologous cellular 
component, and leading to better integration into the native tissues of the pelvic floor. 
Nevertheless, more studies need to be performed to determine which scaffolds and cells 
may be the best candidates to develop a tissue engineered repair material (TERM) 
designed for the pelvic floor, such as to describe the host response against them.  
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1.6 Aims 
 
The aim of this project is to develop a cell-impregnated bioabsorbable material designed 
for the treatment of SUI and POP.  
 
We hypothesise that the inclusion of an autologous cellular component offers the 
potential to drive the formation of new ECM for better integration into native tissues by 
neovascularisation and constructive remodelling achieving long-term mechanical 
integrity, whilst the degradable nature of the scaffold will hopefully avoid a harmful 
chronic inflammatory response.  
 
To achieve and study this, the project was divided in the following main experimental 
objectives: 
 
1. To study the physical properties, in vitro degradation rate and mechanical 
properties of our biodegradable scaffold candidate. 
 
2. To look for the cell candidate with the ability to attach, proliferate and produce 
ECM on the scaffold for developing a TERM. 
 
3. To determine good culture conditions in terms of the number of cells seeded and 
the period of culture, as well as, to investigate the effects of chemical and 
mechanical stimulation on cells during culture of the TERMs. 
 
4. To study the host response against the TERM to learn about inflammatory and 
immune responses and the integration into host tissues looking into neo-
vascularisation and neo-tissue formation.      
 
5. To investigate the possibility of modifying the mechanical properties of the 
scaffolds by altering the manufacturing procedure. This involved examining 
how cells behaved on scaffolds with different fibre configuration and examining 
their mechanical properties.   
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6. To study the performance of ADSCs isolated from different donors for 
developing the TERM and to assess the maintenance of this potential after rapid 
isolation of these cells using new technology.  
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Chapter 2 
 
MATERIALS AND METHODS 
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2.1 Electrospinning of Poly-(L)-lactic acid (PLA) scaffolds 
 
Sterile Poly-(L)-lactic acid (PLA) scaffold was produced in the laboratory clean rooms 
(Good Manufacturing Practice (GMP) accredited) via the electrospinning technique 
(figure 2.1).  
A solution of 10% PLA (Sigma-Aldrich, Dorset, UK) with Dichloromethane (DCM) 
was made one day before electrospinning to dissolve the PLA crystals in DCM 
overnight with a rotating magnet inside. Polymer solutions were loaded into 5 mL 
syringes fitted with blunt tipped stainless steel needles with an internal diameter of 0.8 
mm (I&J Fisnar Inc.). 4 needles with 5 mL solution each were used at the same time 
delivering the solutions at a constant flow rate of 2.4 mL/h using a programmable 
syringe pump (Aladdin 1000) and solutions were electrospun horizontally with an 
accelerating voltage of 17 kV supplied by a high voltage power supply (Brandenburg, 
Alpha series III). Fibrous mats were collected on aluminum foil sheets (18 cm by 16 
cm) wrapped around an earthed aluminum rotating collector (rotating at 300 rpm) 17 cm 
from the tip of the needle. Jet formation/stability was assisted by means of an aluminum 
focusing ring at a voltage of 17 kV, 5 mm behind the tip of the needle.  
 
 
 
 
 
 
 
 
 
 
Figure 2.1 Electrospinning technique in a laboratory clean room. 
 
Everything was done under sterile conditions. All materials (foil, needles, tips) were 
autoclaved before their use and the electrospinning was performed in a GMP accredited 
clean room which maintains particulate-free air through the use filters employing 
laminar air flow. 
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After 2 h, a full sheet of PLA fibres (18 cm by 16 cm) was attached to the sterile foil. 
Then, using sterile gloves, forceps and scissors, the PLA sheet plus foil was collected 
and placed in a square Petri dish (20 cm2), which was closed with tape to maintain the 
PLA inside under sterile conditions.  
Thereafter, the PLA sheet was heat annealed at 600C for 3 h. 
 
 
2.2 Isolation and culture of human oral fibroblasts (OFs) and rat and 
human adipose-derived stem cells (ADSCs) 
 
All procedures for human oral fibroblasts (OFs) and ADSCs were undertaken in a 
sterile laminar flow culture hood reserved specifically for human cell lines.  
Rat ADSCs were isolated and cultured in Laboratory of Experimental Gynecology, 
Department of Obstetrics & Gynecology, University Hospital Leuven, Herestraat 49, B-
3000 Leuven, Belgium, for animal experiments. 
  
Human oral mucosa was selected as the source of fibroblasts. Tissue samples were 
obtained from normal volunteers with full and informed consent and ethical approval to 
produce small pieces of urethroplasty grafts which were surplus to requirements (346). 
All samples were handled on an anonymous basis under a research tissue bank license 
(number 08/H1308/39) under the Human Tissue Authority. 
Specimens were cut into 0.5 cm2 pieces and incubated overnight (12-16 h) at 4°C in 
(0.4%) Difco-trypsin plus 0.1% w/v D-glucose in phosphate buffer solution (PBS), pH 
7.45 (Difco Labs, Michigan, USA). The epidermis was then manually parted from the 
dermis in a Petri dish. The epidermis was discarded and the dermis further minced with 
scalpel blades in a small volume of Dulbecco’s Modified Eagle’s Medium (DMEM) 
medium (Gibco Invitrogen, Paisley, UK) supplemented with 50 mL of fetal bovine 
serum (FBS) (Advanced protein products, Brierley Hill, UK), 5 mL penicillin (100 
units/mL) and streptomycin (100 µg/mL), and 2.5 mL fungizone (630 ng/mL) (Gibco 
Invitrogen, Paisley, UK) (all experiments were in DMEM medium plus 10% FBS 
unless stated otherwise).   
The minced dermis was transferred to a Petri dish containing 10 mL collagenase A 
(0.05% in DMEM medium) and incubated at 37oC in a 5% CO2 atmosphere overnight. 
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The resulting suspension was centrifuged at 1300 rpm for 10 min and the pellet isolated 
and resuspended in DMEM medium. Thereafter a cell count was obtained to guide 
seeding into T25 flasks, which were seeded with a minimum of 5,000 cells per T25 
flask incubated at 37oC in a 5% CO2 atmosphere. Regular visual inspections were 
undertaken to observe cell morphology and exclude infection. Medium was changed 3 
times a week and all cells were passaged prior to 80% confluence. 
The passage procedure involved a wash in PBS followed by incubation for 5 min at 
37oC 5%CO2 atmosphere with 5 mL Trypsin/EDTA (Sigma-Aldrich, Dorset, UK) per 
T75 flask. Thereafter, the suspension was centrifuged at 1000 rpm for 5 min and the 
cells counted in a haemocytometer. Between 100,000 to 1,000,000 cells were added to 
each T75 flask, depending on the requirements.  
As above, OFs were used from previous isolations. They had been frozen in 1 mL of 
10% FBS with Dimethyl Sulfoxide (DMSO, Sigma-Aldrich, Dorset, UK), and in 1.5 
mL cryogenic vials in liquid nitrogen at density of 1,000,000 cells per vial at passage 4. 
Each frozen vial was quickly defrosted adding 8 mL of DMEM medium. After that, the 
suspension was centrifuged at 1000 rpm for 5 min to obtain a pellet and eliminate 
DMSO which is toxic to cells at high concentrations. The isolated pellet was 
resuspended in DMEM medium to seed the cells at passage 5 in a T75 flask. Cells were 
utilized at passage 6 in the experiments. 
 
Human subcutaneous fat was selected as the source of ADSCs. Biopsies were handled, 
from skin splits, on an anonymous basis under a research tissue bank license (number 
08/H1308/39) under the Human Tissue Authority.  
Samples were placed in Petri dishes, with 10 mL of PBS and 0.1 mL penicillin (100 
units/mL) and streptomycin (100 µg/mL). Firstly, samples were mechanically minced 
with a scalpel and 10 mL of fat were collected in 50 mL tubes. The tissues were washed 
with 15-20 mL of 1% antibiotic (penicillin/streptomycin) in PBS by centrifugation at 
1300 rpm for 5 min. The tissue was collected with a Pasteur pipette and collected in a 
new 50 mL tube. Twice of the volume of the samples was added for HANK solution. 
HANK solution is a saline solution to which it was added 0.1% collagenase type A 
(Roche Diagnostics GmbH, Mannheim, Germany), 0.1% albumin bovine fetal (BSA) 
(Sigma-Aldrich, Dorset, UK) and 1% antibiotic (penicillin/ streptomycin). 50 mL tubes 
were disposed in an incubator at 37ºC for 40 min and they were periodically shaken for 
chemical disaggregation. Digested tissues were centrifuged at 1300 rpm for 8 min. The 
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floating fractions consisting of adipocytes were discarded and the pellets representing 
the stromal vascular fraction (SVF) were resuspended in DMEM medium.  Cells were 
washed by centrifugation at 1300 rpm for 8 min with 20 mL of DMEM medium, and 
finally, pellets were resuspended and cells seeded with 5 mL of DMEM medium in one 
T25 flask. Cells were maintained at 37°C and 5% CO2.  
After 24 h, non-adherent cells were discarded by washing with PBS. Regular visual 
inspections were undertaken to observe cell morphology and exclude infection. During 
all the period of culture, growth medium was changed 3 times a week. After one week, 
ADSCs reached 80%-90% confluence, and then, cells were detached by incubation for 5 
min at 37oC and 5% CO2 atmosphere with 2 mL Trypsin/EDTA (Sigma-Aldrich, 
Dorset, UK) per T25. Thereafter, the suspension was centrifuged at 1000 rpm for 5 min 
and the cells counted in a haemocytometer. 100,000 cells were added to a T75 flask. 
Cells between passages 3-6 were utilized in the experiments. 
 
Rat ADSCs were also isolated from subcutaneous fat under ethical approval with 
license number LA 1210249 in the Laboratory of Experimental Gynecology, 
Department of Obstetrics & Gynecology, University Hospital Leuven.  
After isoflurane anesthesia, a male Sprague-Dawley rat was sacrificed by neck 
dislocation and fat tissue was obtained after laparotomy; the rest of the protocol is 
exactly the same than for human ADCSs but pellets with SVF were seeded in a 6-well 
plate.  Cells at passage 6 were utilized for the experiments.  
 
 
2.3 ADSCs characterization 
 
2.3.1 Flow cytometry  
 
Human and rat ADSCs characterization by fluorescence-activated cell sorting (FACS) 
was performed in the Laboratory of Experimental Gynecology, Department of 
Obstetrics & Gynecology, University Hospital Leuven.  
 
After 6 passages, the vascular cells from the subcutaneous human adipose tissue were 
analyzed by flow cytometry. The specific surface markers used were nine antibodies 
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(Ab) conjugated: mouse anti-human CD73-R-Phycoerythrin (PE) (1:100; BD, 
Pharmagien), mouse anti-human CD90-Fluorescein isothiocyanate (FITC) (1:100; BD, 
Pharmagien), mouse anti-human CD29-FITC (1:100; Acris), mouse anti-human 
CD105-PE (1:100; BD, Pharmagien), mouse anti-human CD44-PE (1:100; BD, 
Pharmagien), mouse anti-human HLA-a/b/c-FITC (1:100; BD, Pharmagien), mouse 
anti-human CD45-PE (1:100; BD, Pharmagien), mouse anti-human CD34-PE (1:100; 
BD, Pharmagien) and mouse anti-human HLA-DR-PE (1:100; BD, Pharmagien). As 
negative controls, cell aliquots were incubated only with isotype-matched mouse PE-
IgG1 ϒ1 (BD, Pharmagien), mouse FITC-IgG1 ϒ1 (BD, Pharmagien), mouse FITC-
IgG2α (BD, Pharmagien) and mouse PE-IgG2b κ (BD, Pharmagien) under the same 
conditions. 
To carry out this procedure, cells were washed with PBS and were detached by 
incubation with trypsin diluted 1:1 in PBS. After trypsin inactivation with DMEM 
medium and centrifugation at 1200 rpm for 5 min, pellets were resuspended with 5 mL 
of DMEM medium to count cells. 100,000 cells were transferred to cytometer tubes, for 
each Ab, and disposed in a float. Then, 1 mL of 1% Blocking Buffer, which contains 
1% of BSA in PBS, was used to wash cells and to block nonspecific unions between Ab 
and other regions. 
The samples were centrifuged at 1,200 rpm for 5 min and pellet was resuspended with 
95 µL of PBS and 5 µL of each Ab, for each tube. Those were incubated at 37ºC for 30 
min in the dark at 4ºC. The samples were washed with 5 mL of PBS, by centrifugation 
at 1200 rpm for 5 min, to eliminate excess of Ab. Pellets were resuspended in 500 µL of 
4% paraformaldehyde in PBS before analyze them using a FACScan flow cytometer 
with Cell Quest software. Data was analyzed using Flow Jo software. 
 
Same analyses were performed for ADSCs isolated from rat at passage 4 but using 
seven conjugated Ab: mouse anti-rat I-E[κ]-PE (1:100; BD, Pharmagien), mouse anti-
rat CD90-FITC (1:100; BD, Pharmagien), mouse anti-rat CD29-FITC (1:100; Acris), 
mouse anti-rat CD31-PE (1:100; BD, Pharmagien), mouse anti-rat CD44-FITC (1:100; 
BD, Pharmagien), mouse anti-rat CD45-PE (1:100; BD, Pharmagien) and mouse anti-
rat CD11b-PE (1:100; BD, Pharmagien). As negative controls, cell aliquots were 
incubated only with isotype-matched mouse PE-IgG2a κ (BD, Pharmagien), mouse 
FITC-IgG2a κ (BD, Pharmagien), mouse PE-IgG1 κ (BD, Pharmagien) and American 
Hamster FITC-IgM λ (BD, Pharmagien) under the same conditions. 
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2.3.2 Adipogenic and osteogenic differentiation assays 
 
At passage 6, 100,000 human ADSCs were seeded per well in a 6-well plate with 
DMEM medium. 
After 24 h, culture medium was then replaced with specific differentiation inductive 
medium. However, one control for each cell type differentiation was cultured with 
DMEM medium changed every 3 days during 3 weeks.   
 
For osteogenic potential cells were cultured with osteogenic induction medium 
containing 10 nM dexamethasone (Sigma-Aldrich, Dorset, UK), 50 µg/mL ascorbate-2-
phosphate (Sigma-Aldrich, Dorset, UK), and 2 mM b-glycerophosphate (Sigma-
Aldrich, Dorset, UK)  in 4.5 mg/mL glucose-DMEM (GlutaMaxTM, Gibco Invitrogen, 
Paisley, UK) supplemented with 10% (v/v) FBS, 5 mL penicillin (100units/mL) and 
streptomycin (100 µg/mL), and 2.5 mL fungizone (630 ng/mL) (Gibco Invitrogen, 
Paisley, UK) for 3 weeks with medium changed every 3 days. Then, these cells and one 
control were fixed with 3,7% (v/v) paraformaldehyde for 20 min and washed with PBS. 
Fixed cells were stained with 1 mg/mL Alizarin RedTM solution (Sigma-Aldrich, 
Dorset, UK) for 30 min. After removing the staining excess with distilled water, several 
photos were taken with light microscope. 
 
For adipogenic potential cells were cultured in adipogenic induction medium consisting 
of 4.5 mg/mL glucose-DMEM (GlutaMaxTM, Gibco Invitrogen, Paisley, UK) 
containing 10% (v/v) FBS, 5 mL penicillin (100units/mL) and streptomycin (100 
µg/mL), 2.5 ml fungizone (630 ng/mL), l µM dexamethasone (Sigma-Aldrich, Dorset, 
UK), 0.5 mM methyl-isobutylxanthine (Sigma-Aldrich, Dorset, UK), 10 µg/mL insulin 
(Sigma-Aldrich, Dorset, UK), and l00 µM indomethacin (Sigma-Aldrich, Dorset, UK) 
for 3 weeks with medium changed every 3 days. Then, these cells and one control were 
fixed with 3.7% (v/v) paraformaldehyde for 20 min and washed with PBS followed by 
incubation with filtered 0.3% Oil Red O (Sigma-Aldrich, Dorset, UK) in 60% 
isopropanol (Fisher Scientific, UK Ltd.) (w/v) for 20 min. After excess stain was 
removed by washing with PBS, several photos were taken with light microscope. 
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2.3.3 Immunostaining for specific antigens  
 
ADSCs and OFs were assessed in 2D culture immunostaining using Ab against 
fibroblasts and surface antigens of MSCs. 
 
Primary Ab included mouse anti-human CD29, CD44 and CD73 PE conjugated (1:50; 
BD, Pharmagien); and mouse anti-human fibroblasts surface protein (1:50; Sigma-
Aldrich, Dorset, UK) unconjugated. The secondary Ab, biotinylated anti mouse IgG 
(Vector labs, Peterborough, UK), was used against the primary Ab for anti human 
fibroblasts. A tertiary Ab, fluroescein-streptavidin (Vector labs, Peterborough, UK), 
was used, which binds the biotin molecule of the secondary Ab.    
OFs at passage 6 and ADSCs from passage 3 and 6 were fixed in 3.7% formaldehyde, 
underwent for 10 min and were then washed in PBS thrice. Thereafter, samples were 
incubated in 0.5% Triton X for 20 min. After 3 washes with PBS, 10% goat serum was 
added as blocking buffer for 1 h. Samples were incubated with primaries Ab (diluted in 
1% goats serum) and incubate for 1.5 h. After 3 more washes with PBS, samples 
incubated with anti fibroblasts Ab were incubated with biotinylated anti-mouse 
secondary Ab (1:1000 in PBS) for 1.5 h. Finally, these samples were incubated with 
tertiary Ab (1:100 in PBS) for 30 min, after 3 more washes with PBS. 
All samples were again washed 3 times with PBS and 4′,6-diamidino-2-phenylindole 
dihydrochloride (DAPI) (1:1000 in PBS) was added for 10 min.  
After three washes in PBS, the fluroescein-streptavidin tertiary Ab used to detect the 
anti fibroblasts Ab was visualized using a green FITC filter through an Axon 
ImageXpressTM fluorescent microscope (Molecular Devices limited, Union city, CA). A 
Leica DM-IRB inverted research microscope (Leica, Bensheim, Germany) was used to 
visualize the 3 Ab PE conjugated using a red PE/Cy5 filter. Excitation and emission 
wavelengths: 
 - for DAPI were λex 385 nm/λem 461 nm.  
- for FITC were λex 495 nm/λem 515 nm.  
- for PE were λex 565 nm/λem 670 nm.  
 
For the 3 PE conjugated Ab, the same protocol was followed for fixed cells but 
avoiding incubation with any of these 3 Ab, which were used as negative control.  
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For the anti-human fibroblast protein surface, negative controls were performed for 
fixed cells following the same procedure avoiding incubation with primary and 
incubating only with secondary Ab and tertiary Ab.   
 
 
2.4 Culture of OFs and/or ADSCs on PLA scaffolds 
 
2.4.1 PLA scaffold preparation 
 
Square samples of scaffolds cut at 2.5 x 2.5 cm (6.25 cm2) or 1.5 x 1.5 cm (2.25 cm2) 
were placed in a 6 well plates with a metal ring on top with a diameter of 2 cm or 1 cm 
respectively for cell seeding. All samples were wet with PBS for 30 min before seeding 
the cells. 
 
2.4.2 Cell seeding 
 
Cells were detached by trypsinisation and counted before they were seeded onto the cut 
pieces with 2 mL or 0.5 mL of DMEM medium, depending on the size of the metal ring 
diameter (2 or 1 cm respectively) which maintains the cells on top of the scaffolds. 
After 2 h, to allow cell attachment, a further 5 mL of DMEM medium was added and 
the 6 well plates were incubated at 37oC in a 5% CO2 atmosphere. We also included cell 
free scaffolds with or without DMEM medium as controls.  
 
2.4.3 Metabolic activity assessed by AlamarBlue® staining 
 
AlamarBlue® (5 or 2.5 mL of 5 µg/mL of AlamarBlue® in PBS, AbD serotec, 
Kiddlington, UK) was added to each six well plate 2 h after seeding the cells. This was 
incubated for 60 min at 37oC in a 5% CO2 atmosphere and then read at 570 nm 
(manufacturer’s recommendations) in a colorimetric plate reader (Bio-TEK, NorthStar 
Scientific LTD, Leeds, UK) to obtain baseline values of colorimetric absorbance. On 
days 0, 7 and 14 of culture, each sample was washed with PBS and incubated with 
AlamarBlue® to assess metabolic activity at these time points.  
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2.4.4 4’,6-Diamidino-2-phenylindole (DAPI) staining 
 
DAPI was utilized to identify the presence and location of nuclei via fluorescence 
imaging. After culture for varying periods, small portions from samples were cut and 
fixed in 3.7% formalin solution (3.7% formaldehyde in PBS) for 10 min. After 3 washes 
with PBS, 0.8 mL of 1 ng/mL of DAPI (Gibco Invitrogen, Paisley, UK) diluted in PBS 
was added to each well (24 well plate) and incubated at 37oC in a 5% CO2 atmosphere 
for 40 min. After 3 washes in PBS, the samples were observed through an Axon 
ImageXpressTM fluorescent microscope (Molecular Devices limited, Union city, CA) at 
λex 385 nm/λem 461 nm. Samples were imaged through their depth in all quadrants. 
 
2.4.5 Total collagen production assessed by Sirius red staining 
 
Total collagen produced by the cells on the scaffolds was assessed using Sirius red 
staining. After the culture period constructs were washed 3 times in PBS and fixed in 
3.7% formalin. Following further 3 washes with PBS samples were stained with 0.8 mL 
of Sirius red stain (0.1% Direct Red 80 in saturated picric acid, Sigma-Aldrich, Dorset, 
UK). After 16 h, excess stain was washed off with distilled water. The specimens were 
then patted dry and weighed. For a quantitative analysis, the stain from the samples was 
eluted with 2 mL 0.2 M NaOH-methanol 1:1 added to each well of the 12 well plates. 
After 10 min 50 µL from each well was transferred into a 96 well plate to read the 
absorbance at 490 nm in a plate reader spectrophotometer (Bio-TEK, NorthStar 
Scientific LTD, Leeds, UK).  
 
Data analysis involved calculating absorbance of stain per gram of dry construct. In 
addition, the difference in collagen stain absorbance per gram of construct between 
samples with cells and controls without cells was calculated to give an indication of 
“new collagen production” by cells on the scaffolds.  
 
2.4.6 Mechanical testing using BOSE electroforce tensiometer 
 
Uniaxial tensile testing was performed after periods of culture and all samples remained 
in medium until the time of testing. Samples were cut, partially dried, measured and 
then the moist samples were clamped in the tensiometer (BOSE Electroforce test 
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a 
b c 
instruments, Minnesota, USA) (figure 2.2a). A small load cell was selected (< 22 N) as 
this was found to be the most accurate during tuning. 
 
Figure 2.2 (a) BOSE Electroforce test instruments. (b) Clamps stretching PLA sample. 
(c) Typical stress vs. strain plot resulting from testing of prosthesis on the BOSE 
electroforce instrument. 
  
PLA material was tuned prior to commencing the experiments. A ramp test was applied 
at a rate of 0.1 mm/sec with a maximum displacement of 7 mm. The two grids stretch 
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each sample (figure 2.2b) and the load cell records the strength produced by the sample. 
Then, the first failure point or plateau was recorded as the load at failure (or ultimate 
tensile strength, UTS), and the displacement at this point was also recorded (strain at 
ultimate tensile strength). These values are represented in figure 2.2c, and the slope of 
this plot was later calculated for the Young’s modulus (or elastic modulus). 
 
2.4.7 Contraction 
 
Scaffold contraction on days 7 and 14 was calculated relative to day 0 using digital 
photographs (figure 2.2) and ImageJ software (NIH, USA). Cell mediated contraction 
was calculated by subtracting the difference between scaffolds with and without cells 
(controls). 
 
 
 
 
 
 
 
Figure 2.3 Example of serial photographs for scaffold contraction at day 0 (a), day 7 
(b) and day 14 (c). 
 
2.4.8 Immunostaining of extracellular matrix components 
 
The presence and distribution of collagen I, III and elastin were assessed using FITC 
Ab. Primary antibodies included goat anti-human collagen I and collagen III, and rabbit 
anti-human alpha elastin antibody (sensitive to both alpha and beta elastin). The 
respective secondary antibodies included FITC labeled anti-goat IgG and anti-rabbit 
IgG. All antibodies were polyclonal (AbD serotec, Oxford, UK).  
 
The same samples were fixed and stained by DAPI as explained above, and were then 
washed 3 times in PBS. Thereafter, 2 mL of 1% BSA was added to each construct in 24 
well plates to reduce non-specific binding. This was washed away with PBS 3 times 
after 30 min. Then 200 µL of primary antibody (Diluted 1:50 in PBS) was added to each 
a b c 
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sample and these were incubated at 37oC in a 5% CO2 atmosphere for 30 min followed 
by 3 washes with PBS. Finally 200 µL of secondary antibody (Diluted 1:200 in PBS) 
was added and samples were incubated at 37oC in a 5% CO2 atmosphere for 30 min and 
washed thrice with PBS. The constructs were imaged with an Axon ImageXpressTM 
fluorescent microscope (Molecular Devices limited, Union City, CA).  
The relative positions of nuclei (DAPI stained) and collagen I, III, IV and elastin were 
ascertained by switching between DAPI and FITC filters. Excitation and emission 
wavelengths for FITC were λex 495 nm/λem 515 nm, and for DAPI were λex 385 nm/λem 
461 nm. 
 
2.4.9 Histology and Haematoxylin and Eosin staining (H&E)  
 
Samples were placed in a plastic cassette and embedded with Optimal Cutting 
Temperature (OCT) compound (Tissue-Tek® 4583) to freeze them down immersing 
samples in liquid nitrogen for few seconds. After formation of blocks, samples were 
labeled and kept at -80ºC. 
 
Samples were sectioned with a cryostat (Leica CM300), refrigeration sectioning device, 
to get 10 µm sections in the School of Dentistry, University of Sheffield, Sheffield and 
mounted on frosted slides (Fisher Scientific, UK Ltd.). 
 
Slides were kept at cold temperature with ice and they were brought back to the Kroto 
Research Institute for direct staining with haematoxylin and eosin staining (H&E). The 
OCT melts and the slides were soaked in water for 2 min before they were stained with 
Harris haematoxylin (Sigma-Aldrich, Dorset, UK) for 8 min. After 2 washes in tap 
water by dunking samples, the slides were stained with eosin (Sigma-Aldrich, Dorset, 
UK) for 3 min. Then, samples were dehydrated through 70% alcohol (IMS; Industrial 
Methylated Spirit, Fisher Scientific, UK Ltd.) for 1 min, 95% alcohol for 1 min and 
100% alcohol for 5 min, respectively. Finally, they were cleaned in 2 changes of xylene 
(Fisher Scientific, UK Ltd.), 1 min each and mounted with a coverslip using a DPX 
mounting medium (Fisher Scientific, UK Ltd.).  
Several images were taken of each slide using a light microscope.  
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2.4.10 Scanning electron microscope (SEM) 
 
All samples were fixed in 3.7% formaldehyde. After three washes in PBS, the samples 
were incubated for 5 min with the addition of 2 mL 0.1 M cacodylate buffer. After 
removal of the cacodylate, 2 mL 2.5% gluteraldehyde in distilled water was added and 
incubated as above for 30 min. The gluteraldehyde was aspirated and again 2 mL of 
cacodylate buffer added to rinse any remaining gluteraldehyde. Thereafter 500 µL of 
osmium tetraoxide was added and incubated for 2 h. The osmium tetraoxide was 
aspirated and 2 mL cacodylate buffer added and left for 15 min. Subsequently the 
samples were incubated for 15 min with 75, 95 and 100% ethanol and finally freeze 
dried for 16 h. 
 
Samples were bisected and mounted on 12.5 mm stubs. The samples were sputter 
coated with approximately 25 nm of gold (Gold coater; Edwards sputter coater S150B, 
Crawley, England), and then examined using a scanning electron microscope (SEM) 
(Philips/FEI XL-20 SEM; Cambridge, UK) at an accelerating voltage of between 10-15 
kV and a SPOT size between 2 and 3.A  
 
 
2.5. Rapid extraction of ADSCs 
 
2.5.1 GentleMACS® Dissociator   
 
9 mL of subcutaneous human adipose tissue was transferred into the gentleMACS C 
Tube (Miltenyi Biotec Ltd, Surrey, UK) containing 1 mL of PBS with 1% of antibiotics; 
penicillin (100 units/mL) and streptomycin (100 µg/mL). The C Tube was tightly closed 
and attached upside down onto the sleeve of the gentleMACS Dissociator (Miltenyi 
Biotec Ltd, Surrey, UK). A defined gentleMACS Program by the manufacturer was run 
(we tried 2 programs both of 30 sec but at different speeds). After termination of the 
program 10 mL of HANK solution with 0.1% collagenase type A (Roche Diagnostics 
GmbH, Mannheim, Germany), 0.1% BSA and 1% antibiotic (penicillin/ streptomycin) 
were added to the tissue, and incubated for 45 min at 37 °C, 5% CO2 under continuous 
rotation using the MACSmix Tube Rotator (Miltenyi Biotec Ltd, Surrey, UK). 
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Digested tissues were centrifuged at 1300 rpm for 8 min. The floating fractions 
consisting of adipocytes were discarded and the pellets representing the SVF were 
resuspended in DMEM medium. Cells were washed by centrifugation at 1300 rpm for 8 
min, and finally, pellets were resuspended and cells seeded with the same medium in 
one T25 flask. Cells were maintained at 37°C and 5% CO2.  
 
2.5.2 MACS® Separation 
 
After isolation of the SVF, the cell number was determined. Cell suspension in DMEM 
medium was centrifuged at 1300 rpm for 10 min and afterwards the supernatant was 
completely aspirated. The cell pellet was resuspended in 60 µL of buffer per 107 total 
cells. Buffer composed by PBS, pH 7.2, 0.5% BSA and 2 mM EDTA. 
20 µL of FcR Blocking Reagent (Miltenyi Biotec Ltd, Surrey, UK) and 20 µL of CD271 
MicroBeads (Miltenyi Biotec Ltd, Surrey, UK) were added, well mixed and incubated 
for 15 min in the refrigerator (2−8 °C). Then, cells were washed by adding 1−2 mL of 
buffer and centrifuged at 1300 rpm for 10 min. The supernatant was completely 
aspirated and cells were resuspended in 500 µL of buffer. 
A LS column (Miltenyi Biotec Ltd, Surrey, UK) was placed in the magnetic field of a 
suitable MACS Separator (Miltenyi Biotec Ltd, Surrey, UK). The column was firstly 
prepared by rinsing 3 mL of buffer. The cell suspension was applied onto the column 
and the flow-through containing unlabeled cells was discarded. The column was washed 
3 times with 3 mL of buffer discarding all the unlabelled cells. Finally, the column was 
removed from the separator and placed it on a suitable collection tube. 5 mL of buffer 
was pipetted onto the column. Labelled cells were centrifuged at 1300 rpm for 5 min 
and pellets were resuspended and seeded with DMEM medium into one T25 flask. Cells 
were maintained at 37°C and 5% CO2. 
 
 
2.6 Animal studies 
 
Scaffold production and human ADSCs isolation was performed in the Kroto Research 
Institute, University of Sheffield, as described above. Cells and PLA scaffolds were sent 
to the Laboratory of Experimental Gynaecology, University Hospital Leuven, for 
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sample preparation. Rat ADCSs isolation and characterization of rat and human ADSCs 
were also carried out in this laboratory. Animal surgery was conducted in the Centre for 
Surgical Technologies, Katholieke Universiteit Leuven. After sacrifice, samples were 
paraffin fixed in the Laboratory of Experimental Gynecology and histological analyses 
were conducted at the Kroto Research Institute. 
 
2.6.1 Implantation 
 
All procedures were conducted under Ethical Approval with license number LA 
1210249 from the Ethical committee of the Katholieke Universiteit Leuven.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4 Animal implantation of Th-PLA scaffolds cultured with and without human 
or rat ADSCs. (a) Preparation for surgical procedure. (b) Skin incision and flaps of the 
subcutaneous layer were raised. (c) Suture of sample at four corners. (d) Subcutaneous 
and skin layers closure. 
a b 
c 
d 
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6 different groups of samples were implanted subcutaneously on the abdominal wall of 
female Sprague-Dawley rats: 
 
1. 6 Th-PLA scaffolds without cells cultured for 2 weeks in DMEM medium were 
implanted in 6 rats respectively to sacrifice them at day 3. 
2. 6 Th-PLA scaffolds without cells cultured for 2 weeks in DMEM medium were 
implanted in 6 rats respectively to sacrifice them at day 7. 
3. 6 Th-PLA scaffolds cultured with rat ADSCs for 2 weeks in DMEM medium were 
implanted in 6 rats respectively to sacrifice them at day 3. 
4. 6 Th-PLA scaffolds cultured with rat ADSCs for 2 weeks in DMEM medium were 
implanted in 6 rats respectively to sacrifice them at day 7. 
5. 6 Th-PLA scaffolds cultured with human ADSCs for 2 weeks in DMEM medium 
were implanted in 6 rats respectively to sacrifice them at day 3. 
6. 6 Th-PLA scaffolds cultured with human ADSCs for 2 weeks in DMEM medium 
were implanted in 6 rats respectively to sacrifice them at day 7. 
 
All samples were incubated with CellTracker™ Green BODIPY ® dye (Gibco 
Invitrogen, Paisley, UK) before seeding on Th-PLA scaffolds to track the rat or human 
ADSCs after implantation and sacrifice. 
When the cells reached the desired confluence, the medium was removed from the dish 
and prewarmed CellTracker™ dye working solution was added. Cells were incubated 
for 30 min under growth conditions. Then, the dye working solution was replaced with 
fresh prewarmed medium and cells were incubated for another 30 min at 37°C. During 
this time, the chloromethyl group (and for some probes, the acetate group) of the dye 
undergoes modification or are secreted from the cell. At this point we centrifuged cells, 
counted them and 700,000 cells were seeded on 1 cm2 PLA scaffolds using a metal ring 
of 1 cm diameter. 
All samples were cultured for 2 weeks with DMEM medium changing medium every 3 
days. 
 
For surgical procedures, animals were placed in a 100% isoflurane (Isoba®) induction 
chamber. After adequate induction of anesthesia (initiated at 3% and further determined 
by lack of response to stimulation and toe pinch) the animal was moved to a warming 
pad. The animal was kept under anesthesia by isoflurane via a nose cone (figure 2.4a).  
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After the belly of the animals were shaved and disinfected with Braunol® 7.5% 
(B/BRAUN), they received a skin incision and flaps of the subcutaneous layer were 
raised (figure 2.4b). Then, samples were sutured on the abdominal wall with 
reabsorbable sutures Ethicon®/Prolene* (4-0/RB-1 17 mm 1/2c) on four corners of each 
sample (figure 2.4c). Closure of subcutaneous and skin layers was performed with 
reabsorbable sutures Ethicon®/Vicryl* (2-0/FS-1 24 mm 3/8c) (figure 2.4d).  
 
After recovery from anesthesia 6 animals from each group were housed in labeled cages 
and observed for recovery. 
 
2.6.2 Sacrifice and sample fixation   
 
After 3 or 7 days post-implantation, as specified above, animals were sacrificed by intra 
heart injection of T-61 (Embutramide 200 mg, mebenzoniumiodide 50 mg, tetracaïne 
hydrochloride 5 mg, per mL) (Intervet, International B.V.) after isoflurine anesthesia.  
Skin and subcutaneous sutures were removed and abdominal walls with scaffold on top 
were exposed (figure 2.5). Square pieces of abdominal wall with samples on top were 
cut, as well as, spleen, liver and lymphoid nodes were removed. 
 
Figure 2.5 Animals sacrificed and the appearance of sample on top of abdominal wall. 
 
Each sample from sacrifice at day 3 of implantation was placed in labeled tubs 
containing 10% formalin (Sigma-Aldrich). Samples from groups sacrificed at day 7 
were cut in half, and half was kept in 10% formalin as well, and the other half was 
placed in a plastic cassette and embedded with OCT compound (Tissue-Tek® 4583). To 
freeze them down samples were immersed in smashed dry ice with 2-methylbutane 
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solution (Sigma-Aldrich). After block formation, OCT labeled samples were kept at -
80ºC. 
 
2.6.3 Histology 
 
After 24 h in 10% formalin, samples were placed in labeled plastic tissue cassettes and 
were moved to new labeled pots containing 96% ethanol (Farogon).  
At this point samples can be kept for a long period, but all of them were placed in a 
tissue processor after 1-3 days being in 96% ethanol. At this stage, samples were 
dehydrated by transfer from 96% ethanol to more concentrated ethanol (100%). Then, 
samples were transferred though baths with toluidine (Labnord) from lower to higher 
concentrations to remove alcohol with a hydrophobic clearing agent. Samples were 
finally placed in molten paraffin wax, as infiltration agent which replaces the toluidine. 
To make the final paraffin blocks samples were processed in an embedding machine 
(Chandon CITADEL 1000, HVL) using molten paraffin and molds which were quickly 
cooled down to form the blocks.   
 
2.6.3.1 Fresh frozen section 
 
Frozen tissues from animals sacrificed 7 days after implantation were processed with a 
cryostat (Leica CM300), refrigeration sectioning device, to get 10 µm sections in the 
School of Dentistry, University of Sheffield and mounted on frosted slides. 
The OCT melts and the slides are soaked in water for 2 min before they were mounted 
with a coverslip using DPX mounting medium. Finally, slides were imaged using Zeiss 
Laser Confocal Microscope LSM 510 META (Carl Zeiss Inc., Germany). 
 
2.6.3.2 H&E 
 
Paraffin formalin fixed samples were processed with a microtome (Leica TP 1020 
Automatic Tissue Processor) for sectioning to produce 6 µm sections placed on frosted 
slides. After letting them dry for one day, samples from each group were processed for 
conventional H&E staining. 
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Sections were deparaffinized by 2 changes of xylene, 3 min each, and then re-hydrated 
in 3 changes in IMS from 100% absolute alcohol (5 min) to 95% alcohol (1 min) and 
finally 70% alcohol (1 min). After this, samples were washed briefly in distilled water, 
and were stained in Harris haematoxylin for 8 min. After another wash in running tap 
water for 5 min samples were stained in eosin for 3 min. Then, samples were 
dehydrated through 70% alcohol (IMS) for 1 min, 95% alcohol for 1 min and 100% 
alcohol for 5 min, respectively. Finally, they were cleaned in 2 changes of xylene, 3 min 
each and mount with a coverslip using a DPX mounting medium.  
Several images were taken of each slide with a light microscope. 
 
2.6.3.3 Immunohistochemistry and Sirius red staining 
 
Paraffin formalin fixed samples were processed with a microtome (Leica TP 1020 
Automatic Tissue Processor) for sectioning to produce 6 µm sections placed on 
Superfrost® plus slides (Menzel-Gläser, Denmark). 
 
After letting the samples dry for one day, samples from each group were processed for 
immunohistochemistry.  
Primary Ab included mouse anti-human CD29, CD44 and CD73 R-Phycoerythrin (PE) 
conjugated (1:50; BD, Pharmagien); and 6 Ab non-conjugated: mouse anti human beta- 
2 microglobulin (1:50; Abcam, UK), mouse anti-rat CD68 (1:200; Abcam, UK), goat 
anti-rat Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) (1:50; Santa Cruz 
Biotechnology, Inc.), goat anti-human collagen I (1:50; AbD serotec, Oxford, UK) and 
goat anti-human collagen III (1:50; AbD serotec, Oxford, UK).  
As secondary antibodies, biotinylated goat anti-mouse Ig (1:200; BD, Pharmagien) (for 
CD68), biotinylated goat anti-mouse IgG (1:1000; Vector labs, Peterborough, UK) (for 
beta-2 microglobulin) and biotinylated anti-goat Ig (1:200; ImmunoCruzTM goat ABC 
Staining System, Santa Cruz Biotechnology, Inc.) (for PECAM-1, collagen I and 
collagen III) were used. 
 
Samples were deparaffinized by 2 changes of xylene, 1 min each, and then, re-hydrated 
with 2 changes in 100% absolute alcohol (IMS), 3 min each, and 10 min in 95% 
alcohol. After this, samples were washed briefly in distilled water, and 2 washes more 
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with Tween 20-PBS (PBS 1% Tween 20, Sigma-Aldrich, Dorset, UK) were given of 2 
min each. 
An antigen retrieval step was performed to break the protein cross-links, therefore 
unmasking the antigens and epitopes in formalin-fixed and paraffin embedded tissue 
sections, thus enhancing staining intensity of antibodies, with 0,05% trypsin (v/w) 
(Porcine trypsin, Sigma-Aldrich, Dorset, UK) and 0.1% Calcium Chloride (v/w) 
(Sigma-Aldrich, Dorset, UK) in distilled water, by 20 min incubation at 37ºC. 
After 10 min at room temperature to cool down samples, sections were washed by two 
changes in Tween 20-PBS, 2 min each, and incubated with 1,5% blocking serum 
(ImmunoCruzTM goat ABC Staining System, Santa Cruz Biotechnology, Inc.) in PBS 
for 30 min to avoid non-specific staining.   
After this, 2 washes were given with Tween 20-PBS, 2 min each, and samples were 
incubated overnight at 4ºC with primary antibodies diluted in 1.5% blocking serum. 
The day after, sections were washed 3 times in Tween 20-PBS, 2 min each, and 
incubated for 10 min with 3% H2O2 (hydrogen peroxide) in distilled water to quench 
endogenous peroxidase activity. 
Again slides are washed once in Tween 20-PBS for 2 min and then incubated with 
secondary antibodies diluted in 1.5% blocking serum. 
After 3 more washes with Tween 20-PBS and samples were incubated with AB reagent 
(2% avidin and 2% biotinylated HRP in PBS, ImmunoCruzTM goat ABC Staining 
System, Santa Cruz Biotechnology, Inc.) binding secondary antibodies. 
Samples were washed 3 more times with Tween 20-PBS, 2 min each, and HRP 
(horseradish peroxidase) activity developed brown staining by a final incubation for a 
few min with chromogen/peroxidase substrate (10X substrate buffer, 50X DAB 
chromogen and 50X peroxidase substrate in distilled water, ImmunoCruzTM goat ABC 
Staining System, Santa Cruz Biotechnology, Inc.). When the desired staining was 
developed, by checking samples under light microscope, these were washed briefly with 
distilled water to stop the reaction followed by 2 more washes with Tween 20-PBS, 2 
min each. 
Samples were counterstained with Harris haematoxylin for 3 seconds and excess 
staining was eliminated by several washes in distilled water.  
Finally, samples were dehydrated again for 10 min in 95% alcohol, followed by 2 
changes in 100% alcohol of 3 min each. Samples were cleaned by 2 changes of xylene, 
3 min each, and were mounted with a coverslip using DPX mounting medium.  
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Several images were taken of each slide with a light microscope.  
 
For the 3 conjugated Ab (CD29, CD44 and CD73) and for beta-2 microglobulin Ab, the 
slides were processed as previously described in section 2.3.3. For the latter a secondary 
Ab biotinylated anti-mouse Ig (1:1000; Vector labs, Peterborough, UK) against the 
primary Ab was used and a tertiary Ab, fluoroescein-streptavidin (1:100; Vector labs, 
Peterborough, UK) was used to image the slides using a Leica DM-IRB inverted 
research microscope (Leica, Bensheim, Germany), as described in section 2.3.3. 
 
Groups of controls were added for this fluorescent staining as described in section 2.3.3.  
For the slides detected by peroxidase detection, 3 more groups of controls were 
performed for each sample following the same immunohistochemistry procedure but 
avoiding incubations with primary and secondary antibodies, or incubating only with 
secondary antibodies (no primary antibodies), therefore, only with biotinylated goat anti 
mouse Ig (1:200; BD, Pharmagien) (for CD68), or only with biotinylated anti-goat Ig 
(1:200; ImmunoCruzTM goat ABC Staining System, Santa Cruz Biotechnology, Inc.) 
(for PECAM-1, collagen I and collagen III).  
 
In another experiment, new sections were stained for Sirius red (0.1% Direct Red 80 in 
saturated picric acid) following a similar protocol.  
Paraffin formalin fixed samples were processed with a microtome (Leica TP 1020 
Automatic Tissue Processor) for sectioning to produce 6 µm sections placed on 
Superfrost® plus slides. 
After letting them dry for one day, samples were deparaffinized with 2 changes of 
xylene, 3 min each, and then, re-hydrated with 2 changes in 100% absolute alcohol 
(IMS), 3 min each, and 10 min in 95% alcohol. After this, samples were washed briefly 
in distilled water and incubated with Sirius red for 1 h. Then, samples were rinsed 
briefly in distilled water and washed in acetic acid solution (VWR International Ltd.) 
for 1 min. Again, sections were rinsed briefly in distilled water and dehydrated by 10 
min in 95% alcohol, followed by 2 changes in 100% alcohol, 3 min each. Slides were 
cleaned by 2 changes of xylene, 3 min each, and were mounted with a coverslip using 
DPX mounting medium.   
Several images of each slide were taken with a light microscope. 
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2.7 Statistical analysis 
 
All the in vitro experiments were carried out at least 3 times. At least 9 images from 
each group were used for the blind scoring of immunostaining and histology images. 
The data was reported as mean± SEM. To determine the significance of differences 
between groups two-sample Student’s t-test analysis was performed for all analyses in 
this thesis.  
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Chapter 3 
 
PRODUCTION OF CANDIDATE SCAFFOLDS  
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3.1 Introduction 
 
PLA is an FDA approved synthetic biodegradable and biocompatible polymer of lactic 
acid produced by ring opening polymerisation of lactic acid. PLA is hydrophobic, semi-
crystalline and amorphous polymer, and has a glass transition temperature between 60-
65o and a melting temperature of around 170o. The monomer has chirality, and has two 
conformations dextro (D) and levo (L), P(L)LA, P(D)LA or P(D,L)LA. Pure P(L)LA 
was first used as a suture material in 1960 (347). Currently, both conformations have 
been used as a biomaterial for a variety of different clinical applications.  
Degradation of PLA occurs via acid catalysed hydrolysis into lactic acid, which is 
metabolised in vivo via the Krebs cycle (348, 349). PLA has a high degree of 
crystallinity and degradation starts in the amorphous regions with random hydrolysis. 
After sufficient degradation has occurred the edges of the crystalline regions become 
degraded. P(D)LA has a significantly reduced crystalline structure, and therefore 
degrades more rapidly than P(L)LA.  
 
Several methods have been used to fabricate highly porous biodegradable polymer 
scaffolds; including particulate-leaching, fibre extrusion and bonding, phase separation, 
gas foaming, emulsion freeze drying, 3-D printing techniques and electrospinning (350-
355).  
The choices of polymer such as its fabrication method and scaffold morphology are 
critical determinants for production of an engineered tissue before adding the cellular 
component (356, 357). A good example for this is PPL mesh which is the gold standard 
material used to treat SUI and POP. Type 1 PPL mesh that is macroporous (>75µm) is 
said to be most favourable for tissue integration into native tissues as microporous (<15-
20µm) mesh may allow infilltration by bacteria but not by the larger host inflammatory 
cells (172). 
 
Electrospinning is a technique where a polymer in a solution is exposed to a high 
voltage and simultaneously drawn into a fibre shape via electrostatic forces as it 
attempts to bridge the gap to earth. The most commonly used setup for an 
electrospinning rig is that of a horizontal rotating collector earthed or negatively 
charged, and of a syringe containing the polymer connected to a voltage generator. The 
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syringe with the polymer solution is placed in front of the collector and when the 
electrostatic force goes above a critical value it overcomes the surface tension of the 
polymer solution and a thin jet travels through the syringe and onto the collector. The 
fibres are stretched and elongated and quickly solidify due to evaporation of solvent.  
Over the years there have been several different setups developed for the production of 
scaffolds made of electrospun fibres. Techniques have been modified to allow the 
spinning of more than one polymer mixed in one collector, to improve the thickness of 
the fibres and/or to produce aligned fibres (358). All these parameters can affect the 
mechanical properties of electrospun scaffolds. Also, post-production treatment can  
impact on mechanical characteristics; we have previously shown that thermo-annealing 
of poly lactic-co-glycolic (PLGA) scaffolds in a dry oven at 60o for 3 hours improved 
the mechanical and handling properties (359). This effect is thought to occur due to 
heating above the glass transition temperature which increases the crystallinity of the 
polymer and leads to changes in fibre morphology from purely fibrillar to a mix of 
fibrillar and nanogranular with greater inter-fibrillar bonding (360).  
 
Electrospinning, in general, has gained increasing popularity in tissue engineering as it 
can be used with a wide range of synthetic and natural polymers. Constructs from the 
nano to micrometer range can be produced for 3D tissue engineering and closely mimic 
the environment of native tissue ECM. In 1999, the electrospinning technique was first 
used for tissue engineering, where spun silk-like polymer was used to produce a 
biocompatible film which was implanted into the central nervous system (361).  
PLA electrospun scaffolds have now been used for a variety of purposes ranging from 
bone (362), skin (363), bladder (364), nerve guide conduits (365), adipose tissue (366) 
and cartilage (367).  
Neural stem cells have been seeded and cultured on electrospun PLA made of aligned 
fibres for nerve tissue guides (368). A lot of work is currently done on this with 
potential for peripheral nerve repair (369, 370). Electrospun PLGA scaffolds have been 
used to create tubes simulating small blood vessels (371). Furthermore, during the last 
few years, electrospun PLA has been combined with osteoblasts as a bone substitute 
(372). 
In vivo, electrospun PLA has been shown to undergo slow degradation since the 
scaffold retained an acceptable strength 8 months after implantation (373). Compared to 
PPL, PLA scaffolds showed a significantly lower inflammatory response when both 
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materials were implanted into the abdominal wall of rats. In addition, the collagen 
produced was better organized in PLA scaffolds (374). They also found decreased 
mechanical properties when the scaffolds were gamma sterilised before implantation. 
On the other hand, mechanical properties of PLA scaffolds post explantation were 
always higher than PPL at all time points up to 90 days implantation in vivo. The same 
authors also reported PLA to have less infection risk compared to other meshes in a rat 
infected abdominal model (375).     
 
The scaffold candidate to develop a TERM for pelvic floor repair was chosen from 
previous work undertaken in our group.   
The potential of 7 different scaffolds materials to develop a TERM were assessed. 
These included synthetic and biological materials currently used as acellular materials 
to treat SUI and POP, including PPL. By seeding and culturing OFs on these materials, 
it was determined that thermo-annealed PLA (Th-PLA) and SIS represented the best 
candidate scaffolds in terms of cell attachment and proliferation and formation of ECM 
proteins (346). From this initial work Th-PLA was chosen as the scaffold to be 
investigated further to avoid the use of  animal material, such as SIS, with risk of 
infectious disease transmission and the potential concerns of surgeons and patients with 
using such material. In addition, already reviewed in the introduction of this thesis, 
acellular SIS is often quickly degraded leading to failure and recurrence when used in 
patients with SUI and POP. 
 
 
3.2 Comparison between PLA and thermo-annealed PLA (Th-PLA) 
scaffolds 
 
Morphological, physical and mechanical properties of PLA scaffolds before and after 
being thermo-annealed were assessed. For this, the pores and fibre diameter (figure 
3.2.1 and 3.2.2) were determined by using ImageJ software from SEM images (n>100 
fibres and from at least 2 images), the bulk density was calculated from the size and 
weight of the different samples and mechanical properties (figure 3.2.3) of these 
scaffolds were assessed by using a BOSE tensiometer.  
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Figure 3.2.1 SEM images of PLA scaffolds (right). Pores diameter (a) and fibre 
diameter distribution (b) calculated from 100 fibres (n = 3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.2 SEM images of Th-PLA scaffolds (right). Pores diameter (a) and fibre 
diameter distribution (b) calculated from 100 fibres (n = 3).  
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As shown in SEM images, PLA scaffolds consisted of random microfibres which form 
a microporous scaffold simulating the ECM of native tissues. From our results, fibres of 
PLA scaffolds had a mean diameter of 3.5 µm forming pores of 40 µm of diameter; 
however, after being thermo-annealed the mean for fibre diameter was reduced at 2.5 
µm, as well as the pores diameter being reduced to around  30 µm. 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.3 Mechanical properties of PLA and Th-PLA scaffolds, mean±SEM (n = 3). 
Last sample shown is the range for native tissue represented by 2 dashed lines (the 
range for native healthy paravaginal tissue). (a) YM, **p<0.005. (b) UTS, 
***p<0.0005. (c) Strain at UTS, **p<0.005. (d) Bulk density of PLA and Th-PLA 
scaffolds (**p<0.001) and its thickness (n = 3). 
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As previously explained, when measuring the tensile properties of a material, Young’s 
modulus is the first linear slope when a material is stretched, observed from a typical 
stress-strain plot (figure 2.2). The higher the slope, the stiffer is the material; however, 
this parameter is called elastic modulus too, because, the elongation of the material 
during this linear slope is elastic deformation allowing recoil to its original size. Once 
the linear portion finishes all the elongation observed is plastic deformation. Then, the 
other 2 parameters, normally found in literature, to describe the tensile properties of a 
material are the UTS and the strain at UTS. UTS is the maximum strength of a material, 
and the strain at UTS shows the maximum elongation of the material before it starts to 
snap.  
All samples assessed in this thesis for a uniaxial tensile test were measured for size. 
Stress-strain data from each sample was normalized before the 3 mechanical properties 
were plotted, dividing the stress by the area of the scaffold (width x thickness) and 
dividing the strain by the length between the 2 grids (length of the scaffolds tested) to 
obtain a percentage of elongation from its original length.  
 
Th-PLA scaffolds showed significantly higher Young’s modulus and UTS when 
compared to non thermo-annealed PLA scaffolds. Alternatively, the strain at UTS was 
significantly higher for non thermo-annealed PLA scaffolds (figure 3.2.3). 
These parameters were compared to the range for the native healthy paravaginal tissues 
(endopelvic fascia) obtained from the literature (194). Non thermo-annealed PLA 
scaffolds were between this range for Young’s modulus and UTS, while Th-PLA 
scaffolds showed a strain at UTS between this range (figure 3.2.3).  
 
Finally, the bulk density and thickness of these scaffolds were measured. The bulk 
density was calculated by measuring the volume of small pieces of these scaffolds 
(length x width x thickness) and their weight. Then, since we know the density of PLA 
we can work out the expected weight for this volume, if it was a compact sheet; and 
finally, the data shown is the percentage of material found in this volume, the rest of 
this is “air” and this is a way to describe the porosity of these materials. The thickness 
was measured with a micrometer. 
Th-PLA scaffolds were significantly more compact leading to lower porosity (figure 
3.2.3).   
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3.3 In vitro degradation of Th-PLA scaffolds 
 
From previous results we had already chosen our scaffold candidate; therefore, the in 
vitro degradation was only studied for Th-PLA scaffolds by looking at the mechanical 
properties of these scaffolds at 0, 14, 30 and 90 days. These were kept in DMEM 
medium under sterile conditions inside the incubator (37oC in a 5% CO2 atmosphere).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.1 Mechanical properties of Th-PLA scaffolds at day 0, day 14, day 30 and 
day 90 after being in DMEM, mean±SEM (n = 3). Last sample shown is the range for 
native tissue represented by 2 dashed lines (the range for native healthy paravaginal 
tissue). (a) YM, *p<0.05. (b) UTS, *p<0.05. (c) Strain at UTS, ***p<0.0001. 
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Th-PLA scaffolds reduced their tensile properties over time. Young’s modulus and UTS 
were significantly reduced from day 0 to day 14. At day 30, both values were 
unchanged, but after 90 days in DMEM medium these were reduced again. At 90 days, 
Young’s modulus remained slightly greater than the range for native tissues though.  
On the other hand, strain at UTS was maintained between the values for native tissues 
without significant differences up to 30 days. Only at day 90, this was reduced very 
significantly and now fell within the range for native tissues (figure 3.3.1).  
 
 
3.4 Discussion  
 
With electrospinning we were able to produce scaffolds made of biodegradable and 
biocompatible PLA. With this technique we can produce a sheet of 18 cm by 16 cm in 
about 2 h. Furthermore, PLA is an extremely cheap product which, as an FDA approved 
material, has been already used for different clinical applications. 
 
PLA scaffolds are composed of microfibres which in turn form microporous scaffolds. 
As described in the first Chapter of this thesis, macroporous materials present pores  
bigger than 75 µm. PPL mesh, that is macroporous, is said to be most favourable, as 
microporous (<15-20 µm) mesh may allow infiltration by bacteria but not by the larger 
host inflammatory cells (376). PLA scaffolds present pores of 40 µm, and are reduced 
to 30 µm after thermo-annealing. Both scaffolds also have a low percentage of 
macropores.  
Most of the fibres of PLA scaffolds seem to reduce their diameter after being thermo-
annealed; nevertheless, a small percentage of fibres are wider, compared with non 
thermo-annealed scaffolds, thus scaffolds are made of 2 different groups of fibres. Fibre 
morphology is changed after thermo-annealing from purely fibrillar to a mix of fibrillar 
and nanogranular fibres. Some parameters such as temperature and humidity have an 
enormous effect on the electrospinning of PLA scaffolds, and this can affect the fibre 
diameter and pore size (377), making the electrospinning process poorly reproducible 
unless these are tightly controlled.   
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On the other hand, thermo-annealing of PLA scaffolds increases the inter-fibrillar 
unions what may be the main reason for the effect on mechanical properties. Th-PLA 
scaffolds were stiffer (higher Young’s modulus) and stronger (higher UTS) compared to 
non thermo-annealed PLA scaffolds. Similarly, these 2 parameters may be also 
increased by a higher crystallinity of the PLA fibres after being thermo-annealed. At the 
same time, this higher crystallinity may lead to more brittle fibres which correlates with 
lower elongation of Th-PLA scaffolds at the point they start to snap. 
Also, the thickness of Th-PLA scaffolds was found to be reduced compared to non 
thermo-annealed PLA scaffolds, which is explained by higher bulk density leading to 
more compact scaffolds (with less porosity), explaining the small reduction in pore 
diameter.  
These changes had an impact on the handling of the Th-PLA scaffolds, making this 
material less fluffy and the fibres less sticky, making it easier to peel the scaffold from 
the foil after the electrospinning.    
For these reasons, Th-PLA scaffolds were chosen for further experiments. In addition, 
the fact that they have stronger mechanical properties than native tissues (194) was 
desirable because of the expected degradation of the PLA fibres over the time. We 
believe if after implantation the mechanical properties drop to under the values for 
native tissues this may lead to the failure of the material and the recurrence of SUI/POP, 
which is further discussed in Chapter 7 of this thesis.  
 
It was observed that there was a reduction of all 3 mechanical properties of Th-PLA 
scaffolds over 90 days when cultured in DMEM medium in vitro.   
Although Young’s modulus and UTS were reduced since the second week in culture, 
this was not very significant and both properties remained always over the values for 
native tissues or within these, respectively. Alternatively, strain at UTS was only 
dropped after 90 days but being very significantly and becoming a brittle material which 
snaps at lower elongation than native tissues.  
 
Other studies have shown long term retention, for up to 8 months, of mechanical 
properties of PLA scaffolds after implantation (373) as they have a slow degradation 
rate. Furthermore, neo-tissue formation by collagen remodelling, that normally happen 
in most materials before 90 days since they are implanted (311, 313), may increase or 
maintain the mechanical properties of the scaffolds for long-term repair. Nevertheless, 
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animal studies are needed for better understanding of this since, for instance, PLA 
scaffolds may be degraded faster in the vaginal environment as has been seen for other 
materials (293).  
It is difficult to answer which are the desired mechanical properties of a material for 
pelvic floor repair, and this will be further discussed in another Chapter of this thesis. 
Our group have published a systematic review trying to answer this question and it was 
impossible to predict the clinical outcomes of a material based on its mechanical 
properties alone (378).  
   
In conclusion, we found that Th-PLA scaffolds increased in stiffness and strength, 
compared to non thermo-annealed PLA scaffolds. We emphasize the relevance of this in 
preparing material for the repair of the pelvic floor, to obtain a material which is easy to 
handle surgically, with the necessary mechanical properties to fulfill its purpose at the 
point of insertion and to maintain the long-term integrity of the repair (378).  
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Chapter 4 
 
EXPLORING CELL CANDIDATES FOR A TISSUE 
ENGINEERED REPAIR MATERIAL (TERM) 
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4.1 Introduction 
 
Cells can be isolated from several sources. The ethical use, safety isolation, timing, 
proliferation, viability, production of the ECM components, and their capacity to 
promote neovascularization or to induce an inflammatory response after their 
transplantation are all relevant. All these characteristics should be considered when 
exploring which cell type is the most appropriate for production of a TERM such as 
their potential for further new tissue formation after their implantation. 
 
4.1.1 Fibroblasts 
 
At first glance vaginal fibroblasts seem to be the most appropriate cell candidate since 
they come from the native tissue. Fibroblasts from vaginal wall have been easily 
excised during vaginal hysterectomies as a minimally invasive method, in patients with 
POP.  
However, studies of cultured vaginal fibroblasts from patients with POP found a 
correlation between slow proliferation and a low ratio of collagen I/III. Patients with a 
higher ratio of collagen I/III had fibroblasts with faster proliferation; nevertheless, this 
fibroblastic behaviour cannot be predicted since it did not correlate with age or POP 
stage (336). Neo-fascia was formed when seeding these cells isolated from the vaginal 
wall of patients with POP on collagen coated PLGA. Alternatively, the ECM was not 
very well organized for slow proliferative fibroblasts. A few more studies have also 
investigated the capacity of vaginal fibroblasts to coat different meshes (379) and to 
synthesize collagen (380) for POP repair.  
How collagen metabolism is affected in vaginal fibroblasts from patients with SUI and 
POP is not completely understood. Nevertheless, there is a high risk of finding cells 
with altered synthesis of structural components and of their metabolic enzymes if 
autologous fibroblasts are isolated from the vaginal wall of these patients. Since we aim 
for an aurologous approach where cells used are isolated from same patient during the 
same operation, and which is further discussed in the last Chapter of this thesis, we did 
not consider vaginal fibroblast for this research. In addition, the excision of these tissues 
can lead to donor site comorbidities and further complications.  
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Buccal mucosa tissue is composed of a thick epithelium and highly vascularized lamina 
propia (381). Buccal mucosa grafts have been used in urethroplasty for fifty years (382). 
OFs are considered the most versatile cell candidate to develop an engineered urethral 
substitute (383). Fibroblasts from buccal mucosa can also adapt easily to new 
environments, the grafts underwent limited contraction, have useful strength and are 
resistant to infection (384). In addition, they present minimal donor and recipient site 
complications, and it is an easy to access tissue (384). These cells have shown good 
proliferation and ECM formation when used in a biodegradable scaffold to form an 
engineered tissue for urethroplasty (385).   
 
There are only a few studies looking at the potential of vaginal fibroblasts or OFs to 
develop engineered tissues for pelvic floor reconstruction. In vivo, only de Filippo et al. 
assessed a vaginal engineered tissue produced from vaginal epithelial cells and smooth 
muscle cells from female rabbits (334).  
 
4.1.2 Adult stem cells 
 
Stem cells can be isolated from different sources, and all of them share several 
characteristics such as long-term replicative potential and self-renewal, maintenance of 
undifferentiated properties and multi-lineage differentiation ability (340).  
Multipotent stem cells are also known as foetal/adult stem cells (ASCs) or tissue-
derived stem cells. An ASC is an undifferentiated cell found in a differentiated tissue 
with the primary function to maintain the steady state functioning of a tissue (called 
homeostasis) and, with limitations, to replace cells that die because of injury or disease. 
When these cells divide into two cells, one cell will keep undifferentiated to maintain 
their population and the other cell is called a somatic stem cell or progenitor cell, which 
are limited in their potential, and will differentiate into mature functioning cells 
responsible for normal tissue renewal. These progenitor cells can be specialized to yield 
all of the cell types of the tissue from which it originated. MSCs are ASCs present in 
tissues derived from the mesodermal embryogenic layer and usually divide to generate 
progenitor or precursor cells, which then, differentiate or develop into "mature" cell 
types that have characteristic shapes and specialized functions (386). 
Their multi-lineage differentiation capacity has been extensively characterized (387). 
They remain able to proliferate and differentiate into tissues of mesenchymal origin, as 
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well as into tissues of both endodermal and ectodermal origin thus allowing speculation 
about their pluripotency (388, 389). 
Furthermore, these cells also are characterised as being noninmunogenic (390) and it is 
believed they release paracrine factors to stimulate the regeneration of surrounding 
tissues (391).  
 
All these properties make these cells an interesting source for tissue regeneration. In 
pelvic floor tissues, MSCs have been used to regenerate the middle urethra in SUI 
animal models. Most of these cell therapy studies are based on MSCs derived from bone 
marrow, muscle and adipose tissue. They have been injected into the extrinsic sphincter 
of the urethra, which comprises striated rhabdosphincter voluntary musculature or into 
the intrinsic sphincter of the urethra, which includes mucosa, submucosa, estrogen-
dependent vascular plexus, and smooth muscle layers (one longitudinal and the other 
circumferential) (27). 
 
BMDSCs were the first MSCs to be studied and not only for urethral sphincter 
regeneration. BMDSCs have been implanted into the bladder musculature with 5-
azacitidine as a myogenic differentiation stimulator, and they verified the expression of 
striated and smooth muscles antigens in these cells (392). BMDSCs were also 
transplanted into the urethral sphincter of Sprague-Dawley rats after urethrolysis. After 
13 weeks, the skeletal muscle of the urethral sphincter was regenerated by integrated 
BMDSCs labelled with green fluorescence protein (GFP) although, the abdominal leak 
point pressures were not improved (393). A later study found similar tissue regeneration 
when BMDSCs were implanted into the urethral sphincter of rats after pudendal nerve 
transaction (PNT). In addition, they also found significantly improved Valsava LLP 4 
weeks after injection (394). 
On the other hand, biopsies from bone marrow are painful, frequently requiring general 
or spinal anaesthesia and often a low number of BMDSCs are isolated (395).  
 
MDSCs are obtained under local anaesthesia. They can be isolated from different 
sources; however, those from striated muscle have shown huge improvements for other 
disease models, such as a myocardial infarct model (396). In addition, these cells can be 
differentiated into all mesenchymal cells layers and into neuronal and endothelial 
lineages as well (397, 398). MDSCs are naturally fused into postmitotic multinucleated 
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myotubes with a great potential for ligament/supportive structures formation (399). This 
cell type is the one most proposed to regenerate the urethral sphincter and several 
studies found good tissue regeneration, improved LLP and recovered contractile 
urethral sphincter function when injecting these cells into the urethral sphincter of 
different SUI animal models (table 8). 
On the other hand, to obtain a reasonable content of MDSCs, a large biopsy of skeletal 
muscle (5-30g) is needed with the disadvantage of scar formation. They differentiate 
quickly without any stimulation before you can expand them to get a large number. 
They differentiate into multinucleated fibres which do not have the regenerative 
properties of the MSCs, such as multipotential and releasing paracrine factors (both for 
nerve and blood vessels regeneration). Furthermore, their slow proliferative potential 
increases the cost of the procedure (400).  
 
Finally, in 2000 ADSCs were the last MSCs to be discovered and they have huge 
potential in mesodermal tissue differentiation (401, 402), such as in regeneration and 
revascularization (403, 404). Only 40-60% of the adipose tissue is composed of mature 
adipocytes. ADSCs are easily and quickly isolated from the SVF of the adipose tissue 
which is composed of fibroblasts, macrophages, endothelial cells, hematopoietic cells 
and ADSCs (400). They proliferate very quickly and do not differentiate without 
stimulating differentiation medium. Furthermore, they secrete organized endogenous 
ECM in culture conditions which is interesting for connective tissue formation (343).  
ADSCs have been proven to differentiate into striated muscle, showing specific markers 
(desmin, myod1, myogenin, myosin heavy chain) (405) and to regenerate damage 
skeletal muscle in rabbits restoring volume and muscular contraction (406). Also, 
ADSCs have been used for urethral sphincter reconstruction to improve continence 
outcomes in SUI animal models (table 9), due to their capacity to differentiate into 
smooth muscle cells (401) and to contract and relax under pharmacological stimulation 
(405). In addition, inside the ADSCs population some cells express endothelial surface 
antigen (CD34) and myogenic surface antigen (CD59). The injection of these 
subpopulations of ADSCs in postnatal mice increased neovascularization through an 
increment in blood flux and capillary density compared with controls (403). Finally, 
their multipotential has been proven by their differentiation into neural cells (407). 
ADSCs have shown good potential to regenerate the urethral sphincter (table 9); 
however, all the studies agree that more studies should be done to explain how MSCs 
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improve urethral function and to investigate whether the cells could release trophic 
factors that modify both cellular and extracellular elements of the urethra. Also, further 
studies are necessary to determine, at long-term, possible migrations and/or undesirable 
differentiations of these cells. 
 
 
4.2 Isolation, culture and characterization of OFs and ADSCs 
 
From the background given in this section, OFs and ADSCs were chosen to develop a 
TERM.  
Frozen OFs were used for these experiments which had been previously isolated by 
other researchers for another project (346).  
ADSCs were isolated, and then, characterized for specific surface antigen expression, 
and for differentiation assays to prove their potential to differentiate into other cell 
types.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.1 Morphology of OFs (a) and ADSCs (b) on a tissue culture plastic flask 
under light microscope. 
b 
a 
  
 122  
 
After isolation, cell cultures of OFs and ADSCs were regularly visualized to inspect cell 
morphology and exclude infection.  
As above, OFs had been isolated previously by other researchers, and were resurrected 
from a cryogenic frozen vial and cultured OFs in a T75 (figure 4.2.1a).  
ADSCs were isolated from the SVF of human subcutaneous fat which is composed of 
other vascular cells. Nevertheless, ADSCs have a higher potential to attach to the plastic 
culture flask and higher proliferation potential than the other cells. Subsequently, after 
first washes, non-adherent cells were discarded and after two passages, due to higher 
proliferation potential, ADSCs displaced the other cell types obtaining a homogeneous 
confluent population of ADSCs as morphologically observed (figure 4.2.1b). 
OFs showed typical fibroblastic morphology reaching a confluent culture of these cells 
without any infection (figure 4.2.1a). ADSCs showed, as well, typical fibroblastic 
morphology but with longer prolongations which is characteristic of mesenchymal/adult 
stem cells. In addition, we could not see any sign of infection (figure 4.2.1b).  
 
Adherent cells isolated from subcutaneous human adipose tissue were characterized by 
flow cytometry at passage 6 cultured in DMEM medium. Human cells showed high 
expression for MSCs markers, such us membrane receptor CD-29 (integrin beta-1, 
which is involved in cell adhesion for processes including embryogenesis, tissue repair, 
immune response and metastatic diffusion of tumour cells), major histocompatibility 
class I receptor HLA-a/b/c, anchored conserved cell surface CD-90 (or Thy-1, 
glycophosphatidylinositol protein involved in cell-cell and cell-matrix interactions), 
adhesion molecule CD-105 (endoglin, involved in the cytoskeletal organization 
affecting cell morphology and migration), surface glycoprotein CD-44 (receptor 
molecule involved in cell–cell interactions, cell adhesion and migration) and enzyme 
CD-73 (5' ecto-nucleotidase) (figure 4.2.2).  
On the other hand, human cells showed low expression of major histocompatibility 
class II receptor HLA-DR (T-cell receptor for immune recognition and antigen 
presentation), surface glycoprotein CD-34 (cell-cell adhesion factor, may mediates 
attachment of bone marrow-derived stem cells to one marrow extracellular matrix or 
directly to stromal cells) and hematopoietic marker CD-45 (member of the protein 
tyrosine phosphatase family, signalling molecules that regulate a variety of cellular 
processes including cell growth, differentiation, mitotic cycle, and oncogenic 
transformation) (figure 4.2.2).    
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Figure 4.2.2 
Characterization of rat 
ADSCs by flow cytometry. 
Fluorescent intensity for 
unlabelled cells is shown in 
red, for isotype controls in 
orange and for each 
specific antigen marker in 
blue along with the 
percentage of expression. 
The number of live cells, 
volume and morphological 
complexity of cells is shown 
in the scatter plot.  
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Figure 4.2.3 Characterization of rat ADSCs by flow cytometry. Fluorescent intensity 
for unlabelled cells is shown in red, for isotype controls in orange and for each specific 
antigen marker in blue along with the percentage of expression. The number of live 
cells, volume and morphological complexity of cells is shown in the scatter plot.  
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OFs passage 6 ADSCs passage 6 ADSCs passage 3 
Primary control 
OFs passage 6 
Primary control 
ADSCs passage 6 
Primary control 
ADSCs passage 3 
Similar results were found for cells isolated from rat subcutaneous adipose tissue when 
characterized by flow cytometry. At passage 4, cells showed high expression for 
anchored conserved cell surface CD-90, surface glycoprotein CD-44, membrane 
receptor CD-29, major histocompatibility class II receptor alloantigen I-E[K] (antigen-
specific T cells) and platelet endothelial cell adhesion (PECAM-1 involved in leukocyte 
migration, angiogenesis, and integrin activation) (figure 4.2.3). 
On the other hand, these cells showed low expression for adhesion molecule CD11b 
(integrin alpha M expressed on surface of many leukocytes mediating inflammation by 
regulating leukocyte adhesion and migration, phagocytosis, cell-mediated cytotoxicity, 
chemotaxis and cellular activation) and the hematopoietic marker CD-45 (figure 4.2.3).   
 
Specifically for the characterization of rat ADSCs, the scatter plot (figure 4.2.3) shows a 
non-homogenous population, as well as some of the plots for specific antigens 
expressions have different profiles suggesting different cell complexity and 
morphology.  
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 4.2.4 Representative  images of immunostaining for anti-human fibroblasts 
surface protein of OFs at passage 3 and ADSCs at passage 3 and 6 cultured in 2D. 
Scale bar = 0.1 mm. 
 
The positive percentages of the positive surface antigens, CD-44 for rat cells, and CD29 
and HLA-a/b/c for human cells are low (figure 4.2.3). These results are obtained 
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ADSCs P6 anti-CD44 
ADSCs P3 anti-CD29 ADSCs P3 anti-CD44 ADSCs P3 anti-CD73 
Primary control  
ADSCs P3 
Primary control  
ADSCs P6 
because profiles for bare cells (not labelled) and for these specific antigens overlap to 
some extent; however, we can distinguish two different profiles which prove the 
expression of these antigens for rat and human cells.  
 
Human ADSCs at passage 3 and passage 6 and human OFs at passage 6 were cultured 
in 2D and stained for anti-human CD29, CD44, CD73 and fibroblast surface protein.  
 
OFs at passage 3 and ADSCs at passage 3 and passage 6 were positively stained for the 
anti-human fibroblast surface protein (figure 4.2.4). On the other hand, only ADSCs at 
passage 3 were clearly positive for the 3 CD markers. While OFs were not stained for 
any of these Ab, ADSCs at passage 6 were slightly positive for CD44 (figure 4.2.5).   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.5 Representative images of immunostaining for anti-human CD29, CD44 
and CD73 of ADSCs at passage 3 and anti human CD44 of ADSCs at passage 6 
cultured in 2D. Scale bar = 0.1 mm. 
 
Multipotency of human ADSCs was evaluated by showing the adipogenic and 
osteogenic differentiation potential of these cells isolated from SVF of human 
subcutaneous adipose tissue.  
Cells were cultured for three weeks in adipogenic and osteogenic mediums; however, 
after 7 days in culture, cells already exhibited some morphological modifications. 
Indeed, cell appearance changed from an elongated fibroblastic to a more cuboidal 
shape (408), when ADSCs were cultured in osteogenic medium, showing higher cell 
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a b 
a b 
density and orientation. Adipogenic differentiation was also observed by lipidic vesicle 
formation and morphological changes from elongated fibroblastic cells to rounded, 
adipocyte cell-like (409). 
 
After 3 weeks, human ADSCs cultured with osteogenic differentiation medium were 
stained positively with 5% Alizarin Red (in red color), which stains calcium deposition, 
a late osteogenic marker. Alternatively, these same cells cultured with DMEM medium 
were completely negative for Alizarin Red staining, with no calcium deposition (figure 
4.2.6).  
Human ADSCs cultured for 3 weeks in adipogenic differentiation medium stained 
positively with 0,3% Oil Red O in 60% Isopropanol, which stains specifically lipid 
vesicles. Oil Red O did not stain same cells when cultured with DMEM medium for 3 
weeks (figure 4.2.7). 
 
Figure 4.2.6 (a) Human 
ADSCs cultured for 3 
weeks with DMEM 
medium and stained with 
5% Alizarin red, after 
fixation with 
paraformaldehyde. (b) 
Human ADSCs cultured for 3 weeks with osteogenic medium and stained with 5 % 
Alizarin red, after fixation with paraformaldehyde. Scale bar = 0.5 mm.  
 
Figure 4.2.7 (a) 
Human ADSCs cultured 
for 3 weeks with 
DMEM medium and 
stained with 0,3% Oil 
Red O, after fixation 
with paraformaldehyde. 
(b) Human ADSCs cultured for 3 weeks with adipogenic medium and stained with 0,3% 
Oil Red O, after fixation with paraformaldehyde. Scale bar = 0.2 mm. 
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4.3 Comparison of OFs and ADSCs cultured on Th-PLA scaffolds 
 
1x106 OFs, ADSCs or a mixture of both, all at passage 6, were seeded on 6.25 cm2 Th-
PLA scaffolds using metal rings with an external diameter of 2 cm (about 3.2x105 cells 
seeded per cm2).   
Each sample was cultured for 2 weeks and the potential of each cell type to attach and 
proliferate on Th-PLA scaffolds was assessed, such as, their capacity to produce ECM 
and the impact of this neo-tissue formation on mechanical properties of the material.   
Our material candidate was biodegradable and microporous Th-PLA scaffold made of 
random microfibres as described in previous Chapter of this thesis. 
 
4.3.1 Cell attachment and proliferation 
 
Cell attachment and proliferation was assessed by metabolic activity of the cells at day 
0, 7 and 14 using AlamarBlue® staining. Then, samples were stained with DAPI after 2 
weeks culture to look at the cell density and distribution into the scaffolds. Similarly, 
cell infiltration was assessed from frozen sections of these samples analyzed by H&E 
staining.    
 
 
 
 
 
 
 
 
Figure 4.3.1 Example of colour change seen after incubation with AlamarBlue® 
staining. Top row (Blue) no cells seeded. Bottom row (pink) cells seeded. 
 
AlamarBlue® staining has been used as a surrogate marker of proliferation (410). It uses 
an oxidation-reduction indicator, resazurin (blue) which is reduced to resorufin (pink), 
and can be assessed by fluorescence and colorimetric methods (figure 4.3.1). The stain 
is non toxic and can simply be washed away and thus used repeatedly on the same 
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sample without damaging cellular viability (411). The resorufin continually develops 
and therefore a precise time point is required for assessment.  
The absorbance of AlamarBlue® is plotted below for each sample (figure 4.3.2) minus 
the absorbance of controls (Th-PLA scaffolds cultured without cells). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3.2 AlamarBlue® staining for OFs, ADSCs and a mixture of both cells on Th-
PLA scaffolds over 2 weeks in culture (n=3±SEM). 
 
Cells attached on Th-PLA scaffolds since metabolic activity from cells was measured 
for all samples a few hours after seeding them. Since some cells can pass underneath the 
metal ring or through big pores of the scaffolds being attached on the tissue culture 
plastic of the well, before performing AlamarBlue protocol®, samples were placed in a 
new 6-well plate and non-adhered cells were washed out with PBS, in terms to just read 
metabolic activity of cells attached to the scaffolds. 
There were no significant differences between samples at any time point and all showed 
evidence of cell proliferation as seen by an increase in metabolic activity from day 0 to 
day 14.  
 
DAPI stains DNA within cells. Images of each sample were undertaken to determinate 
the distribution of cells within scaffolds after 14 days in culture (figure 4.3.3).  
Under a qualitative method, significant differences were not observed between samples, 
achieving a reasonable cell density in all of them. 
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Figure 4.3.3 Representative images of DAPI staining for Th-PLA samples cultured with 
OFs, ADSCs and a mixture of both cell types for 2 weeks. Plain Th-PLA scaffold 
cultured without cells is shown as a negative control. Scale bar = 0.5 mm. 
 
Frozen sections of these samples stained with H&E showed, similarly, a confluent cell 
population homogeneously distributed, for both cell types, throughout the thickness of 
the Th-PLA scaffolds (figure 4.3.4). 
Samples cultured with ADSCs were thicker due to a few layers of cells accumulated on 
one side of the scaffolds (cell seeded side). Also a thin layer of ECM was seen on both 
sides of the scaffolds for both cells types.     
 
 
 
 
 
 
 
 
 
Figure 4.3.4 Representative images of frozen sections of ADSCs (left) and OFs (right) 
cultured for 2 weeks on Th-PLA scaffolds stained for H&E. 
 
4.3.2 Extracellular matrix (ECM) production 
 
ECM formation was observed by SEM after 2 weeks of culture of Th-PLA scaffolds 
with OFs, ADSCs or a mixture of both cells. The nature of this ECM was analysed by 
looking for the specific production of collagen I, collagen III and elastin fibres using 
immunostaining. Quantitatively, total collagen formation was assessed by Sirius red 
staining.  
OFs ADSCs Control OFs + ADSCs 
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Sirius red stains collagen a red colour (figure 4.3.5) and can be detected by polarized 
light and the birefringence of the dye has been described as being specific for collagen 
(412). 
 
 
 
 
 
 
 
 
 
 
Figure 4.3.5 Examples of Sirius red staining after 14 days culture of OFs and ADSCs 
on Th-PLA scaffolds. 1: Control (no cells, no medium); 2: Control (no cells but with  
medium); 3: OFs; 4: ADSCs. 
 
The absorbance of Sirius red is plotted below (figure 4.3.6) minus the absorbance of 
controls without cells (but with medium) per gram of dry constructs. 
ADSCs produced the highest amount of total collagen per gram of dry sample, 
significantly higher than scaffolds cultured with OFs.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3.6 Sirius red staining after 14 days of OFs, ADSCs and a mixture of both 
cells cultured on Th-PLA. (n=3±SEM). *p<0.05. 
OF s ADS C s OF s 	  +ADS C s
0
2
4
6
8
10
T
ot
al
	  c
ol
la
ge
n	  
(S
ir
iu
s	  
re
d	  
st
ai
n/
gr
am
)
* 
1 2
 
3 4 
  
 132  
 
All samples stained with DAPI were later assessed by immunostaining to determine the 
presence and distribution of fibres of collagen I, collagen III and elastin (figure 4.3.7), 
using specific antibodies. Also, samples of Th-PLA scaffolds cultured in DMEM 
medium without cells were assessed as negative controls for each ECM component.  
 
Figure 4.3.7 Representative images of immunostaining for collagen I, collagen III and 
elastin of OFs, ADSCs and a mixture of both cell types cultured on Th-PLA scaffolds for 
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2 weeks. Controls of Th-PLA scaffolds cultured in DMEM medium without cells are 
shown as well. Scale bar = 0.5 mm. 
 
Qualitatively, ADSCs produced higher amounts of collagen I and collagen III fibres. 
Elastin production was similarly low for all groups. 
 
Semi-quantitative assessment of the extent of immunostaining was done on a blinded 
observer basis and the median value was used. 
As seen in figure 4.3.7, ADSCs produced more collagen compared with the other 2 
groups being significant for collagen I fibres (figure 4.3.8). The production of elastin 
was low in general, although, this was higher when both cells were cultured together.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3.8 Assessment of the extent of immunostaining using a blind scoring for OFs, 
ADSCs and a mixture of both cells cultured on Th-PLA scaffolds for 2 weeks. Results 
shown as mean±SEM, (n =3) for collagen I, **p<0.005; collagen III; and elastin. 
Scale: 0 = absent, 1 = small amount, 2 = moderate amount, 3 = extensive amount. 
 
With SEM, a denser layer of ECM was observed on Th-PLA scaffolds cultured with 
ADSCs, in comparison with the samples cultured with OFs (figure 4.3.9), by covering 
most fibres and pores of the scaffolds. 
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Figure 4.3.9 Appearance by SEM of OFs and ADSCs cultured on Th-PLA scaffolds for 
2 weeks in DMEM medium. Scale bar = 200 µm. 
 
4.3.3 Contraction 
 
Cell mediated contraction was calculated using digital serial photographs of the size of 
the scaffolds relative to their area on day 0 (figure 4.3.10). The data is shown with and 
without subtracting the contraction of the controls (Th-PLA scaffolds cultured for 2 
weeks in DMEM medium without cells) at day 14.   
Figure 4.3.10 Scaffold contraction represented as percentage reduced of the original 
scaffold area of Th-PLA scaffolds cultured with OFs, ADSCs and a mixture of both cells 
after 14 days (n=3±SEM). Data is also shown subtracting to the scaffolds with cells the 
percentage reduced for the controls. 
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All samples showed a slight expansion with no significant differences measured 
between groups (negative contraction).  
Controls were more expanded than scaffolds cultured with cells and that is why the 
samples have a positive contraction when contraction from controls is subtracted. 
 
4.3.4 Mechanical properties 
 
Mechanical properties of scaffolds cultured with cells were tested at day 14 for Young’s 
modulus, UTS and strain at UTS using a BOSE electroforce tensiometer. Each property 
is plotted below (figure 4.3.11) and compared to the range for native healthy 
paravaginal tissue (194).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3.11 Mechanical properties of Th-PLA scaffolds cultured with OFs, ADSCs 
and a mixture of both cells for 2 weeks. Results shown are mean±SEM, (n = 3). The last 
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sample shown is the range for native tissue represented by 2 dashed lines (the range for 
native healthy paravaginal tissue). (a) YM, *p<0.01. (b) UTS, ***p<0.0001. (c) Strain 
at UTS. 
 
All 3 mechanical properties were increased with the inclusion of cells. ADSCs gave the 
most significant differences with respect to the controls (scaffolds without cells), 
especially for UTS and were also slightly significant for Young’s modulus. 
 
 
4.4 Discussion  
 
Cells from different sources have different biological properties. Vaginal fibroblasts 
isolated from patients with POP have shown a low proliferation rate and can migrate 
from the injection site (413). As an autologous cell candidate, OFs seem to be more 
appropriate to develop a TERM for pelvic floor repair since oral mucosa can be easily 
accessed and these cells have desirable properties, as seen in many studies when using 
grafts of this tissue for urethroplasty (384).  
Alternatively, MSCs have been widely used as a cell therapy for the treatment of SUI, 
specifically by repair/regeneration of the urethral sphincter unit. MSCs have been 
injected at the submucosal level of the urethra wall, repairing connective tissue, and 
therefore, urethral support as well (413). MSCs are characterized as being 
nonimmunogenic (390). ADSCs, specifically, inhibit inflammatory responses by 
secretion of inhibitor of tumor necrosis factor α (TNFα), which is desirable for an 
anticipated better integration into host tissues (341). ADSCs have been shown to release 
fibroblastic growth factor (FGF) for regeneration of surrounding native tissues by 
stimulation of fibroblast proliferation and fibroblast ECM production (341). This, along 
with the proposed integration of the ADSCs into the whole urethral wall (414), their 
capacity to restore connective tissue (343), their angiogenic potential (403) and their 
easy isolation (400), makes ADSCs an attractive cell candidate to be investigated for the 
production of an autologous engineered tissue to repair fascial defects of the pelvic 
floor.  
 
  
 137  
 
We looked at human OFs, human ADSCs and a mixture of both cells since FGF 
released from ADSCs may stimulate OFs proliferation and/or their ECM production.  
To compare OFs and ADSCs, both cell types were isolated, characterized and cultured 
on Th-PLA scaffolds, and their ability to make ECM examined (415) to develop a 
TERM. 
Human OFs, which had been previously isolated, were used from only one patient. 
Human ADSCs were isolated from different patients and were used for the in vitro and 
in vivo experiments of this thesis while, rat ADSCs were isolated only from one rat 
since these cells were only used for the in vivo experiments.  
Only one batch of human ADSCs were characterized by FACS (the batch of cells used 
for the in vitro experiments of this Chapter, Chapter 5, and the in vivo experiments), 
such as the batch of rat ADSCs.  
Adult MSCs have been shown to have slightly different behaviours between different 
donors. In addition, the passage number may affect the mesenchymal potential of the 
cells with higher potential for lower passages (390). To test this, differentiation assays 
were performed for different batches of human ADSCs and at different passages to 
compare their mesenchymal potential, to compare their performance when seeded and 
cultured on PLA scaffolds. These results are shown and discussed in Chapter 8 of this 
thesis.   
 
Human ADSCs cultured in 2D at passage 3 expressed 3 CD markers specifics for 
mesenchymal stem cells. Human ADSCs at passage 6 may lose expression of some of 
these CD markers, as seen when cultured in 2D; in addition, same cells at the same 
passage also showed low expression for some of these markers. However, these cells 
were well characterized by FACS, expressing surface markers specifics of MSCs and 
being negative for hematopoietic markers. Furthermore, by differentiation assays, it was 
shown that these cells retained the potential at passage 6 to differentiate into osteogenic 
(by calcium deposition) and adipogenic (by lipidic vesicle formation) cell lineages.  
On the other hand, anti-human fibroblast Ab showed expression of the specific protein 
on the surface of OFs and it was bound to ADSCs at passage 6 as well. This could 
suggest the possible differentiation of the ADSCs at high passage into fibroblast; 
however, since the Ab was also bound to these human ADSCs at passage 3 too, this 
suggests low specificity of this Ab or that this surface protein is also expressed in 
MSCs.  
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In general, no significant differences were identified when comparing ADSCs and OFs 
cultured for 2 weeks on Th-PLA scaffolds, and there was no advantage to having a co-
culture of both.  
No differences were observed between groups at any day for metabolic activity. This is 
supported by DAPI images and frozen sections since a confluent cell population 
homogeneously distributed into the scaffolds was found for all groups after 2 weeks 
culture. This also proved the ability of the cells to pass through the pores of the 
scaffolds which have been described in the previous Chapter of this thesis as being 
microporous. Macroporous scaffolds (>75 µm) have been postulated to be better for 
host cell infiltration, however, this infiltration may be explained by the presence of 
some macropores  in our Th-PLA scaffolds or due to the mobility of individual fibres 
which are not fixed at their intersections allowing cell infiltration. 
      
Alternatively, big errors were obtained for metabolic activity at day 0 which means high 
differences between samples seeded with the same type and number of cells. The cell 
seeding may need to be improved in the future for more reproducible experiments. 
However, as explained in the previous Chapter of this thesis, electrospinning is not a 
very reproducible technique and small differences between thickness of fibres and pore 
sizes were found between different sheets of PLA (377). We analyzed 3 samples for 3 
repetitions using different sheets of electrospun PLA; therefore, PLA samples with 
wider pores, for instance, may contribute to a poor cell seeding as cells may rapidly 
move through these scaffolds and go to the bottom of the well.  
Alternatively, these differences at day 0 may not be very relevant since they are reduced 
at day 14 with all samples achieving a confluent cell population with similar metabolic 
activity.  
 
All the analyses for ECM production agree with significantly higher collagen 
production from the ADSCs. Both cells formed an ECM sheet on both sides of the 
scaffold, as seen by frozen sections stained for H&E, and which was denser for ADSCs 
as seen by SEM. This may be explained as a consequence of the few layers of ADSCs 
accumulated on the cell seeded side of the scaffold as seen in H&E images. 
Furthermore, all groups of cells were able to specifically produce fibres of collagen I, 
collagen III and elastin. 
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After cell culture, all cell-seeded groups increased the mechanical properties of the 
scaffolds compared to the controls, all being close to the rage of values for native 
paravaginal tissues of women. Nevertheless, only ADCSs cultured on Th-PLA scaffolds 
achieved a significant increase for Young’s modulus and UTS compared to controls 
without cells, being very significant for the latter, which fits with the ADSCs higher 
production of collagen.  
The variability between Th-PLA scaffolds made by the elctrospinning technique had an 
effect on mechanical properties, particularly for Young’s modulus. Th-PLA scaffolds 
from previous Chapter are much stiffer compared with the scaffolds from this Chapter. 
Similarly to metabolic activity, differences between scaffolds did not interfere in the 
purpose of these experiments. However, especially for mechanical properties, these 
differences may have a relevant effect on the final product for developing a material 
which needs to give enough support to the pelvic floor. The importance of the 
mechanical properties is further discussed in Chapter 7 of this thesis. In addition, as 
discussed in the last Chapter of this thesis, the chosen material will need to go through 
Good Manufacturing Practice conditions for reproducibility when developing the final 
clinical product. 
 
No significant differences were observed in terms of scaffold contraction. All samples 
expanded in size at day 14 relative to day 0. This is very desirable since contraction has 
been observed in implanted skin grafts leading to clinical complications (416). In 
addition, this expansion seems to be lower for the scaffolds cultured with ADSCs which 
may be explained again by higher production of collagen. ECM components would bind 
PLA fibres restricting their expansion in culture. 
 
In summary, on the basis of the current in vitro results we would conclude that both cell 
types are suitable candidates to develop a TERM for fascial repair of the pelvic floor as 
both gave promising results with very small differences between the cell types.  
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Chapter 5 
 
OPTIMISING CULTURE CONDITIONS FOR THE TERMs 
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5.1 Introduction 
 
After identifying the best scaffold and cell candidates to develop a TERM designed for 
pelvic floor repair, in this Chapter we tried to identify the best culture conditions for the 
TERM. For this, we studied the effect of mechanical forces and chemical stimulation on 
cells cultured on Th-PLA scaffolds and we optimized the number of cells seeded and 
period of culture for developing a TERM.  
 
5.1.1 Mechanical stimulation 
 
Mechanical forces have been shown to have a direct impact upon the function of cells 
both in vivo and in vitro (417). Many physical activities of our body are essential for life 
such as the pumping of the heart and the respiratory movement. In addition, mechanical 
forces also regulate cellular processes including migration, adhesion and 
morphogenesis, among others (418, 419). The conversion of a mechanical force into 
cell activity is termed mechanotransduction and can be produced by extracellular and 
intracellular forces (420). Diseases such as arthritis and osteoporosis have been shown 
to be related to the impairment of the cells ability to respond to mechanical signals 
(421). 
 
Mechanical conditioning has been used to stimulate the production of ECM proteins 
and improve the mechanical properties of tissue engineered constructs of scaffolds 
seeded with cells (422). Most of these studies are found in the field of musculoskeletal 
tissue engineering where the effect of forces affecting bone and cartilage tissues seems 
to be more established (423).  
Bioreactors have been designed to study the effect of different mechanical forces on 
engineered tissues (424, 425). A variety of forces have been utilized including fluid 
shear (426), uni-axial (427), biaxial (428) and multi-axial strain (429), compression 
(430) and hydrostatic forces (431). Some of the outcomes of mechanical loading include 
alignment of cells and organization of ECM (432), cell differentiation (433) and 
proliferation and formation of greater ECM (434). 
There are no studies to the best of our knowledge looking at the mechanical 
conditioning of scaffolds seeded with cells for their use in the treatment of SUI or POP. 
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The tissues of the pelvic floor are subjected to forces which are not well characterized. 
These forces will include cyclical increases in intra abdominal pressure due to 
breathing, intermittent increases in pressure associated with movement or more marked 
pressure rises due to heavy lifting and coughing or straining, for instance. The weight of 
the pelvic organs along with their contents will also exert a constant force applied to the 
supportive tissues of the pelvic floor. Furthermore, these forces are unlikely to be 
equally distributed across the whole pelvic floor.  
 
Traditionally, pressure in urology has been measured in cm/H2O during urodynamic 
studies. In an upright position, a pressure of about 40 cm/H2O has been measured in the 
bladder during the storage phase of micturition (i.e. relaxed). It has been proposed that 
since the bladder is situated just above the pelvic floor, there would be a similar 
pressure found in the pelvic floor when standing (435). Cadaveric studies from the same 
group, have provided the dimensions of the female pelvis with an average pelvic floor 
area of 94 cm2 (435). Using both values the estimated physiological loads acting on the 
pelvic floor were described to be around 37 N standing, 19 N supine, 129 N coughing 
and 92 N straining (436). 
Nevertheless, the forces that the materials that are implanted to treat SUI and POP 
undergo may be different. There are no reports of these measurements and there are no 
computational models to obtain these values as yet.  
 
In this Chapter, we first of all studied how different mechanical forces can affect the 
activity of different cells seeded onto a scaffold, as well as, the effect on the mechanical 
properties of the TERM. Although the forces applied to the TERM in vivo may be 
different, affecting the cell behavior in a different way, these studies had the aim of 
showing the potential to increase ECM production and mechanical properties of the 
engineered tissue before implantation by applying mechanical forces.  
 
5.1.2 Chemical stimulation 
 
The addition of chemical factors to the in vitro cell culture environment has been widely 
used in tissue engineering to promote cell proliferation and ECM production, similar to 
mechanical stimulation.  
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Collagen is the main ECM component of the supportive tissues of the pelvic floor and it 
determines the strength of these. Intrinsic and extrinsic growth factors have been used in 
tissue engineering since these have an essential role in the development and remodeling 
of tissues (437). In vitro, TGF-beta-1 has been shown to significantly increase 
production of collagen for development of tissue engineered ligaments (438), as well as, 
having an effect on the maximal tensile load of these engineered tissues (439). 
Similarly, human aortic cells seeded on to poly-glycolic acid patches showed an 
increase in collagen production with more densely organized ECM by TGF-beta-1 
stimulation (440).  
Growth factors can be manufactured using recombinant technology and these are a 
lower risk for clinical use than natural growth factors. Both synthetic and naturally 
derived chemicals can be used to stimulate collagen formation.  
 
Vitamin C is an essential factor for various steps in collagen biosysnthesis (441, 442). 
For the post-production of collagen, these molecules undergo post-translational 
modifications which include the hydroxylation of proline and lysl residues. This process 
is important for cross link formation leading to a strong and stable collagen (443). 
Hydroxylation occurs through prolyl hydroxylase and lysyl hydroxlylase, and Vitamin 
C is a cofactor for both of these enzymes (444). A deficiency in Vitamin C produces a 
disruption in collagen formation leading to diseases such as scurvy.  
Vitamin C supplementation has been shown to promote collagen production of cells in 
vitro (445, 446), and also, it has been used as an additive to the nutrient medium in 
tissue engineering to promote collagen biosynthesis in vitro.  
The effect of 3 different concentrations of Vitamin C was assessed on temparo-
mandibular joint cells cultured on non-woven poly–glycolic acid scaffolds. A 
concentration of 25 µg/mL was found to significantly increase total collagen production 
compared to control cells (447). Similarly, dermal fibroblasts seeded on fibronectin pre-
treated SIS scaffold increased collagen I production when cultured with Vitamin C 
(448). Another study found an increase in collagen production by ascorbic acid 
supplementation on fibroblast seeded on to freeze-dried poly hydrogels (449). 
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5.2 Mechanical stimulation of TERMs 
 
For free or unrestrained conditions, 1x106 OFs, ADSCs or a mixture of both were 
seeded on 6.25 cm2 Th-PLA scaffolds using metal rings with hall diameter of 2 cm, as 
previously described in Chapter 2 and 4 (figure 5.2.1).   
 
5.2.1 Restrained and intermittent stress conditions 
 
For restrained and intermittent stress conditions an improved version of ScaffdexTM 
(Scaffdex Oy, Tampere, Finland) cell culture ring was used. This ring is composed by 
two tightly fitting plastic rings. 4 cm2 scaffolds were clamped between the two rings 
being restrained between one plastic ring and the other, the ring lock (figure 5.2.1). The 
final size of the Th-PLA scaffold for culture is a circle of 2.5 cm of diameter.    
However, for the improved version of ScaffdexTM, the bottom ring was cut to reduce the 
height of the ScaffdexTM. The cut non clamped end was used as a base and the ring 
clamp side was used as intended by the manufacturer (figure 5.2.1).  
 
Figure 5.2.1 Improved version of ScaffdexTM for static and intermittent stress 
conditions. 
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The improved version of ScaffdexTM allowed better cell seeding on Th-PLA scaffolds 
since cells are contained on the top of the scaffold by the plastic ring (figure 5.2.1).  
This version was used for restrained and intermittent stress conditions, and after cell 
seeding, spherical steel weights, 0.261 g each, were placed in the centre of each scaffold 
for 24 h on alternating days, only for samples under intermittent stress conditions 
(figure 5.2.1). The improved version of the ScaffdexTM was also useful for this last 
condition because the ball bearings were contained on top of the scaffold and pressed on 
this to compress it against the well since the scaffold does not touch the bottom of the 6 
well plate.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2.2 Metabolic activity using AlamarBlue® for OFs, ADSCs and a mixture of 
both cultured on Th-PLA scaffolds under unrestrained conditions and restrained (with 
and without intermittent stress) conditions over 2 weeks. Results shown are mean±SEM, 
(n = 3). 
 
As with unrestrained conditions, scaffolds under restrained (with and without 
intermittent stress) conditions were seeded with 1x106 OFs, ADSCs or a mixture of 
both, and cultured for 2 weeks with DMEM medium.   
Then, all samples were analyzed for cell attachment and proliferation using 
AlamarBlue® staining and DAPI staining, total collagen production using Sirius red 
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staining, mechanical properties using a BOSE tensiometer, collagen I, III and elastin 
production using specific antibodies, and appearance of the ECM using SEM, as 
described in Chapter 2. 
 
AlamarBlue® absorbance was recorded on days 0, 7 and 14, and is plotted above minus 
the absorbance of controls without cells (figure 5.2.2). 
Results showed at day 14 showed no significant differences between samples. On the 
other hand, the errors are quite big particularly at day 0 (figure 5.2.2).  
Using a qualitative assessment, DAPI staining did not any clear differences between 
samples, achieving a confluent amount of cells in all of them (figure 5.2.3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2.3 DAPI staining for Th-PLA scaffolds cultured with OFs, ADSCs and a 
mixture of both cultured under unrestrained conditions and restrained (with and 
without intermittent stress) conditions over 2 weeks. Control of Th-PLA scaffold 
cultured in DMEM medium without cells is shown as well. Scale bar = 0.5 mm. 
 
 
U     
 
 
 
 
 
 
 
 
 
 
R      
 
 
 
 
 
 
 
 
 
 I 
OFs ADSCs OFs + ADSCs 
Control (scaffold 
without cells    
with medium) 
U = Unrestrained conditions 
R = Restrained conditions 
I  = Intermittent stress conditions 
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Sirius red was read from all samples at day 14 to calculate total collagen production. 
The absorbance of Sirius red is plotted below (figure 5.2.4) minus the absorbance of 
controls without cells expressed per gram of dry constructs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2.4 Production of total collagen by OFs, ADSCs and a mixture of both cells 
cultured on Th-PLA scaffolds under unrestrained conditions and restrained (with and 
without intermittent stress) conditions. Results from Sirius red staining after 14 days 
shown as means ±SEM, (n = 3), *p<0.05. 
 
In unrestrained conditions, ADSCs produced significantly (p<0.05) more total collagen 
per gram of sample, than OFs (figure 5.2.4). Restrained (with and without intermittent 
stress) conditions did not lead to a significant increase in collagen production for any 
cell group. Similarly, a combination of both cell types did not significantly enhance 
collagen production under any culture conditions. 
 
All 3 mechanical properties increased with the inclusion of cells compared to acellular 
scaffolds (controls) under any culture conditions.  
Th-PLA scaffolds cultured with ADSCs gave the greatest improvement of these 
properties under unrestrained conditions compared with acellular controls (figure 5.2.5), 
and were statistically significant for Young’s modulus (p<0.01) and UTS (p<0.0001). 
Comparing OFs with ADSCs and a mixture of both, the results were similar with no 
benefit in culturing cells under restrained conditions. 
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Figure 5.2.5 Mechanical properties of Th-PLA scaffolds cultured with OFs, ADSCs and 
a mixture of both under unrestrained conditions and restrained (with and without 
intermittent stress) conditions for 2 weeks. Results shown are means ±SEM, (n = 3). The 
last sample shown is the range for native tissue represented by 2 dashed lines (the 
range for native healthy paravaginal tissue). (a) YM, *p<0.01. (b) UTS, ***p<0.0001.  
 
All samples stained with DAPI were later assessed to determine the presence and 
distribution of collagen types I, collagen III and elastin, using immunostaining. Also, 
samples of Th-PLA cultured in DMEM medium without cells were added to the 
immunostaining protocol; as controls for the 3 ECM components. 
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Figure 5.2.6 Representative images for presence and distribution of collagen I, III and 
elastin (green colour) with cell nuclei (blue colour) using immunostaining and DAPI 
respectively, after 14 days culture on Th-PLA scaffolds of ADSCs under unrestrained 
conditions; OFs under restrained with intermittent stress conditions; and a mixture of 
OFs and ADSCs under restrained with intermittent stress conditions. Controls of Th-
PLA scaffolds without cells are shown for immunostaining of collagen I, III and elastin. 
Scale bar = 0.5 mm. 
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* 
           ** 
        *** 
           * 
Representative images for the presence and distribution of specific ECM components 
are shown above in colour (figure 5.2.6), for samples from the 3 group of cells under the 
mechanical culture conditions which gave the best results, respectively. For each 
sample, 2 images were taken at the same point; one for DAPI, which is colored in blue, 
and one for collagen I/ III/ elastin which are colored in green. In the same image cell 
nuclei and collagen or elastin fibres are shown.  
Semi-quantitative assessment of the extent of immunostaining was done on a blinded 
observer basis using a qualitative grading scale; absent = 0, small amount = 1, moderate 
amount = 2, extensive amount = 3. Example photographs depicting 0, 1, 2 and 3 were 
provided for reference and the median value from these scores was used (figure 5.2.7). 
 
Figure 5.2.7 Extent of the immunostaining 
using a blind scoring for OFs, ADSCs 
and a mixture of both cells cultured on 
Th-PLA under unrestrained conditions 
and restrained (with and without 
intermittent stress) conditions for 2 
weeks. Results shown as means ±SEM, (n 
=3) for collagen I, *p<0.005; collagen 
III; and elastin, **p< 0.005, *p<0.05, 
***p<0.0001. Scale: 0 = absent, 1 = 
small amount, 2 = moderate amount,       
        3 = extensive amount. 
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All the cell-seeded scaffolds produced collagen I, III and some elastin fibres (figure 
5.2.6). Semi-quantitatively, ADSCs showed the highest amount of collagen I and III 
cultured under unrestrained conditions (figure 5.2.7). For collagen I, this was 
significantly greater than for OFs under the same conditions (p<0.005). Furthermore, 
there was a suggestion of orientation of collagen I fibres for ADSCs cultured under 
these conditions (figure 5.2.6). There was a trend of increasing elastin when cell types 
were cultured under restrained conditions (figure 5.2.7). Each cell group showed 
significantly higher amounts of elastin under intermittent stress conditions compared, 
individually, to unrestrained conditions (p<0.005 for OFs, p<0.05 for ADSCs and 
p<0.0001 for a mixture of both cells) (figure 5.2.7). This was more obvious and 
significant when using OFs, and with a mixture of both cells again with a suggestion of 
fibre orientation (figure 5.2.6). 
 
The quality of the ECM was studied l by SEM looking at the amount and distribution of 
the ECM for each sample. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2.8 Appearance by SEM of OFs cultured under unrestrained condition on Th-
PLA scaffolds for 2 weeks in DMEM medium.   
 
Qualitatively, OFs cultured under unrestrained conditions produced the least ECM as 
shown by SEM (figure 5.2.8). Consistent with the immunostaining results, ADSCs 
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cultured under unrestrained conditions produced a denser layer of ECM on top of the 
scaffolds (figure 5.2.10).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2.9 Appearance by SEM of OFs cultured under intermittent stress conditions 
on Th-PLA scaffolds for 2 weeks in DMEM medium.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2.10 Appearance by SEM of ADSCs cultured under unrestrained conditions on 
Th-PLA scaffolds for 2 weeks in DMEM medium.   
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Figure 5.2.11 Appearance by SEM of ADSCs cultured under intermittent stress 
conditions on Th-PLA scaffolds for 2 weeks in DMEM medium.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2.12 Appearance by SEM of a mixture of OFs and ADSCs cultured under 
intermittent stress conditions on Th-PLA scaffolds for 2 weeks in DMEM medium.   
  
 154  
 
Again, similar to immunostaining results, ADSCs under unrestrained and intermittent 
stress conditions (figure 5.2.10 and 5.2.6), and a mixture of OFs and ADSCs cultured 
under intermittent stress conditions (figure 5.2.12) showed some orientation of the ECM 
components, as indicated by the small fissures. 
For all cells under restrained conditions there appeared to be more uncoated fibres and 
small fissures in an otherwise continuous sheet of ECM (figure 5.2.9, 5.2.11 and 
5.2.12).  
The highest magnification of ADSCs under unrestrained conditions shows, from a small 
fissure, how cells are completely confluent on top of the scaffold producing a dense 
layer of ECM, but do not appear to have penetrated into the entire thickness of the 
scaffold. 
 
5.2.2 Dynamic conditions 
 
Since previous studies did not show a big effect of direct mechanical force on cell 
activity, we next looked at the effect of dynamic conditions on cells in 2D cell culture.  
Fluid shear forces were applied to the cells with the aim to increase production of ECM. 
For this, 1x105 OFs or ADSCs were seeded in 6-well plates with DMEM medium.  
After, 48 hours incubation, the 6-well plates were placed on a rocking platform outside 
of the incubator and rocked at a tilt angle of 6o flat 40 rpm for 2 hours (figure 5.2.13). 
Fluid shear forces were applied every 2 days. The volume of medium and tilt angle 
ensured the cells were immersed throughout the rocking cycle. Static controls were 
added to these experiments, using the same number of cells seeded in 6-well plates, 
which were left outside the incubator during the duration of rocking.  
 
 
 
 
 
 
 
 
 
Figure 5.2.13 Platform rocker. 
  
 155  
 
All samples were analyzed for cell attachment and proliferation using AlamarBlue® 
staining and total collagen production using Sirius red staining.  
AlamarBlue® absorbance was recorded on days 0, 7 and 14, and is plotted below (figure 
5.2.14) minus the absorbance of controls without cells (AlamarBlue® read after 1 h in a 
6-well plate without cells). 
The results showed no significant differences between these samples at any time point. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2.14 Metabolic activity using AlamarBlue® for OFs and ADSCs cultured on 6-
well plates under static and dynamic conditions over 2 weeks. Results shown are 
means±SEM, (n = 3). FSR = Fluid shear rig. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2.15 Total collagen production using Sirius red staining for OFs and ADSCs 
cultured on 6-well plates under static and dynamic conditions over 2 weeks. Results 
shown are means ±SEM, (n = 3). FSR = Fluid shear rig. 
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Sirius red was read from all samples at day 14 to calculate total collagen production. 
Since all the stain read is from collagen made from cells, no controls need to be 
included. Scaffolds can absorb some staining, therefore, the absorbance of controls was 
subtracted from the absorbance of the samples. Also, in this experiment the values do 
not need to be normalized per gram of dry constructs. The total absorbance of Sirius red 
from the plate reader is plotted above (figure 5.2.15). 
Again, similar to metabolic activity, no significant differences were found between 
groups.    
 
Since dynamic conditions did not affect cell activity, we did not do any further 
experiments for this condition.    
 
 
5.3 Chemical stimulation of TERMs 
 
The effect of Vitamin C on the cell activity of ADSCs was firstly assessed in 2D 
culture. For this, 1x105 cells were seeded in 6-well plates and these were cultured with 
DMEM medium or DMEM medium supplemented with Vitamin C at 0.3 mM. Then, 
the respective medium was changed every 2 days being samples cultured for 14 days. 
 
 
 
 
 
 
 
 
Figure 5.3.1 ADSCs on 6-well plates stained with Sirius red after 2 weeks in culture 
under static or dynamic conditions and with DMEM medium or DMEM medium 
supplemented with Vitamin C. 
 
In parallel, the chemical stimulation was combined with fluid shear forces, as described 
in section 5.2.2, and as shown in figure 5.3.1. 
Static Fluid shear force 
ADSC + 10% 
DMEM +  
Vitamin C 
ADSC + 10% 
DMEM  
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ADSCs +  
DMEM 
medium 
ADSCs +  
DMEM 
medium + 
Vitamin C 
Again, fluid shear forces did not have an effect on cell proliferation or ECM production.   
By visual inspection under the microscope, cells cultured with DMEM medium 
supplemented with Vitamin C proliferated faster than control cells; however, by 2 
weeks of culture, all samples detached from the well plates forming the compact clumps 
of cells observed in figure 5.3.1.    
It did not prove possible to assess the total collagen made by these collapsed cells as it 
was impossible to elute all of the stain from these clumps after incubation with 0.2 M 
NaOH-methanol 1:1. 
 
The effect of vitamin C was then assessed on cells cultured on scaffolds. 1x106 ADSCs 
were seeded on Th-PLA scaffolds and cultured over 2 weeks under unrestrained 
conditions, as previously described, with DMEM medium or DMEM medium 
supplemented with Vitamin C at 0.3 mM.  
  
 
 
 
 
 
 
Figure 5.3.2 ADSCs on Th-PLA scaffolds stained with Sirius red after 2 weeks in 
culture under unrestrained conditions and with DMEM medium or DMEM medium 
supplemented with Vitamin C. 
 
All samples were analyzed for cell attachment and proliferation using AlamarBlue® 
staining, total collagen production using Sirius red staining and mechanical properties 
using a BOSE tensiometer. 
Similar results to 2D culture were found. Clumps of cells in the middle of the seeding 
region were formed leading to an observed contraction of the samples (figure 5.3.2). 
No differences were found between the 2 groups for metabolic activity at any time point 
(day 0, 7 and 14) (data not shown). In addition, mechanical properties of samples 
cultured with DMEM medium supplemented with Vitamin C showed lower mechanical 
properties compared to controls without cells and samples cultured with DMEM 
medium (data not shown). 
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Sirius red was eluted from all samples at day 14 to calculate total collagen production. 
The absorbance of Sirius red is plotted below (figure 5.3.3) minus the absorbance of 
controls without cells and expressed per gram of dry constructs. 
 
  
 
 
 
 
 
 
 
 
 
Figure 5.3.3 Total collagen production using Sirius red staining for ADSCs cultured on 
Th-PLA over 2 weeks under unrestrained conditions and with DMEM medium or 
DMEM medium supplemented with Vitamin C (VIT C). Results shown are means±SEM, 
(n = 3).  
 
Although no significant differences were found between the 2 groups (figure 5.3.3); 
similarly to the 2D culture of these cells, again it was not possible to elute all of the 
Sirius red staining from the clumps formed by the ADSCs cultured with DMEM 
medium supplemented with Vitamin C on the Th-PLA scaffolds using 0.2 M NaOH-
methanol 1:1. 
 
 
5.4 Optimal number of cells and period of culture 
 
Since ADSCs were chosen as our cell candidate for future experiments, only these cells 
were then used in future studies in which different numbers of cells were seeded and 
different periods of culture were assessed on Th-PLA scaffolds. For this, ADSCs were 
seeded on 6.25 cm2 Th-PLA scaffolds using metal rings of 2 cm of diameter at densities 
of 1x105, 3x105, 7x105 and 1x106 and cultured for 2 weeks with DMEM medium under 
unrestrained conditions (optimal mechanical culture condition). 
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Then, the optimal number of cells (7x105) were seeded on Th-PLA scaffolds and 
cultured under unrestrained culture conditions with DMEM medium for 1, 2 and 3 
weeks. 
In both experiments, all samples were analyzed for cell attachment and proliferation 
using AlamarBlue® staining and DAPI staining, total collagen production using Sirius 
red staining and mechanical properties using a BOSE tensiometer, as described in 
Chapter 2. 
Finally, the appearance of the ECM of the best samples for the optimal number of cells 
and period of time were analyzed by SEM, as described in Chapter 2. 
 
5.4.1 ADSCs seeded on Th-PLA scaffolds at different cell concentrations 
 
AlamarBlue® absorbance was recorded on days 0, 7 and 14, and is plotted below minus 
the absorbance of controls without cells (figure 5.4.1).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4.1 Metabolic activity of ADSCs seeded at density of 1x105, 3x105, 7x105 and 
1x106 cultured on Th-PLA scaffolds under unrestrained conditions over 2 weeks, 
stained with AlamarBlue® (n=3±SEM). *p<0.05; **p<0.005.  
 
After 7 days in culture, samples seeded with 7x105 cells achieved the highest metabolic 
activity being significantly higher when compared with samples seeded with the lowest 
number of cells (1x105) (p<0.005). At day 14, the difference in metabolic activity 
between these 2 groups was reduced, but was still significant (p<0.05). After 14 days 
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culture, the metabolic activity of the 3 groups with the highest cell density was similar 
(figure 5.4.1). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4.2 Production of total collagen by ADSCs seeded at density of 1x105, 3x105, 
7x105 and 1x106 cultured on Th-PLA scaffolds under unrestrained conditions. Sirius red 
staining after 14 days (n=3±SEM). *p<0.01. 
 
The absorbance of Sirius red is plotted above (figure 5.4.2) minus the absorbance of 
controls without cells and expressed per gram of dry constructs.  
Similarly to metabolic activity, samples seeded with 7x105 cells had the highest values 
for total collagen production at day 14, which was significantly higher compared to 
samples seeded with 1x105 cells (p<0.01), but similar to the other 2 groups (figure 
5.4.2). 
 
 
 
 
 
 
 
Figure 5.4.3 DAPI staining for Th-PLA scaffolds cultured with 1x105, 3x105, 7x105 and 
1x106 over 2 weeks under unrestrained conditions. Scale bar = 0.5 mm. 
 
1x105 3x105 1x106 7x105 
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Images from each sample were taken to determine the distribution of cells stained with 
DAPI within scaffolds after 14 days in culture (figure 5.4.3). By qualitative assessment, 
ADSCs showed a similar confluent cell population for samples seeded with 1x106 and 
7x105 cells, which were more confluent than samples seeded with 3x105 cells, which in 
turn, were more confluent than samples seeded with 1x105 cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4.4 Mechanical properties of Th-PLA scaffolds cultured under unrestrained 
conditions over 2 weeks without and with cells seeded at densities of 1x105, 3x105, 
7x105 and 1x106 (n=3±SEM). The last sample shown is native tissue represented by 2 
dashed lines (the range for native healthy paravaginal tissue). Blue color for samples 
seeded with 1x106 ADSCs and Th-PLA controls (from same electrospun sheet of PLA). 
Black color for samples seeded with 1x105, 3x105, 7x105 ADSCs and Th-PLA controls 
(from same electrospun sheet of PLA, different from previous one in blue color). (a) 
Young’s modulus. *p<0.01. (b) UTS. **p<0.0001; *p<0.02.  
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Mechanical properties are plotted above (figure 5.4.4) and compared to the range for 
native healthy paravaginal tissue (194).   
Experiments for samples seeded with 1x106 ADSCs (blue color) were conducted at 
different time and with a different sheet of PLA than the rest of the samples (black 
color). The 2 controls, Th-PLA cultured for 2 weeks without cells, from the two 
different sheets of PLA showed mechanical properties with small differences. However, 
for all groups, when scaffolds were cultured with cells, mechanical properties were 
increased respect to the controls, being significantly higher for UTS when 7x105 and 
1x106 cells were seeded compared to their own controls (figure 5.4.4). 
 
5.4.2 Culture of ADSCs on Th-PLA scaffolds for different periods 
 
Since 7x105 ADSCs was the optimum number of cells to develop a TERM when seeded 
on 3.14 cm2 of Th-PLA scaffolds, this number of cells was assessed then for different 
periods of culture (1, 2 and 3 weeks) with DMEM medium under unrestrained 
conditions.  
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4.5 Metabolic activity of ADSCs seeded at density of 7x105 cells on Th-PLA 
scaffolds cultured under unrestrained conditions over 1, 2 and 3 weeks, stained with 
AlamarBlue® (n=3±SEM).  
 
AlamarBlue® absorbance was recorded on days 0, 7 and 14 and 21. The total 
absorbance of AlamarBlue® is plotted above minus the absorbance of controls without 
cells (figure 5.4.5).  
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At day 7, very similar metabolic activity was seen between the 3 different groups. 
Thereafter, AlamarBlue® staining showed a small decrease of the metabolic activity for 
the groups cultured for 2 and 3 weeks. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4.6 Production of total collagen by ADSCs seeded at density of 7x105 cells on 
Th-PLA scaffolds cultured under unrestrained conditions. Sirius red staining after 1, 2 
and 3 weeks (n=3±SEM). *p<0.05.  
 
The absorbance of Sirius red is plotted above (figure 5.4.6) minus the absorbance of 
controls without cells per gram of dry constructs.  
Samples cultured for 2 weeks had the highest values for total collagen production. They 
were significantly higher than samples cultured for 1 week, but similar to samples 
cultured for 3 weeks. 
 
 
 
 
 
 
 
Figure 5.4.7 DAPI staining for Th-PLA scaffolds cultured with 7x105 ADSCs under 
unrestrained conditions for 1, 2 and 3 weeks in DMEM medium. Scale bar = 0.5 mm. 
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Images were undertaken from all samples and were stained with DAPI to determine the 
distribution of cells (figure 5.4.7). With qualitative assessment, samples cultured for 2 
and 3 weeks showed a similar high confluence of cells, being slightly greater than for 
samples cultured for 1 week. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4.8 Mechanical properties of Th-PLA scaffolds cultured without and with 
7x105 ADSCs under unrestrained conditions for 1, 2 and 3 weeks (n=3±SEM). The last 
sample shown is native tissue represented by 2 dashed lines (the range for native 
healthy paravaginal tissue). (b) UTS. *p<0.02.  
 
The mechanical properties are plotted above (figure 5.4.8) and compared to the range 
for native healthy paravaginal tissue (194).  
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Compared to the other 2 groups, samples cultured for 2 weeks showed the highest 
differences between samples cultured with and without cells.  
All samples cultured with cells showed an increase in UTS compared to samples 
cultured without cells. This was significantly higher only for samples cultured for 2 
weeks.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4.9 Appearance by SEM of 7x105ADSCs seeded on Th-PLA scaffolds and 
cultured under unrestrained conditions for 2 weeks in DMEM medium. 
 
The appearance of the ECM produced was studied by SEM for the best cell candidate 
seeded with the optimum number of cells and cultured for the optimum period of time 
on Th-PLA scaffolds (figure 5.4.9). 
As shown for 1x106 ADSCs, 7x105ADSCs seeded and cultured on Th-PLA scaffolds 
over 2 weeks presented a dense sheet of ECM on top of the scaffold. Again, small 
fissures between components of the ECM indicated an orientation of these. 
The highest magnification shows the ability of these cells to penetrate inside the Th-
PLA scaffolds and form ECM within the scaffolds.  
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5.5 Discussion 
 
The aim of this Chapter was to investigate which culture conditions may give the best 
outcomes for developing a TERM.  
For this, we attempted to study cells on the scaffolds cultured under mechanical stress 
conditions by simulating the anticipated strain the cells would experience in vivo. 
However, the stress model we used does not mimic the degree of strain that cells will 
experience in vivo. As discussed earlier, the true strains the female pelvic floor 
undergoes are, to the best of our knowledge, only now beginning to be assessed. 
The rationale for this was to assess the ability of cells on scaffolds to survive and 
proliferate when under stress and in these experiments cells were not adversely affected. 
Mechanical stimulation can be a useful method of enhancing the functional 
characteristics and mechanical properties of engineered tissues prior to implantation 
(450).  
    
The comparison of OFs and ADSCs showed little difference between them under the 
different mechanical conditions and there was no advantage of having a co-culture of 
both cells, as seen in Chapter 4.  
No differences were observed between groups at any day for metabolic activity. 
Alternatively, as seen in Chapter 4, big errors were found for metabolic activity at day 0 
for all groups when same number of cells was seeded. This may be, as explained in 
previous Chapters, due to differences between Th-PLA samples in pore size, fibre 
diameter and thickness, due to the initial low reproducibility of the electrospinning 
technique which may have lead to poor reproducibility in cell seeding.  
Irrespective of this, these errors were reduced by day 14 with cells achieving a confluent 
cell population with similar metabolic activity for all samples.  
 
All groups were able to produce fibres of collagen I and collagen III and a little elastin. 
Using semi-quantitative assessment, collagen production was not increased under any 
mechanical stimulation for any cell type. Although little elastin production occurred, all 
cells increased this production when they were subjected to restraint conditions.   
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Between cell groups, ADSCs under unrestrained conditions produced more collagen 
than OFs under the same conditions, as seen in Chapter 4. In addition, only ADSCs 
under unrestrained conditions had significantly higher Young’s modulus and UTS 
compared to the controls (Th-PLA scaffolds cultured without cells).   
Again, the qualitative appearance of the ECM assessed by SEM indicates that ADSCs 
cultured under unrestrained conditions had denser and more uniform ECM compared to 
the other groups. As seen in Chapter 4 by H&E staining, this ECM seems to be 
produced particularly on the surface of the Th-PLA scaffolds (figure 5.2.10) although 
cells are able to penetrate the scaffold and produce ECM inside them in some areas 
(figure 5.4.9). 
 
Since culturing cells on scaffolds under restrained conditions did not show any 
improvement when developing a TERM, dynamic mechanical stimulation was firstly 
assessed in 2D culture to not waste time and research consumables. Then, since this 
condition did not affect any cell type in 2D culture, we did not do any further 
experiments on cells on scaffolds.    
  
At this point in this project we decided to do further experiments only with ADSCs as 
the preferred cell candidate for developing a TERM due to the slightly better in vitro 
results shown with them compared to OFs but also because of their reported  
regenerative potential as described in a previous Chapter. 
 
Vitamin C stimulated ADSCs to increase collagen production on the scaffolds. 
However, this had a negative effect on the ADSCs leading to contraction of the new 
matrix produced. This effect may have clinical implications as could be seen in skin 
grafts implanted in patients (416), and also Vitamin C may have a negative effect on 
mechanical properties since the contraction pulls the PLA fibres leading to scaffold 
distension.  
 
In conclusion, we could not identify any adverse effect of mechanical stimulation on 
OFs or ADSCs cultured on Th-PLA. On the other hand, this mechanical stimulation 
together or not with chemical stimulation do not have a positive effect for the 
development of a TERM as a method to enhance their functional characteristics.  
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Only elastin was increased by mechanical stimulation but this did not have a positive 
effect on the mechanical properties of the scaffolds. 
Therefore, all further experiments in this thesis involved ADSCs cultured under 
unrestrained conditions. 
 
We found that 7x105 and 1x106 ADSCs seeded on 3.14 cm2 of Th-PLA scaffolds gave 
similar results in the development of a TERM. Therefore, we concluded that 223.000 
ADSCs per cm2 are sufficient to develop a TERM. 
We observed, that the variations previously commented on between different sheets of 
Th-PLA scaffolds was also evident by comparing mechanical properties of these 2 
groups (figure 5.4.4). 
These experiments showed that the quality of a Th-PLA scaffold itself is the main factor 
in obtaining the desired mechanical properties. The addition of cells did however 
significantly increase the UTS which may be explained by the new ECM produced.  
 
Finally, 2 weeks was determined to be the best period of culture for developing a 
TERM before implantation. Cell proliferated during the first week populating the whole 
thickness of the scaffold, as seen by the increase of metabolic activity (figure 5.4.5) 
achieving a confluent cell population after 1 week (figure 5.4.7). However, cells then 
produced most of the ECM during the second week, since the total collagen production 
was significantly higher after 2 weeks of culture compared with 1 week of culture, but 
similar to that seen after 3 weeks of culture (figure 5.4.6). 
As above, although only UTS was significantly increased, the best results for 
mechanical properties were observed for samples after 2 weeks of culture. While after 1 
week of culture cells did not appear to have produced enough ECM to increase these 
properties, after 3 weeks of culture no more ECM produced by the cells made any 
further increment of these properties compared to 2 weeks culture. In addition, longer 
periods of culture could negatively affect the mechanical properties of the scaffolds as 
seen by a decrease of Young’s modulus when looking at the controls from the different 
periods of culture (figure 5.4.8), a fact that is further discussed in Chapter 7 of this 
thesis.  
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Chapter 6 
 
IN VIVO ASSESSMENT OF TERMs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 170  
 
6.1 Introduction 
 
No appropriate animal models for SUI or POP exist since most animals do not develop 
pelvic floor disorders as humans do.   
The vaginal support in humans, made up of the levator ani muscle, ligaments and fascial 
tissues of the pelvic floor, is critical to avoid development of SUI or POP which occurs 
in women due to human bipedal posture. (451). The human anatomy of the pelvic floor 
has been adapted by recruiting the striated muscle of the levator ani to assist in upright 
walking (452, 453). 
 
Nevertheless, animal models have been used to study the importance of different risk 
factors and progression of different events, which may affect different structures of the 
pelvic floor. 
The choice of an animal model has to be based on a specific research question which in 
different cases may need a different animal model. The main points to consider are the 
anatomy, the appearance of these tissues, their cellular and extracellular components 
and their biomechanical properties. 
Currently, non-human primates, sheep, rabbits and rodents are all used in studies for the 
pelvic floor. Each model serves a different function. 
 
Rodents are inexpensive and easy to work with because of their behavior and size. 
While levator ani muscle is mainly associated to tail movement in these animals, 
anatomy of the connective tissues is similar to humans and these make the main vaginal 
support (451).  
Mice and rats require less space and resources than other animals to maintain, and offer 
an accelerated injury recovery time. On the other hand, their small size can increase the 
technical skill required for surgery in some studies.  
At present, rodents are the most common animal model used for prolapse and 
incontinence research, especially for studying the connective tissues. In addition, only 
mice are accessible for developing transgenic knockouts to study the development of 
SUI or POP (454, 455).  
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The larger size of rabbits gives the advantage of allowing easier access to the caudal 
section of the vagina, the creation of several defects in the same animal, the harvesting 
of larger tissue specimens and longer follow-up studies.  On the other hand, the rabbit 
vagina anatomy differs from humans more than that of rodents. The rabbit vagina is not 
supported by connective tissues, thus, the histological appearance is not similar to the 
human vagina. Rabbits do not show weakness of vaginal tissues after birth and do not 
develop POP. Furthermore, collagen metabolism is different to humans, which may 
have an impact on wound healing (456). 
Nevertheless, meshes clinically used to treat POP have been successfully studied in 
rabbits for abdominal wall reconstruction (457-460), and have been also implanted on 
the external posterior vagina wall of these animals (461, 462).    
 
Sheep have been used to develop a POP animal model to study the outcomes of 
implanted different meshes. Sheep spontaneously develop POP related to pregnancy and 
vaginal delivery (463-466). Similar to humans, the same risk factors, such us increased 
intra-abdominal pressure, age and multi-fetal gestation, lead to a similar prevalence of 
uterovaginal prolapse as in humans (8-12%) (465). The anatomy of the connective 
tissues of the pelvic floor is also very similar to humans with 3 supportive levels. 
 
Non-human primates represent the POP animal model closest to humans (453, 467, 
468). On the other hand, they are less accessible, more expensive than any other animal 
model and they require more space and resources. For ethical reasons, primates are only 
used when absolutely necessary. 
Primates have similar reproductive physiology to humans including reproductive cycles, 
levels of estrogens and progesterone which affects metabolism of the components of the 
supportive tissues, and, spontaneously, develop POP related to vaginal delivery. 
Vaginal connective tissues attach similarly to the lateral and apex of the vagina, and 
para-vaginally, to the levator ani muscle (through ATFP ligaments, as in women). At 
this point, remodeling of ATFP has been associated with anterior and posterior vaginal 
wall prolapse. As in humans (123, 199, 469), changes in the rate of collagen I and III 
have been shown to be altered after vaginal delivery associated with POP (467).  
 
Urodynamic measurements used in women for SUI diagnosis require intention since 
women are requested to cough and exercise to increase their abdominal pressure. In 
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addition, anesthesia is usually required in animals which may affect urodynamic 
measurements. Therefore, SUI in animal models is assessed by measuring the resistance 
of the urethra based on a modification of clinical methods of diagnosing SUI. 
 
As above, rodents are the main animal used to study SUI. Methods to determine this 
condition in rats include sneeze testing (470), manual, vertical tilt table (471) and 
electrical stimulation for LPP testing (472).  
Three main strategies have been used to develop SUI models in rats: simulation of 
childbirth injury, simulation of anatomic support damage and intrinsic urethra deficit.    
Balloons inflated into the vagina of rats produce vaginal distension and simulate 
childbirth injury leading to SUI (473-477). Anatomical support damage has been caused 
in rats by urethrolysis for a SUI animal model leading to urethra hypermobility. 
However, these methods are difficult to reproduce without injure to other structures. For 
this, proximal urethra detachment by incision of the fascia has been used (478, 479), as 
well as, injury of the pubo-urethral ligament of rats (480). Finally, direct sphincter 
injury also develops a more durable SUI model which includes peri-urethral 
cauterization (481), urethral sphincterectomy (482), reagent peri-urethral injection (by 
botulinum-A toxin injection) (483) and pudendal nerve transaction (PNT) (484-486), 
the last one used for extrinsic urethra sphincter dennervation. 
 
6.1.1 Animal models to assess materials used to treat SUI and POP  
 
An animal model also allows us to improve the management strategy to treat SUI and 
POP. These involve the implantation in animals of materials currently used, or with 
potential to be used, for the surgical management of these disorders. 
These animal models also have the purpose of answering questions about the safety and 
the efficacy of using these materials in women.  
 
As described in the first Chapter of this thesis, many studies have implanted in animals 
different synthetic and biological materials clinically used to treat SUI and POP to 
assess the host response to them.  
Although many factors may influence the clinical outcome of mesh surgery including 
the physical properties of the material and surgical and constitutional factors (487), the 
host response to the implanted materials is particularly important.  
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Polypropylene implants cannot be remodelled and induce release of a pro-inflammatory 
cytokine and some patients respond to them with chronic inflammation leading to 
excessive fibrosis and encapsulation (488). Alternatively, a range of acellular biological 
grafts have also been trailed in small studies, but the main problem encountered was a 
host response leading to rapid degradation, and consequently, to high failure rates (376). 
Although the “ideal” biomaterial is often described as inert, in practice any material can 
cause a degree of inflammation; and indeed, an acute host response is considered to be 
necessary leading to rapid neovascularization and collagen deposition for constructive 
remodelling of the implant to be long-term integrated into the host tissues (489).  
 
It is well established in most studies that the host response is analyzed after 7, 14, 30, 60 
and 90 days post-implantation. While inflammatory and acute immune responses are 
studied in the first stage, long-term implantation allows us to evaluate integration, 
chronic immune response and mechanical properties post-implantation. The last one is 
particularly important for POP reconstruction since most of these materials implanted in 
humans have been shown to be degraded leading to failure (283).  
 
Materials used to treat SUI and POP have been implanted subcutaneously on the 
abdominal wall of mice (305) and rats (490) to assess inflammation, immune response, 
angiogenesis and ECM production.  
Mechanical properties have been also assessed from long-term implantation of bigger 
samples of these materials to repair an abdominal wall defect in rats (491), pigs (492) 
and rabbits (458, 493-495). 
Only in rabbits (458, 459, 494) and sheep (496) have these materials been implanted on 
the vaginal wall for fascial repair. These models would be more reliable since the 
material is under dynamic distension and the vaginal environment has been 
demonstrated to increase the degradation of the implant (494). 
  
As the immediate host response elicited by any biomaterial is critical to its long-term 
success, in this Chapter, we assessed the acute host response against our best TERM 
candidate chosen from experiments described in previous Chapters. 
For this, we subcutaneously implanted in Sprague-Dawley rats Th-PLA scaffolds 
previously seeded and cultured with human ADSCs. Th-PLA scaffolds were implanted 
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as a control, and scaffolds previously cultured with rat ADSCs were also included in 
this study as an allogeneic implantation control. 
The simplest animal model, which has been already used to assess the host response 
against an implanted material, was chosen before moving to more complex models.  
   
 
6.2 Integration into host tissues 
 
All animals survived both the operation and period of implantation without any 
observed alteration in their physiological functions.  
Furthermore, after sacrifice, by visual inspection, there was no infection or rejection of 
any implant.  
 
Human and rat ADSCs cultured with Th-PLA scaffolds were labeled with green cell 
tracker before being implanted into the animals with the idea of being able to identify 
them after animal sacrifice to check whether or not our cells would survive in the 
scaffolds after implantation, and/or if they could migrate to some other parts of the 
tissue or to other organs.    
 
 
 
 
 
 
 
 
 
 
Figure 6.2.1 Confocal microscope images using a green filter of fresh frozen sections of 
abdominal wall of Sprague-Dawley rats after 7 days implantation of Th-PLA scaffolds 
on top, previously cultured with rat (a) or human (b) ADSCs labeled with green cell 
tracker in DMEM medium for 2 weeks. Images are shown as colored in green or in 
black and white respectively. Scale bars of 0.2 mm.     
a b 
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Frozen sections were analyzed with a confocal microscope to identify in the host tissues 
the ADSCs by fluorescence due to the green cell tracker. However, we could not 
recognize the ADSCs from the implanted TERMs (figure 6.2.1). Cell tracker is diluted 
after cell proliferation, and furthermore, collagen has a strong green autofluorescence 
which could mask low fluorescence intensity from the cells.  
 
Figure 6.2.2 shows a panoramic image of a normal rat abdominal wall without scaffold 
implantation, which is composed of multiple bundles of skeletal muscle fibres held 
together by connective tissue called fascia. This fascia is composed by a thick layer of 
collagen fibres and a submesothelium and mesothelium on top. The fascia covers the 
skeletal muscle of the abdominal wall and is where blood vessels and nerves are found. 
On top of the mesothelium, not shown in this figure, we would find the cutaneous and 
subcutaneous layers which compose the skin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2.2 Representative light microscopy H&E stained sections of normal 
abdominal wall of female Sprague-Dawley rats (no implantation).  
 
1 cm2 Th-PLA scaffolds cultured with and without rat or human ADSCs were implanted 
subcutaneously on top of this mesothelium by suturing the 4 corners. All scaffolds 
previously cultured with and without cells were well integrated into the fascia, as shown 
Mesothelium 
Skeletal 
muscle 
 
Collagen fibres 
Fascia 
Submesothelium 
Blood vessels 
2.5 mm 
mm 
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2.5 mm 
Th PLA scaffold 
by H&E staining, with the mesothelium on top which covered all the scaffolds (figure 
6.2.3).  
 
Figure 6.2.3 is a representative panoramic image of the full section of abdominal wall 
showing where the scaffold was integrated. 
 
After 3 days implantation all samples were already integrated into the fascia and host 
cells infiltrated samples, as seen in the control group of Th-PLA scaffolds implanted 
without cells (figure 6.2.4).  
After 7 days the cell infiltration was increased in all samples, as well as the thickness of 
the fascia and new small blood vessels were visible inside all samples (figure 6.2.5). 
 
 
Figure 6.2.3 Representative light microscopy H&E stained panoramic image of the 
abdominal wall of female Sprague-Dawley rats, after 3 days implantation of Th-PLA 
scaffold on top, previously cultured with human ADSCs in DMEM medium for 2 weeks. 
Small blood vessels are identified by (↑). 
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Figure 6.2.4 Representative light microscopy H&E stained sections of abdominal wall 
of female Sprague-Dawley rats after 3 days implantation of Th-PLA scaffolds on top, 
previously cultured with and without (control) rat or human ADSCs in DMEM medium 
for 2 weeks. Top images: scale bars of 0.2 mm (10X magnification). Bottom images: 
scale bars of 0.1 mm (40X magnification). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2.5 Representative light microscopy H&E stained sections of abdominal wall 
of female Sprague-Dawley rats after 7 days implantation of Th-PLA scaffolds on top, 
previously cultured with and without (control) rat or human ADSCs in DMEM medium 
Control (no cells) Rat cells Human cells 
Control (no cells) Rat cells Human cells 
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for 2 weeks. Small blood vessels are identified by (↑). Top images: scale bars of 0.2 mm 
(10X magnification). Bottom images: scale bars of 0.1 mm (40X magnification). 
 
 
6.3 Acute inflammatory response 
 
At day 3, an acute macrophage response was observed with CD68 positive cells seen 
throughout all samples, localized inside the scaffolds and not found in the surrounding 
tissues (figure 6.3.1).  
Semi-quantitative assessment of the immunohistochemistry demonstrated the 
macrophage response to be moderate, becoming more intense after 7 days implantation 
(figure 6.3.5) and again limited to the samples (figure 6.3.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3.1 Representative light microscopy image of sections of abdominal wall of 
female Sprague-Dawley rats after 3 (top images) and 7 days (bottom images) 
implantation of PLA scaffolds on top, previously cultured with and without (control) rat 
or human ADSCs in DMEM medium for 2 weeks; following immunohistochemistry for 
anti-CD68 antibody. Macrophages stained for CD68 surrounding individual Th-PLA 
fibres are identify by (↑); and foreign giant cells containing several macrophages are 
identified by up pointing triangle (▲). Scale bars of 0.1 mm (40X magnification).  
Human cells  Control (no cells) Rat cells 
c 
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Figure 6.3.2 Representative light microscopy image of sections of abdominal wall of 
female Sprague-Dawley rats after 3 (top images) and 7 days (bottom images) 
implantation of Th-PLA scaffold on top, previously cultured with and without (control) 
rat or human ADSCs in DMEM medium for 2 weeks; following immunohistochemistry 
for anti-PECAM-1 antibody. Endothelial cells stained for PECAM-1 around blood 
vessels are identified by (↑). Scale bars of 0.1 mm (40X magnification). 
 
Figure 6.3.3 Semi-
quantitative analyses of the 
host response against the 
implanted samples. 
Assessment of the extent of 
immunohistochemistry using 
a blind scoring for the 
expression of CD68 and 
PECAM-1 from sections of 
abdominal wall of female 
Sprague-Dawley rats after 3 and 7 days implantation of Th-PLA scaffold on top, 
previously cultured with and without (control) rat or human ADSCs in DMEM medium 
for 2 weeks. Results shown as mean ± SEM (n=3). Scale: 0=absent, 1=mild presence, 
2=large presence, 3=abundance, 4=great abundance. 
Human cells  Rat cells Control (no cells) 
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Although PECAM-1 stained many cells only inside the samples, similarly to CD68, at 
both days of sacrifice (figure 6.3.2); this staining was also found around large blood 
vessels in the fascia at day 3, while, after 7 days implantation, new small blood vessels 
inside the scaffolds for all samples were stained (figure 6.3.2).   
A moderate staining was identified after 3 days with no differences between groups 
(figure 6.3.3). By 7 days, there was a similar expression between samples with rat or 
human ADSCs but lower staining for cell-free Th-PLA scaffolds (figure 6.3.3).       
 
 
6.4 ECM remodelling 
 
Connective tissue of the fascia was stained for collagen I from all sections at any day. 
On the other hand, after 3 days implantation, only a small amount of collagen I was 
observed inside the scaffolds for all samples (figure 6.4.1), which was slightly increased 
after 7 days implantation without visible differences between them (figure 6.4.2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4.1 Representative light microscopy of sections of abdominal wall of female 
Sprague-Dawley rats after 3 days implantation of Th-PLA scaffold on top, previously 
cultured with and without (control) rat or human ADSCs in DMEM for 2 weeks; 
following immunohistochemistry for anti-collagen I antibody. Top images: scale bars of 
0.2 mm (10X magnification). Bottom images: scale bars of 0.1 mm (40X magnification). 
Control Rat cells Human cells 
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Figure 6.4.2 Representative light microscopy of sections of abdominal wall of female 
Sprague-Dawley rats after 7 days implantation of Th-PLA scaffold on top, previously 
cultured with and without (control) rat or human ADSCs in DMEM for 2 weeks; 
following immunohistochemistry for anti-collagen I antibody. Top images: scale bars of 
0.2 mm (10X magnification). Bottom images: scale bars of 0.1 mm (40X magnification). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4.3 Representative light microscopy of sections of abdominal wall of female 
Sprague-Dawley rats after 3 days implantation of Th-PLA scaffold on top, previously 
Control Rat cells Human cells 
Rat cells Human cells  Control (no cells) 
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cultured with and without (control) rat or human ADSCs in DMEM medium for 2 
weeks; following immunohistochemistry for anti-collagen III antibody. Top images: 
scale bars of 0.2 mm (10X magnification). Bottom images: scale bars of 0.1 mm (40X 
magnification). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4.4 Representative light microscopy of sections of abdominal wall of female 
Sprague-Dawley rats after 7 days implantation of Th-PLA scaffold on top, previously 
cultured with and without (control) rat or human ADSCs in DMEM medium for 2 
weeks; following immunohistochemistry for anti-collagen III antibody. Top images: 
scale bars of 0.2 mm (10X magnification). Bottom images: scale bars of 0.1 mm (40X 
magnification). 
 
After 3 days implantation, immunohistochemistry for collagen III revealed a thin layer 
of collagen production on the lower surface of the scaffolds from all the samples (figure 
6.4.3). Nevertheless, by day 7, thin new fibres of collagen III were visible throughout 
the scaffolds of all samples, as shown in figure 6.4.4. 
 
Total collagen from all samples was stained with Sirius red staining. Similar to collagen 
I staining the connective tissue of the fascia was highly stained for all sections at any 
day. Alternatively, similar to collagen III staining, while a thin layer of collagen was 
found on the lower surface of the scaffolds from all the samples (figure 6.4.5), new thin 
fibres of collagen were stained throughout the scaffolds of all samples (figure 6.4.6). 
Rat cells Human cells  Control (no cells) 
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Figure 6.4.5 Representative light microscopy of sections of abdominal wall of female 
Sprague-Dawley rats after 3 days implantation of Th-PLA scaffold on top, previously 
cultured with and without (control) rat or human ADSCs in DMEM medium for 2 
weeks; following Sirius red staining. Top images: scale bars of 0.2 mm (10X 
magnification). Bottom images: scale bars of 0.1 mm (40X magnification). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4.6 Representative light microscopy of sections of abdominal wall of female 
Sprague-Dawley rats after 7 days implantation of Th-PLA scaffold on top, previously 
Rat cells Human cells  Control (no cells) 
Control (no cells) Rat cells Human cells  
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cultured with and without (control) rat or human ADSCs in DMEM medium for 2 
weeks; following Sirius red staining. Top images: scale bars of 0.2 mm (10X 
magnification). Bottom images: scale bars of 0.1 mm (40X magnification). 
 
Finally, the controls for all 3 groups did not show any staining when sections were 
incubated without primary and secondary antibodies, or incubated only with secondary 
antibodies, but following the rest of the immunohistochemistry protocol (figure 6.4.7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4.7 Representative light microscopy of sections of abdominal wall of female 
Sprague-Dawley rats after 7 days implantation of Th-PLA scaffold on top, previously 
cultured with and without (control) rat or human ADSCs in DMEM medium for 2 
weeks. Each sample was followed by immunohistochemistry control procedure; the 
same process only avoiding incubations with primary and secondary antibodies, or 
incubating only with secondary antibodies. Top images: scale bars of 0.2 mm (10X 
magnification). Bottom images: scale bars of 0.1 mm (40X magnification). 
 
 
Control (Only 2ary Ab  
anti-goat) 
Control (Only 2ary Ab  
anti-mouse)  Control (No Ab) 
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6.5 Discussion 
 
Ideally, a biomaterial to be implanted into the pelvic floor of humans has been described 
as being sterile, inert, non-carcinogenic, non-inflammatory, non-immunogenic, 
mechanically durable, not degradable, inexpensive, readily accessible, and easy to use 
(497).   
Clearly, currently there is no material that meets the above criteria. Alternatively, a 
material that produces a an initial vigorous inflammatory response is more likely trigger 
the cascade of events leading to tissue integration and reduce risk of encapsulation 
(498). However, the persistence of the inflammatory response into a chronic phase (M1 
macrophage response) (499) is undesirable and is associated with pain, erosion or 
infection, as seen with non-degradable materials.  
A degradable material may be preferable since, ideally, it can undergo controlled 
degradation whilst at the same time inducing the production of new ECM and 
remodeling of the tissue (M2 macrophage response) with ingrowth of fibroblast and 
rapid angiogenesis (489).   
 
As above, several studies have investigated in animals the acute host response against 
different cell-free synthetic and biological materials as being a critical indicator to 
predict their long-term outcomes. 
Nevertheless, only a few studies have previously assessed in animals a TERM designed 
for pelvic floor repair. These were developed from biodegradable poly-glycolic acid 
(PGA) (334) or PLGA (336, 500) scaffolds. In vivo, PGA scaffolds have been shown to 
be completely degraded in a few weeks and PLGA scaffolds in 3 months whilst PLA 
scaffolds are present after 12 months (501). The degradation rate has relevance for 
maintenance of mechanical properties of the implants and needs to be studied for pelvic 
floor repair.  
Cells used to develop the TERMs in these previous studies were obtained from rabbits 
(334) or humans (336, 500) and were subcutaneously implanted in nude mice. All 
demonstrated integration of the samples into the host tissues with neo-fascia formation, 
particularly for the cell-seeded scaffolds. Alternatively, the immune response against the 
implants was not characterized in any study. 
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Only 2 studies have used rat models for SUI, both by direct sphincter injury using PNT, 
to implant and assess a TERM. MDSCs and BMDSCs isolated from same rats, 
respectively, were used to develop engineered tissues from biological (338) and 
synthetic degradable scaffolds (339). Both studies showed neo-tissue formation for the 
cell-seeded scaffolds which was hypothesized as having potential for long-term 
integration; however, continence outcomes were similar for the acellular and cell-
seeded groups and again the host response to the implants was not assessed. 
 
Although in our study we implanted human cells in immunocompetent Sprague-Dawley 
rats, rat cells were also included as a control. All samples were implanted in different 
rats since interpretation of responses to different materials in the same animal is not 
recommended with a body wide immune response.  
There were little differences, in terms of the host inflammatory response elicited, 
between cell-free scaffolds and those seeded with human or rat ADSCs. ADSCs were 
well characterized prior to implantation but there was no identification of them post 
implantation so it is not possible to comment on any direct regenerative effect of these 
cells, however, there were no major differences with non cell-seeded implants and in 
these acute experiments the major objective was to assess the acute inflammatory 
response to implants.  
 
Although PECAM-1 is an adhesion molecule expressed on platelets and subsets of 
leukocytes, it mainly stains endothelial cells with cell adhesion, trans-endothelial 
migration of myeloid-derived cells and angiogenesis functions; and therefore, it has 
been widely use to assess neovascularization (502). PECAM-1 stained blood vessels 
inside samples and the semi-quantitative assessment of this staining was higher after 7 
days implantation for cell-seeded scaffolds compared to acellular samples. However, we 
cannot explain this as an effect of the ADSCs since these cells were not identified post 
implantation.  
There is no data showed about the immunohistochemistry of these slides for anti-human 
CD29, CD44, CD73 and beta-2 microglobulin. Since the cell tracker staining failed, the 
idea was to identify the human cells implanted into rat tissues by using these Abs; 
however, while the PE conjugated Abs (CD29, CD44 and CD73) did not work beta-2 
microglobulin Ab stained all the cells from the fascia of the rats. The secondary Ab 
control did not shown any staining; however, sections from the control group (scaffolds 
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implanted without cells) showed staining for this Ab suggesting unspecificity against 
human specie and probably it reacted against rat cells too.      
 
All PLA scaffolds, both without and with cells, were integrated into the fascia of the 
abdominal wall with rapid host cell infiltration and ingrowth of small blood vessels after 
7 days implantation as seen for H&E and PECAM-1 staining.  
 
The macrophage response against the cell-seeded Th-PLA scaffolds is clearly evident, 
especially 7 days after implantation. This response seems to be specific to the synthetic 
foreign material since macrophages were not found in tissues surrounding the samples 
and macrophages enclosed individual PLA fibres.  
Macroporous polypropylene mesh is said to be more favourable to permit host cells 
infiltration (376). The current study shows that a microporous electrospun Th-PLA 
scaffold permitted the infiltration of host inflammatory cells throughout its entire 
thickness which is highly encouraging for its potential to resist infection by any bacteria 
during implantation in a clean contaminated environment.  
Additionally, the host response led to host fibroblast infiltration and ECM formation, as 
seen for collagen I, collagen III and Sirius red staining, for all samples.  
Small amounts of collagen I was produced inside all scaffolds, particularly after 7 days; 
while loads of new collagen III fibres were seen after 7 days implantation in all samples 
throughout the thickness of the scaffolds. Collagen III is the first type produced when 
new ECM is formed during constructive remodelling. Afterwards, this is replaced by 
collagen I which is more stable (489).  
Reassuringly there was no sign of encapsulation observed; a problem that has been seen 
with chemically cross-linked biological grafts in animals (456) and humans (503). 
 
3 and 7 days time points for subcutaneous implantation in rats were basically selected as 
being the easiest and cheapest way to assess the host response against our materials. 
Since this work was a collaborative research between institutions of different countries, 
involving many people and resources as well as high level of organization; we thought 
to use first this short-term implantation and cheaper animal model before moving to 
more complex and expensive long-term models. Alternatively, this was the major 
limitation of this work since the short-term nature the model cannot be used to assess 
definitely whether a chronic inflammatory response ensues.  
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Additionally, implanted cells were not labelled; something that will be necessary in 
longer-term experiments to provide information on their survival or migration. The 
immune system of the rats could have eliminated human cells via cellular rejection 
(504). 
Long-term animal experiments will also be required to study the performance of the 
TERM investigating the development of any chronic immune response, the fate of the 
ADSCs and the mechanical properties of the TERM after several months of 
implantation. 
 
Nevertheless, we believe this is the first study that examines the acute host response 
against a TERM designed for pelvic floor repair, developed from human ADSCs 
cultured on biodegradable Th-PLA scaffolds.   
In addition, although 7 days is too short to test the regenerative potential of the ADSCs, 
there was no higher immune response against the human cell-seeded scaffolds 
compared to the other groups of implants. All groups were well integrated into host 
tissues with an acute response suggesting the potential for production of neo-tissue 
formation by host cell infiltration and new blood vessels formation; all early indicators 
of constructive remodelling and promising for long-term integration. 
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Chapter 7 
 
 MECHANICAL PROPERTIES OF THE TERMs 
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7.1 Introduction 
 
There are no standardised protocols for testing the mechanical properties of pelvic floor 
tissues or materials used to treat SUI and POP. However, many studies have used 
uniaxial tensile testing to calculate the stress (force divided by cross sectional area of 
tissue) versus the strain (change in elongation in relation to initial length) of these 
tissues/materials, which are described in the introduction of this thesis and summarized 
in this Chapter.  
Therefore, all mechanical data of this thesis is based on this method to measure the 
breaking load of our materials.  
 
The plot obtained, after uniaxial testing, is normally a non-linear curve and has 3 
distinct sections: the initial toe, linear and failure regions (505).  
In order to normalize the data from a tensile test of different materials, the volume of 
the tested material was calculated using contact methods. These,  may be less precise 
than non-contact methods and have the risk of causing weakening (506). Then, we used 
clamp grips as the method of securing the tissue for uniaxial loading, which may be 
more accurate than pin grips, for instance, since the clamp can purchase the full width 
of the tissue and distribute the force more evenly across the tissue. Another variable is 
the strain rate applied to this test; however, this has not been shown to affect the 
mechanical properties when studying ligaments and tendons from animals (507, 508).  
 
In addition, studies have looked at the effects of ambient air, storage in saline, 
temperature, and freezing, when testing mechanical properties (509, 510). Nevertheless, 
it has been shown that there is no effect on mechanical properties of vaginal tissue when 
comparing fresh and frozen samples, as well as, comparing samples at room 
temperature and samples at 370C. In addition, in the same study, samples soaked in 
saline remained stable for up to 24 hours and storage in paraffin did not affect the 
results either (510).  
Irrespective of this, every uniaxial testing performed in this thesis to test the mechanical 
properties of TERMs was done with fresh samples after their culture, taken straight 
from the incubator.  
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7.1.1 Mechanical properties of the native tissues and of the prostheses used to treat 
SUI and POP  
 
Only 3 studies could be found where the mechanical properties of paravaginal tissue 
were investigated (194, 511, 512). These all looked at women with POP, and no similar 
studies were found for women with SUI. Furthermore, only one of these studies looked 
at the mechanical properties of healthy (non-prolapsed) paravaginal tissue (194) from 
pre and pot-menopausal women. These values were used to provide the ranges for 
native tissues which are used in this thesis when comparing mechanical properties of 
different materials.   
 
Although all materials used to surgically treat SUI and POP present higher mechanical 
properties than native tissues, the closest in terms of UTS and Young’s modulus are 
rabbit rectus fascia (494), cross-linked porcine dermis (458) and macroporous 
monofilament PPL (458). Cadaveric dermis and fenestrated porcine dermis (494) 
showed greater Young’s modulus and UTS than native tissues.  
 
After implantation of these materials, clinical and animal studies have reported different 
results for alterations in mechanical properties. Whereas PPL become stiffer and UTS 
was decreased, the mechanical properties of autologous rabbit fascia was unchanged 
(494, 513), which correlates with a lower host response to the latter, as is also seen in 
women (514).  
Cadaveric tissues undergo the greatest decrease in UTS which correlates with the 
clinical findings of gross degradation with these tissues (515, 516).  
Fenestrated porcine dermis grafts lose strength (UTS) and increase stiffness (Young’s 
modulus), but cross linked porcine dermis does not change a great deal. This may be 
because encapsulation without remodelling has been observed for the latter material 
after implantation (514, 517).  
 
7.1.2 Correlation between mechanical properties and outcomes of the prosthesis 
used to treat SUI and POP  
 
As already described in the introduction Chapter of this thesis, macroporous PPL has 
been shown to have good success rates for SUI and POP repair, although a greater risk 
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of erosion is associated with this material (518-521). At 5 year follow up, in a 
randomised trial, better objective success rate with PPL mesh were described when 
compared to autologous fascia lata (522).  
The success of biological materials, such as cross-linked porcine dermis, is very low but 
the erosion rate is also low (84). When comparing PPL mesh with fenestrated porcine 
dermis, an objective cure rate of 71.9% and 56.4% was found but the erosion rate was 
6.3% and 0% respectively (523).  
Alternatively, cadaveric dermis showed high failure rates of 50% at 6-12 months (79, 
524).  
 
From the above evaluation, there was no correlation between changes in mechanical 
properties and the success and/or erosion rates after the implantation of these materials 
(378).  
PPL presents extremely high Young’s modulus, which may explain its greater risk of 
causing erosion, and although UTS is decreased post implantation it remains higher than 
for native tissues (458).  
Autologous grafts and fenestrated porcine dermis have shown reasonable maintenance 
of mechanical properties after implantation with UTS higher than native tissues, but 
slightly lower Young’s modulus and this may be associated with the lower success rate 
of these materials when compared to PPL.   
For cadaveric dermis and cadaveric fascia although mechanical properties are highly 
decreased, these have same Young’s modulus and higher UTS than native tissue after 
implantation, which does not correlate with their clinical findings.  
Similarly, cross-linked porcine dermis has very low success rates, even though, its 
mechanical properties are maintained after implantation with the same Young’s 
modulus and higher UTS than native tissues.  
 
It is likely that factors other than the mechanical properties of the materials will 
influence the final outcome, as commented on in a previous Chapter.  The host response 
to these materials is very relevant and varies considerably with the different implanted 
materials.  
In response to PPL there is often a fibrotic response followed by some strengthening 
and particularly increasing the stiffness of the material. On one hand, this seems to be 
desirable for long-term retention but it is more likely to produce erosion.  
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In general, a good integration into native tissues by constructive remodelling of the 
implant, as seen for autologous fascia and  fenestrated porcine dermis seems to be 
necessary for better outcomes, which is also the case in hernia models (492). In 
addition, although mechanical properties of cadaveric tissues are higher than other 
materials, the high degradation associated with cadaveric tissues may lead to early 
failure. Probably, encapsulation is not desirable either, since cross-linked porcine 
dermis is also related to high failure rates whereas its mechanical properties are 
maintained after implantation, being stronger than native tissues.    
 
7.1.3 Mechanical properties for TERMs 
 
Mechanical properties of healthy native paravaginal tissue from premenopausal women 
without SUI or POP were used as a target to aim for based on the assumption that these 
values are representative of the requirements for physiological load bearing. Whether 
these values are the “ideal” for a TERM is unknown but it seems desirable that an 
implantable material should have as minimum requirement equivalent values to the 
native tissue at the time of implantation.  
 
In this thesis, it has been shown that electrospun Th-PLA scaffolds seeded and cultured 
with ADSCs achieved mechanical properties close to healthy native paravaginal tissue. 
While the Young’s modulus was slightly lower compared to native tissues, the UTS was 
higher. 
This seems to be desirable since excessively stiff materials may lead to tissue erosion 
whilst excessively lax materials will fail to provide sufficient support (525). Since PPL 
shows a high Young’s modulus and this material is associated initially with high 
success rates, stiffer materials may be desirable (at least initially) for initial support but 
better long-term outcomes probably require a good host response to the material as well 
as adequate mechanical properties.  
 
There are also good arguments that perhaps we should aim for an even stronger material 
in terms of UTS.  
Since we are not replacing a native tissue we may aim for a stronger material than these 
to compensate for global deficiencies in muscular, ligamentous and fascial supports. 
Indeed, for the current prosthesis these are all stronger than native tissues at the time of 
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implantation. On the other hand, PLA fibres will degrade over time as previously 
observed in vitro, leading to a weakened TERM, and this may be accelerated in vivo. 
Therefore, starting with a stronger material will theoretically be less likely to result in 
early failure (figure 7.1.1 and figure 7.1.2).  
Nevertheless, questions, such as, how much stronger, in vivo degradation rate, and the 
effect of neo-tissue formation on mechanical properties, will need to be answer with 
long-term animal experiments. 
 
Figure 7.1.1 The ideal in vivo response to a material with optimal tensile properties. 
 
Figure 7.1.2 Anticipated in vivo response to a material leading to early failure. 
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7.2 Increasing mechanical properties of PLA scaffolds 
 
In the previous Chapter of this thesis it was shown that mechanical or chemical 
stimulation, in terms to increase ECM production, did not have any significant effect on 
the mechanical properties on the TERMs. In addition, it was demonstrated that, 
although the culture of cells on scaffolds can increase the values for mechanical 
properties, the main mechanical properties of a TERM are given by the scaffold.  
For this reason in this Chapter we aimed to develop PLA scaffolds designed with 
different fibre configurations to improve their mechanical properties.  
 
As described in Chapter 3 of this thesis, the electrospinning technique allows the 
modification of different parameters to produce random or aligned fibres which can 
affect the mechanical properties of the electrospun scaffolds. 
 
Scaffolds were initially made by aligned fibres to be compared with other scaffolds and 
we then explored hybrid scaffolds combining aligned and random fibres. Following the 
setup for the electrospinning rig described in Chapter 2, aligned fibres were produced, 
based on previous work done in our laboratory, by increasing the speed of the rotation 
of the collector and reducing the distance between the needles and the collector. It has 
also been shown in our lab that relatively high voltage reduces the diameter of the fibres 
which become nanofibres. In addition, reducing the flow rate of the syringe pump 
reduces the diameter of the fibres too (data not published).  
Another issue was getting these aligned fibres all along the width of the collector. The 
fibres are collected only in a narrow portion of the collector just in front the syringe 
which has to be very close to the collector. 
 
Therefore, different electrospinning rigs were developed to produce scaffolds made of 
different combinations of aligned and random PLA fibres as described below: 
• PLA random 
• Th-PLA random 
• Hybrid PLA (280 µm) (figure 7.2.3) 
• Hybrid PLA (150 µm) (figure 7.2.2) 
• PLA mainly aligned (figure 7.2.1) 
  
 196  
 
• PLA aligned 
 
7.2.1 Description of the different setups for the electrospinning rig  
  
PLA random and Th-PLA random scaffolds were produced from 16 mL of PLA 
solution. The electrospinning rig for production of both scaffolds is already described in 
Chapter 2 and both scaffolds have already been compared in Chapter 3 of this thesis. 
 
Figure 7.2.1 Illustration of the electrospinning rig used to produce the mainly aligned 
PLA scaffolds.   
 
The first rig used to produce hybrid PLA scaffolds is described below which was 
developed in our lab by PhD student Mr Frazer Bye. 
As shown in figure 7.2.1, the left hand setup was adjusted for the formation of randomly 
oriented fibres, as previously described (8 mL of solution, 4 syringes, 2.4 mL/h, 17 kV, 
17 cm from the tip of the needle). The right hand setup was adjusted to favour the 
formation of aligned fibres (8 mL of solution, 4 syringes, 2.4 mL/h, 12 kV, 5 cm from 
the tip of the needle). In order to ensure an equal distribution of aligned fibres across the 
rotating collector, the right hand syringe pump was mounted on a LegoTM robot 
programmed to reciprocate at 1/30 Hz in front of the collector and its travel set to the 
collector's width.  
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Finally, the speed of the rotation of the collector was set to spin at 600 rpm (only one 
speed setting for both the left and right hand set ups were possible).  
 
A problem not commented before on in this thesis about the electrospinning technique 
is that, even though the collector is earthed, the fibres are attracted by metals around the 
rig and it is impossible to work out how much of the initial PLA solution is actually 
collected on the foil. On the other hand, since syringes for aligned fibres are placed very 
close to the collector these do not spread out and are mostly collected on the aluminium 
foil. 
Therefore, although we used same amount of polymer solution pumped at the same 
flow rate, we believe these scaffolds were mainly composed by aligned fibres and that is 
why these scaffolds were called PLA mainly aligned. 
 
Figure 7.2.2 Illustration of the electrospinning rig used to produce the hybrid PLA 
scaffold (150 µm).   
 
The second electrospinning rig to produce hybrid scaffolds was developed in our lab by 
Mr Julio Bissoli.  
As shown in figure 7.2.2, the left hand setup was adjusted for the formation of randomly 
oriented fibres, as previously described 20 mL of solution, 4 syringes, 2.4 mL/h, 17 kV, 
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17 cm from the tip of the needle). The right hand setup was adjusted to favour the 
formation of aligned fibres using a 50 mL syringe incorporated to a multichannel steel 
tube (figure 7.2.3) with 12 orifices to incorporate 12 tips; however, 6 of these tips in 
alternating order were blocked (15 mL of solution, 14.4 mL/h, 12 kV, 5 cm from the tip 
of the needle). The multichannel needle allowed the homogeneous distribution of the 
aligned fibres along the width of the collector. 
As previously, the speed of the rotation of the collector was set to spin at 600 rpm. 
 
 
Figure 7.2.3 Image of the electrospinning rig using the multichannel needle. 
 
Since we had 6 needles working for the multichannel needle the solution was spun in 
less time. Therefore, we started to spin the random fibres 30 min before the aligned 
fibres and we finished the electrospinning of the random fibres 30 min later. 
Nevertheless, again, we believe that more aligned fibres were collected on the foil 
compared to random fibres. For this reason, we also believe that more random fibres 
were collected in the aluminium foil compared with PLA mainly aligned scaffolds. 
Furthermore, the last scaffolds produced were thicker than previous scaffolds (figure 
7.2.5a) since we used more polymer solution. These scaffolds were called hybrid PLA 
(150 µm). 
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The last electrospinning rig was developed again by Mr Julio Bissoli aiming for thicker 
scaffolds with an equal ratio of random and aligned fibres. 
As shown in figure 7.2.4, the left hand setup was adjusted for the formation of randomly 
oriented fibres, now using a multichannel needle (29 mL of solution, 28.8 mL/h, 17 kV, 
17 cm from the tip of the needle). The right hand setup was adjusted to form aligned 
fibres using another multichannel needle (15 mL of solution, 28.8 mL/h, 12 kV, 5 cm 
from the tip of the needle). Again, the speed of the rotation of the collector was set to 
spin at 600 rpm. 
 
Figure 7.2.4 Illustration of the electrospinning rig used to produce the hybrid PLA 
scaffold (280 µm).   
 
For this rig, both syringes had the same amount of tips and were pumped at the same 
rate; however, since we had more PLA solution in the multichannel needle for the 
random fibres these started to be spun 15 min before the aligned fibres and we finished 
the electrospinning of the random fibres 15 min later. 
As above, we could not work out the amount of solution actually spun and collected on 
the aluminium foil. Again a percentage of the amount of random fibres was lost; 
however, since we used a higher volume of solution for the random fibres we believe 
we obtained a more equal ratio of aligned vs random fibres for these last scaffolds 
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compared with previous scaffolds. In addition, these scaffolds were the thickest (figure 
7.2.5a), and therefore, they were called hybrid PLA (280 µm). 
 
As previously mentioned, we also produced 100% aligned scaffolds  made with only 
one pump syringe and 4 needles with a collector set to spin at 600 rpm (20 mL of 
solution, 4 needles, 2.4 mL/h, 12 kV, 5 cm from the tip of the needle).   
 
7.2.2 Physical and mechanical properties of PLA scaffolds with different fibre 
configuration  
 
Mechanical properties of all these scaffolds were measured by using a BOSE 
tensiometer. SEM images and bulk density, calculated as previously described in 
Chapter 3, were also used for comparison. 
 
 
 
 
   
 
 
 
 
 
Figure 7.2.5 (a) Thickness of the 6 different PLA scaffolds, mean±SEM (n = 3). (b) Bulk 
density of the 6 different PLA scaffolds, mean±SEM (n = 3); *p<0.05, **p<0.005, 
***p<0.0005.  
 
Figure 7.2.5 shows the thickness and bulk density of the PLA scaffolds with 6 different 
fibre configurations which are presented in the table (figure 7.2.5 a) as the anticipated 
expectation from higher amount of random fibres to higher amount of aligned fibres, 
such as described in previous section of this Chapter.  
The bulk density was significantly increased from PLA random to PLA aligned 
scaffolds.    
 
PLA 
random 
260           
±1.472 
Th-PLA 
random  
97.5 
±0.6292 
Hybrid PLA 
(280 µm) 
277.5  
±1.75 
Hybrid PLA 
(150 µm) 
155 
±1.0408 
PLA mainly 
aligned 
50   
±0.4082 
PLA  
aligned 
122.5 
±1.1087 
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Same kind of correlation was found for mechanical properties of these 6 materials with 
an increase in Young’s modulus and UTS from PLA random to PLA aligned scaffolds, 
and a decrease in the strain at the UTS from PLA random to PLA aligned scaffolds 
(figure 7.2.6). In addition, these differences were more significant for the increase of 
strength (UTS) and stiffness (Young’s modulus) than for the decrease of the strain at 
UTS.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.2.6 Mechanical properties of 6 different PLA fibre configuration scaffolds, 
mean±SEM (n = 3). The last sample shown is the range for native tissue represented by 
2 dashed lines (the range for native healthy paravaginal tissue). (a) YM, **p<0.005; 
***p<0.0001. (b) UTS, **p<0.005; ***p<0.0005. (c) Strain at UTS, *p<0.05; 
**p<0.005. 
 
c 
a b 
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SEM images confirmed the trend already commented on from random fibres to aligned 
fibres (figure 7.2.7). Furthermore, scaffolds containing aligned fibres were easier to peel 
off the aluminium foil and they were flatter scaffolds as can be observed from SEM 
images too.   
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.2.7 Representative SEM images of PLA scaffolds with different fibre 
configurations. 
 
 
7.3 Effect of different scaffold configurations on cell behaviour 
 
To compare the performance of the cells on scaffolds with different fibre 
configurations, human ADSCs were seeded on Th-PLA random, hybrid PLA (280 µm) 
and PLA mainly aligned scaffolds, and were cultured for 2 weeks.  
Scaffold preparation was performed as previously described in Chapter 2 of this thesis, 
but from this point of the project, we used samples of 1.5 x 1.5 cm seeded with 5x105 
ADSCs at passage 6 using metal rings with hall diameter of 1 cm (about 6.3x105 cells 
seeded per cm2).  
PLA random Hybrid PLA (280 µm) 
Hybrid PLA (150 µm) PLA mainly aligned 
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Metabolic activity of all samples at day 0, 7 and 14 was measured by AlamarBlue® 
staining and, after 14 days, total collagen production using Sirius red staining and 
mechanical properties using a BOSE tensiometer were also assessed for comparison of 
these scaffolds.   
For PLA mainly aligned scaffolds immunostaining for f-actin, elastin and collagen I and 
III was performed to assess the distribution of the cells and the ECM components along 
the PLA fibres.    
 
Metabolic activity was increased for all samples from day 0 to day 14; nevertheless, 
while cells on Th-PLA random scaffolds had a linear increment, cells on scaffolds 
containing aligned fibres had a small increment during the first week and a big 
increment during the second week reaching similar values compared to Th-PLA random 
scaffolds (figure 7.3.1). 
This difference at day 7 was only significant between Th-PLA random and PLA mainly 
aligned scaffolds. 
      
 
 
 
 
 
 
 
 
 
Figure 7.3.1 AlamarBlue® staining for ADSCs on Th-PLA random, hybrid PLA (280 
µm) and PLA mainly aligned scaffolds over 2 weeks in culture (n=3±SEM). *p<0.05. 
 
Sirius red staining of PLA mainly aligned scaffolds showed significantly higher 
production of total collagen compared to Th-PLA random scaffolds (figure 7.3.2).  
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Immunostaining for f-actin, one of the main components of the cytoskeleton, and for the 
different ECM components demonstrated an aligned distribution of the cells along the 
fibres of the PLA mainly aligned scaffolds producing the ECM components in an 
aligned manner too (figure 7.3.3).   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3.2 Sirius red staining after 14 days of ADSCs cultured on Th-PLA random, 
hybrid PLA (280 µm) and PLA mainly aligned scaffolds. (n=3±SEM). *p<0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3.3 Representative images of immunostaining for f-actin, collagen I and 
elastin of ADSCs cultured on PLA mainly aligned scaffolds for 2 weeks. Scale bar = 0.5 
mm. 
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After 2 weeks in culture with or without ADSCs, mechanical properties of the 3 PLA 
scaffolds with different fibre configurations showed differences between them as 
already commented on in the previous section of this Chapter. PLA mainly aligned 
scaffolds were stiffer and stronger than the others but they snapped very quickly; 
whereas Th-PLA random scaffolds were the weakest, although they allowed more 
displacement before they span, and hybrid PLA (280 µm) scaffolds had values for these 
3 mechanical properties between the other 2 materials (figure 7.3.4 and 7.3.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3.4 Mechanical properties of Th-PLA random, hybrid PLA (280 µm) and PLA 
mainly aligned scaffolds cultured with ADSCs for 2 weeks. Results shown are 
mean±SEM, (n = 3). The last sample shown is the range for native tissue represented by 
2 dashed lines (the range for native healthy paravaginal tissue). 
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Alternatively, when looking at the effect of the cells on the mechanical properties we 
can see that cell proliferation and ECM production did not modify the mechanical 
properties of the hybrid PLA (280 µm) and PLA mainly aligned scaffolds, compared 
with their respective controls (scaffolds cultured for 2 weeks in DMEM medium 
without cells); whereas mechanical properties of Th-PLA random scaffolds were 
increased after the culture of ADSCs as previously shown in Chapter 4 of this thesis 
(figure 7.3.4). 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3.5 Examples of stress-strain plots of Th-PLA random, hybrid PLA (280 µm) 
and PLA mainly aligned scaffolds cultured with ADSCs for 2 weeks. 
 
 
7.4 Suture retention test, wettability and degradation  
 
As previously mentioned, suturing PLA scaffolds with aligned fibres, needed for their 
clinical application, may be an issue. 
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To study this, a suture retention test using the BOSE tensiometer was performed for 5 of 
the 6 materials previously assessed in this Chapter. 
Each material was cut to a length of 1 cm and a width of 0.5 cm. Then, a stainless steel 
wire of 0.20 mm of diameter (50 g, Scientific Wire Company, Essex, UK) was passed 
through a point 0.25 cm away from the top edge in the centre of the scaffold. Finally, 
each scaffold was clamped from the bottom 0.5 cm away from the edge, and the suture 
was clamped with the top grid with a gap between the 2 grids of 0.75 cm. 
A ramp test of 0.1 mm/sec, same used to assess tensile properties of the scaffolds, was 
run on the direction of the aligned fibres. Then, the data was normalized by thickness of 
each scaffold and was plotted bellow, as N/mm, showing the maximum strength 
supported by each material before the suture slitted the scaffolds.       
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.4.1 Suture retention test of 5 different PLA fibre configuration scaffolds, 
mean±SEM (n = 3). *p<0.05.  
 
Non-thermoannealed PLA random scaffolds showed the highest strength before the 
material was slitted by the suture. This was significantly higher than Th-PLA random 
scaffolds. However, the suture retention strength of the latter was only significantly 
higher when compared to PLA aligned scaffolds.  
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Since PLA scaffolds are hydrophobic, we looked at the effects of increasing the 
wettability of the PLA fibres by using ethanol with the aim to increase the number of 
cells seeded on our samples.  
Hybrid PLA (280 µm) scaffolds composed of a mixture of random and aligned fibres, 
were used to study this effect. 
One day before cell seeding, half of the scaffolds were soaked in 70% ethanol for 3 
seconds. Afterwards, these samples were 3 times washed with PBS and were kept wet 
until the cell seeding. The rest of the sample preparation and cell seeding was performed 
as previously described in the second section of this Chapter, obtaining cell-seeded 
scaffolds and scaffolds without cells (controls) for the non-alcohol treated group and the 
alcohol treated group, shown as “non-OH treated” and “OH treated” in figures, 
respectively.   
 
Then, the metabolic activity of all samples from the 2 groups were measured at day 0, 7 
and 14 by AlamarBlue® staining and, after 14 days, total collagen production using 
Sirius red staining and mechanical properties using a BOSE tensiometer were also 
assessed for comparison of these 2 groups.  
 
  
  
 
 
 
 
 
 
 
 
 
 
Figure 7.4.2 (a) AlamarBlue® staining for ADSCs on hybrid PLA (280 µm) scaffolds 
treated and non-treated with 70% alcohol over 2 weeks in culture (n=3±SEM). p<0.05. 
(b) Sirius red staining after 14 days of ADSCs cultured on hybrid PLA (280 µm) 
scaffolds (n=3±SEM). *p<0.05. 
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Although ADSCs cultured on hybrid PLA (280 µm) scaffolds treated or non-treated 
previously with alcohol similarly increased their metabolic activity from day 0 to day 14 
(figure 7.4.2a), the metabolic activity of the cells on the alcohol treated scaffolds was 
significantly higher from day 0 to day 14. 
Total collagen production was also significantly higher for ADSCs cultured on alcohol 
treated scaffolds compared with the other group (figure 7.4.2b).   
 
 
 
 
 
 
 
 
 
 
 
 
     
 
 
 
 
 
 
Figure 7.4.3 Examples of stress-strain plots of hybrid PLA (280 µm) scaffolds cultured 
with and without ADSCs for 2 weeks, and previously treated or non-treated with 
alcohol. 
 
Examples of stress-train plots of hybrid PLA (280 µm), alcohol or non-alcohol treated, 
after 2 weeks in culture with or without ADSCs were next made (figure 7.4.3). There 
were no differences observed between samples cultured with or without cells. However, 
treating the scaffolds with alcohol significantly reduced the strain at the UTS compared 
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with the non-alcohol treated samples, although they maintained similar Young’s 
modulus and the reduction of UTS observed was not significant (figure 7.4.4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.4.4 Mechanical properties of hybrid PLA (280 µm) scaffolds cultured with 
ADSCs for 2 weeks, and previously treated or non-treated with alcohol. Results shown 
are means ±SEM, (n = 3). The last sample shown is the range for native tissue 
represented by 2 dashed lines (the range for native healthy paravaginal tissue). (c) 
Strain at UTS, *p<0.01. 
 
Since PLA scaffolds are degraded by hydrolysis, higher wettability may increase the 
degradation rate. Therefore, the degradation of scaffolds with different PLA fibre 
configurations was studied, as well as, the effect of increasing wettability on the 
degradation of the scaffolds. 
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To learn about this, Th-PLA random scaffolds and hybrid PLA (150 µm) scaffolds were 
cut to 1 cm x 0.5 cm and were soaked in PBS or 70% ethanol for 3 seconds. Then, these 
samples were kept in DMEM medium inside the incubator at 37ºC up to 90 days.  
Mechanical properties of samples from the 2 different materials, treated and non-treated 
with alcohol, were tested at day 0, 14, 30 and 90.        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.4.5 Mechanical properties of Th-PLA random and hybrid PLA (150 µm) 
scaffolds, previously treated or non-treated with alcohol, at day 0, 14, 30 and 90 
cultured in DMEM medium. Results shown are mean±SEM, (n = 3).The last sample 
shown is the range for native tissue represented by 2 dashed lines (the range for native 
healthy paravaginal tissue). (a) YM, *p<0.05; **p<0.01. (b) UTS, *p<0.05; 
***p<0.0005. (c) Strain at UTS, ***p<0.0001. 
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As already described in the second section of this Chapter, at day 0 non-alcohol treated 
scaffolds with a higher aligned fibre content (hybrid PLA (150 µm) scaffolds) were 
much stronger (higher UTS) and much stiffer (higher Young’s modulus) than Th-PLA 
random scaffolds. In addition, these values of the mechanical properties of hybrid PLA 
(150 µm) scaffolds were also higher than those of native tissues. However, the hybrid 
scaffold snapped at a lower elongation than the Th-PLA random scaffolds, and values 
for this mechanical property were also below the values of the native tissues.  
Looking at the mechanical properties of the 2 different scaffolds (figure 7.4.5; hybrid 
PLA (150 µm) scaffold = blue, and Th-PLA random scaffold = black) there was a small 
reduction in the UTS of the non-alcohol treated scaffolds by 2 weeks, but then no 
further reduction in the following 90 days. 
The Young’s modulus of Th-PLA random scaffolds was significantly reduced at 14 
days, but was significantly reduced in hybrid PLA (150 µm) scaffolds after 30 days in 
culture. However, after this first small drop, Young’s modulus was not significantly 
reduced any further by up to 90 days.  In addition, UTS and Young’s modulus for both 
materials were either above or within the range of values for native tissues for up to 90 
days.  
On the other hand, the main difference between both materials was in the strain at UTS 
which decreased significantly after 14 days for hybrid PLA (150 µm) scaffolds; while 
for Th-PLA random scaffolds this reduction only became significant at 90 days. After 
14 days the hybrid scaffolds snapped with very minor elongation, and being lower than 
the values for native tissues, whereas this did not happen for the Th-PLA scaffolds until 
90 days in culture.  
 
The treatment of Th-PLA scaffolds with ethanol particularly affected the strain at UTS 
compared to same scaffolds without alcohol treatment. However, only the reduction in 
Young’s modulus for hybrid PLA (150 µm) alcohol treated scaffolds was similarly 
affected over time compared with the non-alcohol group. UTS and strain at UTS were 
significantly reduced after 14 days, although the latter mechanical property was also 
significantly reduced after 14 days for both groups and under the values for native 
tissues. In contrast, the UTS of the alcohol treated hybrid PLA (150 µm) was always 
above the native tissue values for up to 90 days.  
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7.5 Discussion 
 
We have demonstrated that using the electrospinning technique we can develop a range 
of materials using one polymer but with different fibre configurations which modulate 
the mechanical properties of the resulting scaffold, as well as influencing the behaviour 
of cells cultured on the scaffold. 
This was studied in terms of how to modulate the mechanical properties of the 
scaffolds. We did not compare the mechanical properties of our scaffolds to those of 
current clinical materials as we previously demonstrated that there is no simple 
correlation between the mechanical properties and clinical outcome with different 
materials. Certainly, the host response to the scaffold may be just as important as 
mechanical properties in determining the clinical success of our materials.    
We initially aimed to make a material stronger than native tissue, as a biodegradable 
scaffold may breakdown and weaken, resulting in early failure of the material 
 
We showed we could make a range of PLA scaffolds made of 100% random fibres to 
scaffolds with different ratios of random to aligned fibres and to completely aligned 
PLA scaffolds. 
Scaffolds with more random fibres had a lower bulk density due to more porosity within 
them, whereas, scaffolds with aligned fibres had a higher bulk density as the PLA fibres 
are organized to more efficiently occupy space, leaving less space between fibres. 
The effect on mechanical properties was very clear, leading to scaffolds that were very 
strong and stiff when a higher content of aligned fibres was present but, on the other 
hand, scaffolds with a higher content of random fibres allowed more elongation before 
snapping.  
Therefore, weak materials may fail due to elevated forces applied in the pelvic floor 
while strong, stiff materials such as the current non-degradable clinical material PPL 
may not snap, but they may lead to a chronic inflammatory response, pain and/or 
erosion through the vaginal tissues. 
 
Its is known that scaffold porosity and pore size plays a significant role in allowing cell 
infiltration and nutrient diffusion (526). We showed that ADSCs grew well on scaffolds 
with aligned fibres which influenced the distribution of the cells on the fibres and the 
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ECM produced. In addition, cells on aligned scaffolds produced greater amounts of total 
collagen. Collagen is strong under tension and its organisation ultimately determines the 
mechanical properties of the native tissue.  
It has been shown previously that the alignment of fibroblasts controls the orientation of 
the collagen produced (527). Other groups have shown that elongated human ligament 
fibroblasts seeded on aligned nanofibres were orientated in the fibre direction (528). 
These cells also produced significantly more collagen (orientated in the fibre direction) 
compared to cells on random fibres.  
However, this increased production and orientation of the ECM observed in our PLA 
mainly aligned scaffolds did not have any noticeable effect on the mechanical properties 
of scaffolds which were already very strong and stiff. Collagen production did slightly 
increase the mechanical properties of Th-PLA random scaffolds but it was shown that 
most of the mechanical properties were attributable to the material itself. 
  
Finally, we looked at other important issues such as suture retention, wettability of the 
scaffolds, and their degradation rate in vitro. 
Tension-free sutureless suburethral slings were introduced for the treatment of SUI 
based on their good results in hernia repair (529). This approach showed better 
outcomes than suturing the same materials since they avoid complications such us 
voiding obstruction (530). These slings allow an initial small degree of movement to be 
achieved avoiding excessive suburethral support/pressure. The whole sling is ultimately 
fibrosed being integrated into native tissues, a fact that makes difficult to remove these 
slings if a second surgical procedure is needed, due to recurrence of SUI, worsening the 
situation by further damage of supportive tissues. 
After this surgical procedure, patients may resume most normal activities within 1 to 2 
weeks and are advised to refrain from driving for 2 weeks, and from sexual intercourse 
and other strenuous activities for 6 weeks. For POP reconstruction however, sutures are 
needed for these much bigger meshes. 
 
There are no standardized protocols in the literature for performing a suture retention 
test; however, we believe that the method used here proved that PLA-random scaffolds 
had higher strength in retaining a suture compared to aligned scaffolds. On the other 
hand, this difference was only slightly significant when comparing Th-PLA random and 
aligned PLA scaffolds.       
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As expected, we showed that increasing the wettability of the PLA fibres by pre-
soaking fibres in alcohol (ethanol) increased the number of seeded ADSCs which 
attached to hybrid PLA (280 µm) scaffolds, shown by a higher metabolic activity 
measurement, and higher collagen production after 14 days culture. However, ethanol 
pre-treatment also increases the in vitro degradation rate of the scaffolds. In addition, 
previous work (385) and these experiments (as discussed shortly) show that ethanol pre-
treatment adversely affects the mechanical properties of the scaffolds. 
 
Th-PLA random scaffolds were chosen as a representative material made by random 
fibres, while, hybrid PLA (150 µm) scaffolds were representative of scaffolds with a 
higher content of aligned fibres. 
In vitro degradation experiments with these 2 materials showed a reduction of all 
mechanical properties after 90 days, although this was principally observed for the 
strain at UTS. Furthermore, this drop appeared to be accelerated in scaffolds with a high 
content of aligned fibres. Young’s modulus and UTS of both materials were reduced 
after 90 days of culture but were always above the range of values for native tissues.  
Alcohol treatment accelerated the reduction of the strain at UTS for both materials, and 
accelerated up the decrease of UTS of scaffolds with a higher content of aligned fibres; 
alternatively, the UTS of these scaffolds treated with alcohol were always above the 
values for native tissues.  
From cell testing experiments, hybrid PLA (280 µm) scaffolds did not show any 
reduction in mechanical properties from day 0 (figure 7.2.6) to day 14 (figure 7.4.4). 
Only after alcohol treatment was the strain at UTS of this scaffold reduced at 14 days 
and being lower than values for native tissues (figure 7.4.4). Since mechanical 
properties of hybrid PLA (280 µm) scaffolds, treated with and without alcohol, were 
similarly affected over the time in culture than Th-PLA random scaffolds, theoretically, 
this hybrid scaffold may be composed by higher amount of random fibres. 
 
Living tissues have the ability to retain stretch with repetitive strain. An elastic material 
can return to its original shape when a force or load is removed. However, if residual 
deformation is present then it is recognised as plasticity. Most biologic materials will 
exhibit a mixture of these properties (512), which are determined by the interactions 
between collagen, elastin, proteoglycans, and water within the tissue. Therefore, while 
after an initial force the material is able to return to its original size, after a higher 
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amount of force the material starts to be plastically deformed and will not return to its 
original shape.    
These behaviours are important to adapt mechanical properties to different biological 
situations such as during parturition when the pelvic stretch ratio in the pelvic muscles 
can reach 3.26 (436). 
 
Women with POP have been shown to have less elastic tissue which snaps at lower 
stress and strain than those without POP. In addition, while UTS was reduced in vaginal 
tissues of women with prolapse and in postmenopausal women too, the Young’s 
modulus was increased.  
A variety of tests can be performed (531) to test the viscoelasticity of the material such 
as cyclical loading. The extent of stress supported by the pelvic floor is an important 
issue to consider (436). As already described in Chapter 5, since the average area of the 
female pelvis was found to be 94 cm2 (435), the load on the pelvis was measured as 
being 19N in the supine position, which rises to 37N in the standing position and 
reaches 129N on coughing. Therefore testing to failure, usually to a level much higher 
than this, is thought not to be required, and more importantly should not be used for 
comparison between tissues. In addition, at present there is still data lacking on the 
uniaxial testing properties of vaginal tissue and on more complicated biaxial testing 
which may need to be developed later, as well as, cyclical loading.  
Similarly, the strains that the different tissues of the pelvic floor undergo have not been 
well studied and established. In addition, these strains can be much higher or lower in 
different situations such as during bowel opening, voiding, intercourse and pregnancy. 
Therefore, we do not know which strains our material needs to cope with.   
 
In conclusion, we do not know which scaffold with a particular PLA fibre configuration 
may be the most appropriate to develop our best TERM candidate. 
We can develop weaker materials allowing some degree of elastic deformation (PLA 
and Th-PLA random scaffolds) or we can make very strong and stiff materials which do 
not allow any elastic deformation. 
An intermediate material, such as a hybrid PLA (280 µm) scaffold, which has shown 
good results for metabolic activity and collagen production may be our anticipated 
candidate. However, only long-term animal experiments will determine how in vivo 
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degradation and neo-tissue formation affect the mechanical properties of these materials 
for a long-term repair of the pelvic floor tissues when treating SUI or POP.   
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Chapter 8 
 
EXPLORING METHODOLOGIES OF EXTRACTING AND 
CULTURING ADSCs 
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8.1 Introduction 
 
Human MSCs have been shown to have limited proliferative potential in vitro due to 
replicative senescence (532, 533). This is a problem with practical implications since 
cells need to be expanded for a tissue engineering approach. In addition, these cells in 
culture can lose their phenotypic characteristics and differentiation potential, which, at 
the same time, can be slightly different between patients (534, 535). Also, different 
subpopulations of MSCs isolated from the same tissue can present heterogeneity (536). 
 
The number of passages and the age of the donor have been shown to affect the 
differentiation potential of BMDCSs leading to donor variability (537, 538). However, 
other groups have shown that these cells can be cryopreserved and retain differentiation 
potential after being resurrected up to 15 passages (539).  
On the other hand, ADSCs and MSCs isolated from the umbilical cord present higher 
proliferative ability and differentiation potential than BMDSCs when evaluating their 
senescence, although both have similar phenotypes and gene expression profiles 
compared to BMDSCs (540, 541).  Donor age and the number of passages also have an 
effect on the “stemness” of these cells too (542). 
 
It has been suggested that the “stemness” of MSCs can be maintained in vitro for long-
term when these cells are cultured from explants of the tissues containing these cells, 
suggesting that the corresponding tissue provides a microenvironment which is essential 
for keeping MSCs in a stem cell-like state (543). 
Other people have also shown the relevance of other conditions such as the culture 
medium and culture parameters during the isolation of MSCs for better preservation of 
the proliferative ability and “stemness” (544, 545). It has been shown that initial seeding 
at very low density of these cells may decrease their proliferative kinetics; although, it 
does not affect their differentiation potential. On the other hand, it is reported that it is 
better to passage these cells before they reach a high confluence to keep a high 
proliferative capacity (546). 
 
To avoid the issues related to senescence and loss of “stemness” of these cells when 
expanding them, we used new technology from Miltenyi Biotech Company to purify 
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and enrich ADSCs isolated from fat tissue. This includes faster disaggregation of the 
tissue and rapid separation of the desired cell population. The devices could be installed 
inside the theatre to isolate the patient’s cells under sterile conditions. This procedure 
offers the potential to extract ADSCs from lipoaspirate to provide clinically relevant 
numbers of cells ready to be seeded on the scaffolds and implanted in the patient during 
the same operation or on the same day. In addition, this approach may avoid some of 
the regulations concerning the use of cultured cells since these rapidly extracted cells do 
not need to leave the theatre.  
 
For all these reasons, we decided to compare in this Chapter the potential of ADSCs 
from different donors and at different passages to develop our TERMs. 
We also compared the ability of the cells isolated with this new technology to 
proliferate and their differentiation potential. We also compared them to cells isolated 
using the conventional method for their potential to develop a TERM.  
Finally, we also looked at the potential of seeding the SVF isolated from adipose tissue 
directly onto the scaffolds. As previously described, the SVF contain other cell types 
such as fibroblasts and endothelial cells, which actually may be useful for developing a 
TERM, as an autologous approach.   
 
 
8.2 Donor variability 
 
ADSCs were isolated as described in Chapter 2 of this thesis from 3 different donors. 
These cells were expanded and their differentiation potential was assessed after culture 
in adipogenic and osteogenic medium, as described in Chapter 2.  Batches of cells 1 and 
3 were tested at passage 6 and batch 2 was assessed at passage 3.  
 
ADSCs from the 3 batches were positively stained for Oil red O (specific for lipid 
vesicles) and Alizarin red (specific for calcium deposition) after being cultured for 3 
weeks with adipogenic and osteogenic medium respectively (figure 8.2.1). All cells 
cultured with DMEM medium were slightly stained for Alizarin red, being lower for 
cells at passage 3 (batch 2); however, the stain of ADSCs cultured with osteogenic 
medium was similar for all batches and much higher than the controls. 
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More ADSCs at passage 3 (batch 2) were clearly differentiated into adipocytes by lipid 
vesicle formation compared with cells at passage 6 (batches 1 and 3). 
   
 
 
 
 
 
 
 
 
 
Figure 8.2.1 Top images: Human ADSCs isolated from 3 donors cultured for 3 weeks 
with adipogenic medium and stained with 0.3% Oil Red O. Scale bar = 0.5 mm. Bottom 
images: Human ADSCs isolated from 3 donors cultured for 3 weeks with osteogenic 
medium (OM) or DMEM medium (for controls) and stained with 5% Alizarin red. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.2.2 AlamarBlue® staining for ADSCs isolated from 3 donors on PLA mainly 
aligned scaffolds over 2 weeks in culture (n=3±SEM). *p<0.05. 
 
Thereafter, the cells from the 3 batches were seeded in different scaffolds. For this, PLA  
aligned samples were prepared as previously described in a previous Chapter of this 
3rd batch 2nd batch 1st batch 
DMEM OM DMEM OM DMEM OM 
Day	  0 Day	  7 Day	  14
0,000
0,005
0,010
0,015
0,020
0,025
0,030
0,035
0,040
0,045
	  
M
et
ab
ol
ic
	  a
ct
iv
ity
	  a
ss
es
se
d	  
us
in
g	  
A
la
m
ar
B
lu
e
	  1s t	  ba tch
	  2nd	  ba tch
	  3rd	  ba tch
* 
  
 222  
 
thesis, and 5x105 ADSCs from each batch were seeded on 1.5 x 1.5 cm scaffolds using 
metal rings with an internal diameter of 1 cm. In addition, these cells were seeded at 
passage 6 for batches 1 and 3, and at passage 3 for batch 2. All samples were then 
cultured for 2 weeks with DMEM medium. 
 
Metabolic activity of all samples was measured at day 0, 7 and 14 by AlamarBlue® 
staining. After 14 days, samples were stained with DAPI to look at the cell density, and 
total collagen production was measured using Sirius red staining for comparison of the 
3 different batches of ADSCs. Furthermore, for scaffolds seeded with cells from batch 
2, immunostaining for collagen I and III, and elastin was performed to assess the 
potential of ADSCs at passage 3 to produce the different ECM components.    
 
Metabolic activity measured by AlamarBlue® staining showed a very similar behaviour 
of cells at passage 6 without differences between the 2 batches, increasing their 
metabolic activity from day 0 to day 14 (figure 8.2.2). However, ADSCs at passage 3 
did not increase their metabolic activity after the first week showing a significant 
difference in their metabolic activity at day 14 compared with the other 2 batches. 
Looking at DAPI staining after 2 weeks culture, all samples were populated in a 
confluent manner by cells from the 3 different batches, without any visible difference 
between them (figure 8.2.3).  
 
 
 
 
 
 
 
 
Figure 8.2.3 Representative images of DAPI staining for PLA aligned samples cultured 
with ADSCs from 3 different donors for 2 weeks. Scale bar = 0.5 mm. 
 
Sirius red staining did not show any difference in terms of total collagen production 
between the 3 batches of cells and, therefore, without differences in total collagen 
   3rd batch   2nd batch     1st batch 
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production between ADSCs at passage 3 and 6 when cultured on PLA scaffolds (figure 
8.2.4).  
Furthermore, as seen by immunostaining (figure 8.2.5), ADCSs at passage 3 were able 
to produce the different ECM components which have been already shown in this thesis 
to be produced by ADSCs at passage 6. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.2.4 Sirius red staining after 14 days of ADSCs from 3 donors cultured on PLA 
mainly aligned scaffolds. (n=3±SEM). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.2.5 Representative images of immunostaining for collagen III and elastin of 
ADSCs at passage 3 cultured on PLA mainly aligned scaffolds for 2 weeks. Scale bar = 
0.5 mm. 
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8.3 One stage “in theatre” approach 
 
New technology developed by Miltenyi Biotech was assessed for rapid separation of a 
clinical relevant number of ADSCs which could be seeded on a scaffold and implanted 
in a one day operation. Similarly, the SVF isolated from adipose tissue was seeded on 
scaffolds with the aim of developing a TERM avoiding cell expansion.    
 
8.3.1 Rapid ADSCs isolation 
 
ADSCs were isolated using a GentleMACS® Dissociator from Miltenyi Biotech, as 
described in Chapter 2 of this thesis, and using 2 different speeds (defined GentleMACS 
Programs which were called “gentle” and “high” speed). ADSCs were also isolated 
from the same donor using the conventional method (termed as “hand minced”), also 
described in the second Chapter, for comparison.  
We also studied the need for using collagenase and the period of incubation with this 
enzyme to isolate ADSCs; therefore, we had the following groups: 
 
• High speed, 0.1% collagenase, 45 min incubation. 
• High speed, 0.1% collagenase, 15 min incubation.  
• High speed, 0.05% collagenase, 45 min incubation. 
• High speed, 0.05% collagenase, 15 min incubation.  
• High speed, no collagenase. 
• Gentle speed, 0.1% collagenase, 45 min incubation. 
• Gentle speed, 0.1% collagenase, 15 min incubation.  
• Gentle speed, 0.05% collagenase, 45 min incubation. 
• Gentle speed, 0.05% collagenase, 15 min incubation.  
• Gentle speed, no collagenase. 
• Hand minced, 0.1% collagenase, 45 min incubation. 
• Hand minced, 0.1% collagenase, 15 min incubation.  
• Hand minced, 0.05% collagenase, 45 min incubation. 
• Hand minced, 0.05% collagenase, 15 min incubation.  
• Hand minced, no collagenase. 
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10 mL of subcutaneous fat, the same amount previously used for all ADSC isolations in 
this project, were used for each one of the groups above to isolate ADSCs. All extracted 
cells from different groups were seeded in individual T25 plastic culture flasks. 
 
When collagenase was not used no cells attached to the flask. Some cells were attached 
for all of the other groups; however, only from 3 groups were there enough cells to 
proliferate to confluence for a first passage (figure 8.3.1). 
The gentle speed did not work for any group. For high speed and hand minced, only 
when using 0.1% of collagenase incubated with the fat tissue for 45 min could we 
expand cells and obtain a confluent population of cells after 1 week from a T25 flask, as 
previously seen.  
Cells isolated using the hand minced procedure, using 0.05% collagenase for 45 min 
incubation, achieved a confluent population after more than 2 weeks in culture. 
However, these cells were not used for further experiments as they may have lost 
proliferative potential due to their length of culture at low density. 
    
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.3.1 Day of passage and number of cells counted in each passage since the 
isolation of ADSCs using high speed (0.1% collagenase, 45 min incubation) and hand 
minced (0.1% and 0.05% collagenase, 45 min incubation) methods. P1 = passage 1; P2 
= passage 2; col = collagenase.  
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At passage 3 and 6, ADSCs isolated by high speed and hand minced methods (0.1% 
collagenase, 45 min incubation) were assessed for differentiation assays by culture of 
these cells in adipogenic and osteogenic medium.   
ADSCs isolated by both methods, and at passage 3 and 6, were positively stained for 
Oil red O (specific for lipid vesicles) and Alizarin red (specific for calcium deposition) 
after being cultured for 3 weeks with adipogenic and osteogenic medium respectively 
(figure 8.3.2). All controls, cells cultured with DMEM medium, stained slightly for 
Alizarin red; however, the stain of ADSCs isolated by both methods and cultured with 
osteogenic medium was much higher than the controls, particularly at passage 3. 
Similarly, cells at passage 3 isolated by both methods had higher potential to 
differentiate into adipocytes with more cells showing lipid vesicles formation compared 
with cells at passage 6.   
 
 
 
 
 
 
 
 
 
Figure 8.3.2 Top images: Human ADSCs isolated using high speed and hand minced 
methods (0.1% collagenase, 45 min incubation) cultured for 3 weeks with adipogenic 
medium and stained with 0.3% Oil Red O. Scale bar = 0.5 mm. Bottom images: Human 
ADSCs isolated using high speed and hand minced methods (0.1% collagenase, 45 min 
incubation) cultured for 3 weeks with osteogenic medium (OM) or DMEM medium (for 
controls) and stained with 5% Alizarin red. HS = High speed; HM = Hand minced. 
 
Thereafter, cells isolated using high speed and hand minced methods (0.1% collagenase, 
45 min incubation) were seeded in scaffolds. For this, hybrid PLA (280 µm) samples 
were prepared as previously described in a previous Chapter of this thesis, and 5x105 
ADSCs at passage 6 from each isolation method were seeded on 1.5 x 1.5 cm scaffolds 
using metal rings with an internal diameter of 1 cm. All samples were then cultured for 
2 weeks with DMEM medium. 
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Metabolic activity of samples from both groups was measured at day 0, 7 and 14 by 
AlamarBlue® staining. In addition, after 14 days, total collagen production of both 
groups was measured using Sirius red staining. 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.3.3 AlamarBlue® staining for ADSCs isolated using high speed and hand 
minced methods (0.1% collagenase, 45 min incubation) on hybrid PLA (280 µm) 
scaffolds over 2 weeks in culture (n=3±SEM). 
 
Metabolic activity was increased over 2 weeks of culture of ADSCs isolated by both 
high speed and hand minced methods (0.1% collagenase, 45 min incubation), without 
significant differences between the 2 groups (figure 8.3.3). 
 
 
 
 
 
 
 
 
 
 
Figure 8.3.4 Sirius red staining after 14 days of ADSCs isolated using high speed and 
hand minced methods (0.1% collagenase, 45 min incubation) cultured on hybrid PLA 
(280 µm) scaffolds. (n=3±SEM). 
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Similarly, by Sirius red staining, the total collagen produced by these cells from the 2 
groups did not show significant differences (figure 8.3.4).  
 
8.3.2 Seeding the stromal vascular fraction (SVF) on PLA scaffolds 
 
The SVF isolated from 10 mL of fat, as previously described in the second Chapter of 
this thesis, which is normally seeded into a T25 tissue culture flask for ADSCs 
isolation, was seeded directly onto hybrid PLA (280 µm) scaffolds to assess the 
potential of the mixture of cells from this stromal fraction to develop a TERM. These 
cells were compared to same scaffolds seeded with 5x105 ADSCs at passage 6 (results 
from Chapter 7).  
All samples were cultured for 2 weeks in DMEM medium and metabolic activity was 
measured at day 0, 7 and 14 by AlamarBlue® staining. In addition, after 14 days, total 
collagen production of both groups was measured using Sirius red staining. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.3.5 AlamarBlue® staining of hybrid PLA (280 µm) scaffolds seeded with the 
SVF and ADSCs over 2 weeks in culture (n=3±SEM). 
 
Although there were no significant differences between the 2 groups for metabolic 
activity at any day over 2 weeks culture on PLA scaffolds, ADSCs at passage 6 clearly 
showed greater metabolic activity by day 14 and the SVF did not show any significant 
increase from day 0 to day 14 (figure 8.3.5).  
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 Total collagen production was also significantly greater for ADSCs at passage 6, after 2 
weeks culture on PLA scaffolds, compared to the SVF cells seeded and cultured on 
same scaffolds (figure 8.3.6). 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.3.6 Sirius red staining after 14 days of hybrid PLA (280 µm) scaffolds 
cultured with the SVF and ADSCs. (n=3±SEM). *p<0.05. 
 
 
8.5 Discussion 
 
Although, as expected, small variations between ADSCs from different donors were 
found, different batches of cells did not show significant differences in differentiation 
and proliferation potential, as well as in their ability to develop a TERM using PLA 
scaffolds. 
Also as expected, these cells showed higher potential to differentiate into adipocytes 
and osteocytes at lower passage number. Interestingly, ADSCs at both passage 3 and 6 
were able to develop a TERM. 
Only the metabolic activity showed any differences, which was lower for cells at 
passage 3 compared to the same cells at passage 6 when cultured on PLA scaffolds. 
This is difficult to explain since it has been demonstrated that these cells have higher 
proliferative ability in 2D culture at lower passages (533). In addition, after 14 days 
culture, DAPI staining showed similar confluent populations of cells in the scaffolds 
between groups, as well as, similar total collagen production. Also immunostaining 
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demonstrated a similar ability of ADSCs at passage 3 and passage 6 to produce some of 
the specific components of the ECM, such as collagen III and elastin.      
 
Using the Milteniy Biotech technology to rapidly isolate ADSCs did not affect the 
potential of these cells to differentiate or proliferate compared to ADSCs isolated from 
the same patient using the conventional method. Slight variations were seen when 
looking at the proliferative rate up to the second passage of both groups; however, this 
may be affected by the number of cells isolated/seeded at day 0 rather than the method 
used.  
Again these cells showed higher potential to differentiate into adipocytes and osteocytes 
at lower passage. Both groups of cells similarly increased their metabolic activity over 2 
weeks of culture when seeded on PLA scaffolds and produced the same amounts of 
total collagen. 
 
As described in Chapter 2 of this thesis, we also tested the MACS® Separation 
technology using antibodies magnetically labeled to separate the relevant population of 
cells from the SVF. This was used to avoid contamination of other cells types, as well 
as, to know how many of the desired cells are actually isolated from a particular amount 
of fat. For this, we used an antibody against CD271, a marker which has been used to 
isolate a subset of multipotent stromal cells from bone marrow (547).  
Unfortunately, this antibody did not label any cells from the SVF isolated from 
subcutaneous fat tissue as all cells were washed out at the end of the protocol. Also, this 
marker did not show good results for the isolation of multipotent stromal cells from 
umbilical cord (548).  
Alternatively, CD271 together with CD34 have been shown to be expressed in 
perivascular ADSCs (549-551). These cells have been described to be multipotent stem 
cells with more regenerative potential, while other subsets of ADSCs would be more 
committed to differentiate into adult cells from the tissue/organ itself (552). 
The literature so far shows only one study where CD271 was used for immunomagnetic 
separation of ADSCs and they did not find differences compared to cells isolated by the 
conventional method in terms of gene expression and differentiation potential and lower 
cell yields were isolated (553). 
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At this point in this project we do not know whether a particular subset of ADSCs may 
be more desirable to develop a TERM for the pelvic floor with higher regenerative 
potential or, in contrast, we actually need to look for another marker to isolate as many 
ADSCs as possible, since the number of cells isolated by “one stage” in theatre 
approach may be very relevant. 
For these reason, we investigated the potential of seeding the whole SVF on PLA 
scaffolds using as many cells as possible from this stromal fraction to develop a TERM. 
As above, since the final clinical approach involves an autologous implantation, other 
cells types found in this SVF, such as fibroblasts and endothelial cells, may be desirable 
for this too. 
We found promising results since these cells from the SVF were able to seed the 
scaffolds and produced small amounts of total collagen after 2 weeks culture on PLA 
scaffolds, although the latter values were significantly lower than seeding elevated 
number of ADSCs. 
However, there are still many issues to look at, such as characterising the actual cells 
attached to the PLA scaffolds from this fraction and which type of tissue they develop. 
Also, the main cell type found in this fraction is erythrocytes which are not able to 
attach the plastic culture flask. Therefore, looking at the use of lysis buffer for 
erythrocytes may be interesting to help the adherent cells to attach more efficiently the 
scaffolds as well as, to work out the actual number of the adherent cells isolated from 
the SVF and found in a specific amount of fat. 
 
Around 2 million ADSCs can be isolated from 250 mL of fat routinely obtained from a 
low invasive liposuction (554). If we obtained the same number of cells, we should 
have isolated about 80,000 cells from 10 mL of fat.  
However, we may have isolated about 20,000 cells explained by the increase in cell 
number after 1 week in culture (figure 8.3.1). These cells present growth curves with an 
initial lag phase of 2 days and then a log phase at exponential growth rate from 3 to 5 
days with a doubling time of 24 hours, and has been similar found for ADSCs from 
passage 3 through to passage 12 (555). 
 
Finally, it has been shown that these cells can be isolated from a fraction called blood 
and saline fraction of a liposuction (554). For a clinical approach of isolating and using 
the cells on the day of operation, ADSCs isolated from this fraction would appear to be 
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ideal since the use of animal derived enzymes for chemical disaggregation of the tissue 
would also be avoided. This method has been demonstrated to isolate a yield of 250,000 
ADSCs from 250 mL of subcutaneous fat. However, whether this number is enough and 
whether these cells have the potential to develop the final clinical TERM will need to be 
determined with further studies.   
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Chapter 9 
 
CONCLUSIONS AND FUTURE DIRECTIONS  
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Urinary incontinence is a major public health issue, affecting 40% (6 million) of women 
over 40 in the UK (556). When leakage of urine occurs on coughing or movement it is 
termed SUI. POP is a related disorder where the pelvic organs bulge into the vagina, 
and similarly affects half of women over 40. Although not life threatening, these 
conditions significantly impair physical, social and psychological wellbeing. Over the 
next 30 years the proportion of women over the age of 75 is estimated to double 
emphasising the need for durable surgical options without causing complications. 
 
Essentially, POP and SUI occur due to a combination of age and the consequences of 
pregnancy related weakening of the pelvic floor structures.  
SUI is developed by intrinsic sphincter weakness and/or para-urethral tissue weakness 
leading to urethral hypermobility, which may co-exist to some degree (20). Similarly, 
weakness in the supportive connective tissues of the vagina, which have been described 
by Delancey in 3 levels (134), leads to herniation of the underlying tissues into the 
vagina, and consequently, the prolapse of female pelvic organs. 
Both conditions are related to weakness of the pelvic floor tissues by 2 different 
mechanisms, and are due to different risk factors (16). While, in elderly women, the 
quality of the ECM of pelvic floor tissues decreases, as well as neurogenic defects can 
both lead to sphincter  dysfunction; a traumatic process in young women such as 
vaginal delivery, can lead to damage of these tissues (16).  
As the etiologies can be so different it is difficult to study the alterations in the ECM in 
the different conditions. Thus it is not established whether the poor quality of the tissue 
is due to abnormal synthesis of structural proteins (195-197, 199-202) or an imbalance 
between the activity of the major proteolytic enzymes that degrade them (203-205) and 
the inhibitors of proteolysis (206-208).  
Similarly, imaging studies do not agree on anatomical alterations at the different levels 
of the supportive connective tissues analyzed in patients with POP and/or SUI (125, 
126, 129, 130).  
 
In the UK one in ten women will need primary surgery for SUI or POP, and 20% of 
these will require a repeat procedure (557) with over 40,000 operations performed 
annually in England and Wales alone.  
Currently, the best chance of cure is the use of prostheses using either synthetic or 
biological grafts to reinforce supportive pelvic floor tissues. 
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Fascial grafts taken from the patient’s thigh or abdominal wall, long used as slings to 
support the urethra in SUI, introduce a risk of complications (e.g. wound infection or 
hernia) which precludes obtaining larger grafts for the repair of POP. 
In the mid 1990’s PPL mesh slings were introduced to repair SUI. Mesh is placed 
through the vagina in a simpler, quicker, less invasive technique, which became rapidly 
adopted. Soon a plethora of mesh “kits” were marketed, gaining clearance on the basis 
of their similarity to mesh for abdominal wall hernias, being approved for POP surgery 
as well to reinforce fascial defects where native tissue repair techniques fail which they 
do in 20-30% of cases. In the absence of robust long-term safety and efficacy data, this 
is now considered to have been premature (286). 
Alarming reports of debilitating complications of vaginal non-degradable synthetic 
mesh implantation have since emerged including vaginal wall erosion (0-25.6%) 
chronic pain (0-5.5%) and sexual problems (1.9-17%). These meshes can become 
encased in scar tissue, and it is near impossible to safely remove them from the 
surrounding tissue often requiring multiple operations with no guarantee of resolution. 
Recently, warning alerts were issued by UK and US regulators whilst in 2013 class 
action lawsuits against manufacturers by patients led to withdrawal of these synthetic 
meshes in the USA (286). 
 
Experts agree complications are more likely when surgeons lack sufficient experience 
and training (286). However, it has been previously described in this thesis that the 
immune responses against each material are important and may determine the outcome 
of different materials (558).  
A chronic inflammatory response occurring after implantation is likely to be implicated 
in mesh exposure. As above, PPL implants cannot be remodelled and they can induce 
the release of a pro-inflammatory cytokine; therefore, some patients respond to them 
with chronic inflammation leading to excessive fibrosis and encapsulation (488). 
Alternatively, a range of acellular biological grafts have also been trailed in small 
studies, but the main problem encountered was a vigorous host response leading to 
rapid degradation, and consequently, to high failure rates (267). 
 
Therefore, we aimed to develop a tissue engineered alternative material for the 
treatment of SUI and POP. We hypothesize that a TERM developed from a scaffold 
designed to degrade slowly may lead to better outcomes than current materials, whilst 
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the introduction of autologous cells will produce new ECM for long-term support of the 
patient’s pelvic floor. An absorbable material is less likely to result in exposure due to 
the lack of persisting foreign material in the host tissues and together with the 
autologous cells component may lead to better integration into host tissues. 
To assess this, the main objectives of this project were to identify the best scaffold and 
cell candidates cultured under optimal conditions to develop a TERM designed for 
pelvic floor repair. Then, this material was tested in animals to characterize the host 
response against it. In addition, we explored the possibility of producing a range of 
architectures of this degradable scaffold with different mechanical properties. Finally, 
the potential of the chosen cells from different donors was assessed, as well as, some 
preliminary exploration of how to achieve rapid extraction of cells from fat.  
 
 
9.1 Scaffold candidates 
 
Th-PLA scaffolds, produced under sterile manner in our clean room by electrospinning 
technique, were shown to be easy to handle with mechanical properties close to native 
tissues and with an appropriate pore size to avoid risk of infection (267).  
As above, we aimed for a slow rate of biodegradation, and it was shown in vitro that 
this material retained its mechanical strength for at least 90 days achieving values 
around those of native tissues.     
For this thesis, this material was chosen from previous work in our group where this 
scaffold was compared to 6 other candidate materials used to treat SUI and POP, 
including PPL, and PLA scaffolds showed better results for cell attachment and ECM 
production (346). It was hypothesized that good cell attachment would be desirable for 
better integration into the host tissues to hopefully avoid fibrous encapsulation and/or 
erosion.  
 
 
9.2 Cell candidates 
 
Vaginal fibroblasts would intuitively appear to be the most appropriate cell type for 
developing a TERM designed for pelvic floor repair. However, as an autologous 
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approach, the isolation of these cells requires invasive methods which may worsen the 
clinical condition, as well as, these cells have been shown to have altered synthesis of 
ECM structural components in women with POP (236).  
Accordingly, OFs and ADSCs were compared for developing a TERM cultured on Th-
PLA scaffolds as both are accessible and are used clinically in tissue engineering 
applications. In general there were no significant differences identified between these 
cells since both led to cell proliferation and production of the key ECM components.  
OFs can be extracted from small buccal mucosal biopsy taken under local anesthetic, 
and have been used for urethroplasty (385). Nevertheless, ADSCs were selected for 
further investigation as these have been found to have considerable potential for 
regeneration and revascularization in a number of studies (400). Large numbers of these 
cells can also be quickly isolated using a minimally invasive liposuction in humans 
(400). ADSCs do not differentiate when cultured in basic DMEM medium displaying 
fibroblastic behavior, and they produce an endogenous ECM (341); additionally they 
have been shown to release a growth factor to stimulate fibroblast proliferation with the 
potential to regenerate connective tissues (343). Furthermore, ADSCs have the potential 
to inhibit inflammatory responses by secretion of the inhibitor of TNFα (343), and a 
sub-population of ADSCs express an endothelial surface antigen (CD34) which can 
promote neo-vascularization (559). Taken together these become the most attractive 
candidate for clinical use for tissue regeneration. 
 
 
9.3 Culture conditions 
 
We optimized the number of ADSCs and the period of culture of cells on Th-PLA 
scaffolds to develop a TERM.  
We also looked at the effect of different mechanical forces applied to the scaffolds to 
study how these may affect the survival and behavior of the cells in a dynamic 
environment such as the pelvic floor. However, these experiments did not show any 
effect on the tissue produced when these samples were cultured under different 
mechanical conditions. The methods of mechanically loading the tissues were very 
basic and may be insufficient to answer the question. 
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Other experiments have shown that cells on scaffolds subjected to dynamic loading did 
lead to elastin production which is important in the elastic recoil of an engineered 
biomaterial (560). Accordingly, this area should be investigated further using a better 
equipment to subject cells to dynamic loading.  
 
 
9.4 Host response to TERM 
 
It has been reported that the amount of host tissue infiltration is dependent upon mesh 
composition, pore size and configuration which will, in turn, influence mesh integration 
and new ECM production. Interstices of multifilaments bigger than 75 µm may allow 
the passage of leukocytes increasing resistance to infection, as well as allowing good 
cell proliferation and blood vessel formation (561). 
 
An acute macrophage response against the Th-PLA scaffolds led to new blood vessels 
and neo-tissue formation after the host cell infiltration which was promising for long-
term integration into the native tissues and would act to tackle infection. This also 
suggested a quick remodelling by collagen formation for long-term retention of the 
mechanical properties. In addition, there was no encapsulation which has been 
described for other biological materials implanted leading to a chronic inflammatory 
response (324, 456). 
On the other hand, from these results we could not attribute any beneficial effect made 
by the ADSCs in the cell-seeded group of implants and these cells were not tracked in 
these experiments (attempts to do so by using a cell tracker failed). Therefore, future 
experiments in animals will need to determine the fate of these cells to assess any 
regenerative effect made by the ADSCs and a collaboration has been established to 
obtain GFP transfected ADSCs for future longer term animal experiments. 
 
 
9.5 Mechanical properties of the TERM 
 
Only long-term animal experiments will establish how the host response against PLA 
scaffolds will affect the mechanical properties of our TERM. Therefore, although PLA 
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scaffolds have shown a good retention of the mechanical properties when long-term 
cultured in vitro, a higher degradation rate which may well occur in vivo may lead to 
early failure. On the other hand, a highly fibrotic process may lead to an elevated 
increase in the stiffness and strength of these TERMs leading to the sort of 
complications reported for non-degradable synthetic materials. 
 
We proved we can produce a range of PLA scaffolds with different mechanical 
properties made by different fibre configuration using the electrospinning technique, 
which can retain their tensile properties. In vitro experiments showed a dramatic 
reduction in the elongation of the scaffolds before they snapped, but this was only seen 
at 90 days. All of these scaffolds showed good cell attachment and proliferation; in 
addition, fibre alignment stimulated higher production of total collagen. It has already 
been shown that the fibre configuration of scaffolds can affect the shape of the cells, 
their migration, and the organization of the ECM produced (528, 562). Furthermore, 
this cell organization determines the particular adhesion between cells and between the 
cells and the scaffolds which can lead to tensile forces applied to the cells stimulating 
production of the ECM components and MSCs differentiation (563, 564).     
 
    
9.6 Potential of ADSCs  
 
MSCs have been reported to show variability between donors (534, 535); however, we 
demonstrated that ADSCs from 3 different donors all developed a TERM using PLA 
scaffolds, and encouragingly these cells showed the same ability for this over a range of 
cell passages.  
 
Next the rapid isolation of these cells was assessed using new technology which can be 
installed in the theatre, as an enclosed system, to achieve a rapid isolation from 
lipoaspirate of a clinically relevant number of cells which can be implanted into the 
same patient that day. ADSCs isolated using these devices showed the same 
proliferative and differentiation potential than the same cells isolated through 
conventional methods. In addition, cells isolated by both routes did not show significant 
differences when developing a TERM from PLA scaffolds.   
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On the other hand, there are other issues to consider in the future. The cells tested in our 
laboratory were obtained from patients under an anonymous basis; therefore, it will be 
necessary to test the potential of these cells from elderly women since these patients are 
more likely to undergo surgery for SUI or POP. Another issue will be to establish the 
number of these cells which are actually needed and which can be isolated from a 
patient. As previously mentioned, around 2 million cells can be separated from 250 mL 
obtained from a routine minimally invasive liposuction. However, the number of 
ADSCs with potential for this clinical purpose can vary between young and old women, 
as well as, in lean patients the amount of fat obtained can be much lower. Thus more 
work is required in this area which nevertheless looks very promising. 
 
SUMMARY OF THESIS RESULTS 
 
Scaffold 
candidates 
- Development and characterization of PLA electrospun scaffolds. 
- PLA scaffolds were more biocompatible in vitro than 6 clinical 
materials with mechanical properties close to native tissues of the 
pelvic floor. 
Cell 
candidates 
- In vitro, good cell attachment and proliferation of well characterized 
OFs and ADSCs with production of ECM. 
Culture 
conditions 
- Identification of optimal culture conditions in vitro including number 
of cells seeded and period of culture.   
 
Host 
response 
- In a rat model, an acute macrophage response against the implanted 
scaffolds seeded with and without cells led to new blood vessels and 
neo-tissue formation after the host cell infiltration being all this 
promising for long-term integration into the native tissues. 
 
 
Mechanical 
properties 
- Production of electrospun PLA scaffolds from mechanically softer to 
stronger due to different fibre configuration. 
- Cells performed similarly well on the different scaffolds. 
- Degradation studies in vitro showed minimal effects on mechanical 
properties. These were only relevantly dropped at 90 days for stronger 
scaffolds. 
 
Potential of 
ADSCs 
- ADSCs did not show variations between donors in culture (2D, 3D). 
- With translational clinical value, early data showed the potential of 
culturing ADSCs on PLA scaffolds quickly isolated with new 
technology or by using the SVF.  
Table 10 Summary of the results of the thesis.  
  
  
9.7 Future work 
 
At this point of this project, we came up with more possibilities which may need to be 
considered in the future for the final clinical product. Therefore, a future plan may 
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involve the production of 2 different materials for pelvic floor surgery that are more 
suited for purpose than current mesh. 
For SUI, since the material implanted can cover relatively small area, we may produce a 
biocompatible material, which may be non-degradable, with sufficient strength and 
stiffness to support the urethra and withstand repetitive strain by elastic recoil as the 
most relevant property for the treatment of this condition. PPL is highly deformed 
during cycling loading (565); therefore, the implantation of this material can lead to 
voiding obstruction due to high strength and stiffness, but it can also lead to failure due 
to plastic deformation after distension. In addition, PPL presents rough edges and rigid 
forms which are a mismatch with the supple and mobile vaginal tissues in which they 
are placed.  
For POP, fascial defects require much larger meshes and this may have contributed to a 
higher complication rate, particularly erosion (<15%) (566). To overcome this we 
propose to stick to the development of the TERM combining a bioreabsorbable scaffold 
with autologous ADSCs aiming for a constructive remodelling process that result in a 
long-term repair of this condition. The next challenge is to also introduce some degree 
of elasticity into this material too.  
Although autologous fascia has success rates of 70-90% in SUI and it does not erode or 
cause chronic pain (567), it is not considered for POP, and even for SUI it is usually 
avoided due to the donor site co-morbidites already described. Nevertheless, fascia is a 
logical tissue to emulate and use as a guide for the design of new materials. Accordingly 
the mechanical behaviour and properties of rectus fascia will need to be established, 
since it has been shown in this thesis that there is little data about it in the literature. 
This can be used along with data on the forces encountered in the pelvic floor to build a 
profile of the mechanical criteria to be considered for the design of future materials.   
 
As previously described, electrospinning technology allows co-spinning of two 
polymers in random or aligned orientations which may be used for the scaffold 
fabrication. For SUI, the desired strength and elasticity may be achieved by 
interweaving variable proportions of electrospun fibres of non-degradable 
polyurethanes, capable of stretch and elastic recoil into a sling akin to autologous fascia 
in mechanical behaviour. For POP, the introduction of biodegradable polyurethane 
interwoven with the PLA fibres may provide the desired physical support until the 
native tissue has remodelled.  
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These materials will require a comprehensive in vitro analysis of mechanical behaviour 
and properties (both with and without cells). Uniaxial tensiometry could be performed 
before and after a cyclical loading (uniaxial strain) regime in a bioreactor lasting several 
weeks. A new Ebers bioreactor acquired in our lab may allow a useful testing regime to 
be introduced into the development of materials based loosely on our current 
understanding of the forces experienced in the pelvic floor.  
 
The successful outcome of implantation of large scale engineered tissues also depends 
on how well a vascular network is formed for nutrient diffusion and gas exchange into 
the centre of the scaffold. It has been shown that MSCs seeded with endothelial cells on 
scaffolds have potential for angiogenic differentiation using suitable growth factors to 
guide these cells toward the centre of the scaffold to induce a vascular network (568).  
Therefore, another possibility during the scaffold manufacture is the production of a 
pro-angiogenic material. This would involve different coatings of the scaffolds to 
positively charge them for heparin binding. Our group has already shown the potential 
to produce hydrogels with these properties which can bind and release bioactive 
vascular endothelial growth factor to stimulate endothelial cells proliferation (569). 
Other approaches to coat scaffolds using the technique of plasma polymerisation to 
develop a layer by layer electrostatic coating are underway within the group. 
 
As a final clinical product many other aspects will need to be considered for clinical 
translation such as scaffold production under Good Manufacturing Practice conditions. 
As part of this, cleanroom production facilities will be needed and gamma irradiation 
and e-beam sterilisation may be compared to investigate the extent to which these will 
affect the properties of the materials. Also, every aspect of the choice of solvents, 
protocols for the removal and measurement of residual solvent, packaging and storage 
of the products under vacuum and labelling will need to be considered. 
 
Also as we were not able to separate the desired MSC cell population by using CD271 
Ab with Miltenyi Biotech technology, this will need to be further studied which may 
include the comparison of other CD45 negative perivascular ADSCs subpopulations 
such as the CD34-CD146+ pericytes and CD34+CD146- adventitial cells (570). To 
determine their clinical potential, the selected cell preparation will have to be 
characterised for their phenotype, colony-forming unit content, and their trilineage 
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adipogenic, chondrogenic and osteogenic potential, as well as, the potential to promote 
vessel formation, secretome fingerprints, senescence markers and karyotype will need to 
be assessed as previously described (571-573).   
 
Finally, the most important work will be the implantation in animals of these materials 
which, ultimately, will determine their long-term performance and outcomes. This will 
investigate the development of any chronic immune response, the fate of the ADSCs 
and the mechanical properties of the TERM after several months of implantation. This 
will be particularly important for establishing the in vivo degradation of these scaffolds 
and establishing the desirable mechanical properties of these materials at time of 
implantation. As above, the capability to track the implanted ADSCs from the explants 
after sacrifice will be very relevant to determine survival and migration of these cells, 
which, in turn, will be necessary to attribute any regenerative contribution of these cells 
for better outcomes of the TERM. 
For this we propose an immunocompetent rabbit model as the animal’s size allows 
simultaneous testing of several large implants (allowing biaxial biomechanical testing).  
In addition, our collaborators in Leuven from previous animal work have extensive 
experience with this model, and the outcome measurements (456). For each animal, four 
full thickness abdominal wall defects can be induced, primarily repaired, and overlaid 
with experimental or control meshes. For each animal 2 of the 4 defects would be 
assigned to experimental implants, whereas the 2 other sites will be sham operated 
(primarily sutured closure, no implant) or overlaid with PPL for comparison. 
 
In conclusion, this thesis answers many questions about cell type and culture on 
scaffolds for the production of TERM for the pelvic floor but as it is evident from the 
above these are early steps in this journey. 
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APPENDIX 
 
Table 3 Mechanical properties and host response against synthetic materials implanted 
in animals and humans: 
Author Sample Mechanical Properties Host Response 
Falconer et al. 
2001 (574) Mersilene - Prolene  
Mersilene induce a higher 
inflammatory response that 
Prolene. Mersilene is easier 
to extract than Prolene.  
Klinge et al. 
2002 (575) 
heavy weight 
monofilament (HWM) 
and low weight 
multifilament (LWM) 
on the posterior 
abdominal wall 
 
HWM: intense 
inflammation, embedded in 
connective tissue.  
LWM: less pronounce 
inflammatory response and 
fibrotic capsule, collagen 
distributed within the mesh. 
Dietz et al. 
2003 (274) 
Prolene – Mersilene – 
TVT – IVS tape – 
SPARC tape – GoreTex 
Micromesh – GoreTex 
Soft Tissue Patch 
TVT has the lowest initial 
stiffness.  
Spiess et al. 
2004 (271) 
Polypropylene TVT 
Cadaveric fascia lata 
(CFL) 
TVT has the greater break 
load and the maximum 
average load compared to 
CFL. 
 
Rabah et al. 
2004 (277) Polypropylene mesh   
Inflammation localized in 
the graft. 
Wang et al. 
2004 (278) 
Polypropylene TVT – 
Polypropelene SPARC  
Pronounced fibrosis around 
the fibres, it might 
correlates with erosion. 
Govier et al. 
2004 (276) 
Polypropelene mesh vs. 
Silicone-coated mesh  
Polypropylene mesh allows 
a dense tissue ingrowth 
Thiel et al. 
2005 (319) Polypropylene mesh   
- Mild inflammatory 
response. 
- Mild collagen formation. 
Yildirim et al. 
2005 (300) 
Gynecare TVT – 
SPARC™ - 
polypropylene mesh - 
 
Inflammation and fibrosis 
are decreased in large pores 
meshes. 
Konstantinovic 
et al. 2005 
(313) 
Marlex into the anterior 
abdominal wall  
Pronounced inflammatory 
reaction and vascularization 
throughout the graft  
Krambeck et 
al. 2006 (304) Polypropylene mesh   
- Great scar formation. 
- Mild inflammatory 
response. 
Boulanger et 
al. 2006 (576) 
Vicryl – Vypro – 
Prolene – Prolene Soft - 
Mersuture 
 
Vicryl: low level of 
inflammation and 
completely absorbed. 
Vypro: intense 
inflammation and strong 
fibrotic response. 
Prolene and Prolene Soft: 
well integrated, weak 
inflammatory response. 
Mersuture: no good 
integration. 
Bogusiewicz 
et al. 2006 
Macrporous TVT – 
Microporous IVS  
- Both induced production 
of similar amount of 
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(279) collagen. 
- Differences in the 
arrangement of collagen and 
inflammation intensity. 
Bazi et al. 
2007 (280) 
Polypropylene IVS – 
polypropylene 
SPARC™ - 
polypropylene TVT 
They all show similar 
mechanical properties after 
removal. 
They induce different host 
responses due to different 
porosity. 
Zorn et al. 
2007 (272) 
SPARC – TVT –
Stratasis 
TVT has tensile properties 
similar to SPARC and They 
are superior to Stratasis. 
 
Spelzini et al. 
2007 (577) 
Polypropylene type I 
mesh vs. A 
macroporous silk 
construct 
 
Polypropylene meshes 
induce a moderate 
inflammatory response and 
not architectural 
degradation. 
Woodruff et 
al. 2008 (283) Polypropylene mesh   
- No evidences of 
degradation or 
encapsulation, abundant 
host infiltration.  
- Neovascularisation was 
visible. 
Krause et al. 
2008 (578) 
Atrium (x4), Dexon 
(x4), Gynemesh (x5), 
IVS (x5), Prolene (x4), 
SPARC (x5), TVT 
(x5), Vypro II (x5) and 
3 controls. 
Mechanical properties are 
variables across many 
polypropylene meshes. IVS 
and Vypro: high level of 
stress-shielding. Dexon, 
SPARC, TVT and Vypro III 
compliant at low loads. 
Gynemesh, prolene and 
Atrium have intermediate 
properties. 
Type I meshes 
(monofilamentous): small 
tissue fibrosis, minimal 
giant cells or histiocytes 
Type III meshes: moderate 
fibrotic reaction, highest 
proportion of giant cells. 
Huffaker et al. 
2008 (282) 
Pelvitex (Collagen-
coated) and Gynemesh 
(uncoated 
Polypropylene meshes) 
 
Both materials induce a 
mild foreign body reaction 
with minimal fibrosis. 
Alfonso et al. 
2008 (275) 
Aris – TVTO – Uretex 
– Avaulta – Auto 
Suture 
Polypropylene filament 
thickness influence 
mechanical properties. 
TVT has the lowest tensile 
strength. 
 
Pierce et al. 
2009 (285) Polypropylene mesh  
Polypropelene have similar 
mechanical properties to the 
native tissues in terms of 
ultimate tensile strength and 
Young’s modulus. 
- Mild inflammatory 
reaction for long term.  
- Good host tissue 
incorporation. 
Jones et al. 
2009 (273) 
Tension Free Gynecare 
PS® 
New generations of 
polypropylene meshes are 
less stiff. 
 
Elmer et al. 
2009 (284) PROLIFT®  
- Increase in macrophages 
and mast cells count. 
- Mild but persistent foreign 
body response. 
Melman et al. 
2011 (270) 
Bard® mesh (HWPP) - 
Ultrapro® (LWPP) - 
GORE®Infinit mesh 
(ePTFE) 
Their maximum tensile 
strength decreases over time 
for all of them. 
- Inflammation decreases 
with time. 
- Cell infiltration increases 
with time. 
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Table 4 Mechanical properties and host response against autologous grafts implanted in 
animals and humans: 
Author Sample Mechanical Properties Host Response 
FitzGerald 
et at. 2000 
(296) 
Autologous rectus fascia 
implanted in 5 patients 
suffering SUI. Samples 
obtained, respectively, from 
transvaginal revision after 3, 5, 
8 and 17 weeks, and from 
replacement after 4 years. 
 
- Moderate and uniform 
infiltration of host fibroblasts 
and neovascularization after 5 
and 8 weeks implantation. 
- After 4 years implantation, no 
evidence of inflammatory cell 
infiltrate or foreign body 
reaction, and collagen 
remodelling by connective tissue 
organized longitudinally. 
Jeong et al. 
2000 (294) 
Autologous lata fascia 
implanted in 16 rabbits 
randomized into 4 survival 
groups (1, 2, 4 and 8 weeks). 
Implantation into upper 
eyelids. 
 
- Low inflammatory cells 
infiltration. 
- Fibroblast infiltration and 
collagen remodelling. 
Dora et al. 
2004 (292) 
Autologous rectus fascia 
implanted in 15 rabbits 
randomized into 3 survival 
groups (2, 6 and 12 weeks). 
Implantation on the anterior 
rectus fascia. 
No significant 
decrease of 
biomechanical 
properties after 12 
weeks implantation. 
- 50% decrease of surface area. 
Hilger et al. 
2006 (293) 
Autologous rectus fascia 
implanted in 20 rabbits 
randomized into 2 survival 
groups (6 and 12 weeks). Half 
implanted on the rectus fascia 
and half on the posterior 
vagina fascia. 
No significant 
decrease of 
biomechanical 
properties after 12 
weeks implantation. 
- Collagen remodelling by 
moderate collagen infiltration but 
encapsulation as well. 
- Minimal inflammatory 
response. 
- Minimal neovascularization. 
Krambeck 
et al. 2006 
(304) 
Autologous rectus fascia 
implanted subcutaneously on 
the anterior rectus fascia of 10 
rabbits randomized into 2 
survival groups (6 and 12 
weeks). 
 
- Moderate fibrosis. 
- High degree of scar. 
- High degree of inflammatory 
infiltrate. 
Woodruff et 
al. 2008 
(283) 
Autologous fascia grafts 
explanted after sling revision 
from 5 women, due to different 
complications, between 2-65 
months after implantation. 
 
- Moderate and uniform 
infiltration of host fibroblasts 
and few neovascularization. 
- Collagen remodelling by new 
collagen fibres organized 
longitudinally. 
- No evidence of encapsulation 
or gross infection. 
- Moderate degradation. 
Pinna et al. 
2011 (295) 
Autologous fascia lata 
implanted 14 rabbits 
randomized into 2 survival 
groups (30 and 60 days). 
Implantation into the right 
voice muscle. 
 
- No significant inflammatory 
reaction. 
- No significant fibrosis or 
scarring. 
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Table 5 Mechanical properties and host response against allografts implanted in 
animals and humans: 
Author Sample Mechanical Properties Host Response 
Sclafani et 
al. 2000 
(299) 
Human cadaveric dermis 
(AlloDerm®) disk implanted 
subdermally behind a patient’s 
ear. Micronized human cadaveric 
dermis (AlloDerm®) injected 
intradermally and subdermally in 
2 different locations behind a 
patient’s ear. Both implants 
examined 3 and 1 month after 
implantation, respectively. 
 
- Both materials extensively 
invaded by host fibroblasts. 
- Both materials present new 
collagen in-growth. 
Walter et al. 
2003 (298) 
Freeze-dried and gamma-
irradiated human cadaveric lata 
fascia implanted in 18 rabbits and 
excised 12 weeks after 
implantation. 
Significant decrease 
of biomechanical 
properties after 12 
weeks implantation. 
 
Spiess et al. 
2004 (271) 
Human cadaveric fascia lata 
implanted subcutaneously on the 
abdominal wall of 20 rats 
randomized into 2 survival 
groups (6 and 12 weeks). 
No significant 
decrease of tensile 
strength with time. 
 
Yildirim et 
al. 2005 
(300) 
Human cadaveric lata fascia 
implanted in 20 rabbits 
randomized into 4 survival 
groups (2, 7, 15 and 30 days). 
Implantation subcutaneously on 
the abdominal wall. 
 
- Acute inflammation by high 
cell infiltration 
predominantly of 
polymorphous granulocytes.  
- Integration in host tissue by 
moderate fibrotic process and 
muscle infiltration on day 30, 
with persistent inflammatory 
response. 
Krambeck 
et al. 2006 
(304) 
Cadaveric fascia lata implanted 
subcutaneously on the anterior 
rectus fascia of 10 rabbits 
randomized into 2 survival 
groups (6 and 12 weeks). 
 
- Moderate to high focal 
fibrosis.  
- Minimal to moderate 
degree of scar.  
- High degree of 
inflammatory infiltrate. 
Hilger et al. 
2006 (293) 
Human cadaveric dermis and lata 
fascia implanted in 20 rabbits 
randomized into 2 survival 
groups (6 and 12 weeks). Half 
implanted on the rectus fascia and 
half on the posterior vagina 
fascia. 
Very significant 
decrease of 
biomechanical 
properties after 12 
weeks implantation. 
- 2 missing or fragmented 
materials implanted on the 
vagina after 12 weeks. 
- Moderate inflammatory 
response. 
- Minimal 
neovascularization.  
- Minimal collagen ingrowth 
without significant cell 
infiltration.  
Richtes et 
al. 2008 
(301) 
 
Human cadaveric dermis 
subcutaneously implanted in 16 
rats randomized into 4 groups 
(materials descellularized with 
NaOH after 4 different periods). 
All animals sacrificed after 4 
weeks. 
 
- No degradation and good 
integration with the 
surrounding tissues.  
- Higher inflammatory 
response for samples 
descellularized for shorter 
periods, and associated to 
more vessels formation. 
- Fibrovascular in-growth 
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with better collagen 
organization for same 
samples. 
Woodruff et 
al. 2008 
(283) 
Human cadaveric dermis slings 
explanted after revision from 2 
women, due to different 
complications, between 2-65 
months after implantation. 
 
- Moderate levels of 
encapsulation. 
- High levels of degradation. 
- Peripheries of the grafts 
invaded by fibroblasts but 
central portions remained 
acellular.    
VandeVord 
et al. 2010 
(305) 
Human cadaveric dermis and 
fascia lata implanted in 16 rats, 
respectively, and both 
randomized into 4 survival 
groups (2, 4, 8, 12 weeks). 
Implantation around the bladder 
neck, anchored to the surrounding 
tissues. 
 
- Thin fibrous capsule 
formation. 
- Moderate cell infiltration 
and angiogenesis. 
Rice et al. 
2010 (302) 
Human cadaveric dermis 
(AlloDerm®) implanted in 18 rats 
randomized into 2 survival 
groups (30 and 60 days). 
Implantation subcutaneously on 
abdominis rectus muscle defect. 
Increase of tensile 
strength after 30 
days and, again, 
increase of tensile 
strength after 60 
days respectively to 
30 days. 
- Moderate amounts of 
collagen deposition well 
organized. 
- Abundant revascularization. 
Kolb et al. 
2012 (303) 
Human cadaveric dermis 
(AlloDerm®) implanted 
subcutaneously in 5 pigs 
randomized into 4 survival 
groups (7, 21, 90 and 180 days). 
 
- Robust inflammatory 
response after 7 days 
implantation, which achieved 
maximal level at 21 days, 
with formation of 
granulomas and areas of 
necrosis noted within the 
graft.  
- Moderate fibroblast 
infiltration, collagen in-
growth and 
neovascularisation. 
- Moderate levels of 
encapsulation.  
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Table 6 Mechanical properties and host response against xenografts implanted in 
animals and humans: 
Author Sample Mechanical Properties Host Response 
Badylak et al. 
2001 (318) 
Abdominal wall defect 
repaired with SIS in 40 
dogs randomized into 8 
survival groups (1, 4, 7, 
and 10 days; and 1, 3, 6, 
and 24 months). 
Strength was decreased 
from day 1 to day 10 after 
implantation, followed by a 
progressive increased, until 
double of the original 
strength 24 months after 
implantation. 
- Rapid degradation with 
associated and subsequent 
host remodelling. 
Zhang et al. 
2002 (312) 
Abdominal wall defect 
repaired with SIS in 52 
rats randomized into 4 
survival groups (3 days, 2 
weeks, 1 and 2 months). 
No significant changes of 
biomechanical properties 
from 2 weeks to 1 month 
after implantation. 
- Moderately organized 
collagenous connective 
tissue. 
- Mild lymphocyte 
infiltration and fibroblast 
proliferation. 
- Inflammatory response 
decreased after 1 month and 
connective tissue becomes 
more organized and 
incorporate into the native 
surrounding tissues.   
Badylak et al. 
2002 (311) 
Abdominal wall defect 
repaired with SIS in 10 
dogs and 30 rats, both, 
randomized into 4 
survival groups (1 week, 
1 month, 3 months, 6 
months, and 2 years). 
 
- No shrinkage or expansion 
of the graft site over the 2-
year period of the study. 
- 1 week after implantation, 
abundant levels of poly-
morphonuclear leukocytes 
diminished to negligible 
after 1 month.  
- Moderate 
neovascularization. 
- By 3 months, graft 
material was not 
recognizable and was 
replaced by moderately 
well organized host tissues 
including collagenous 
connective tissue, adipose 
tissue, and skeletal muscle. 
Cole et al. 2003 
(322) 
SIS removed from a 42-
years-old female patient 
4 months after 
puvovaginal implantation 
of the sling due to severe 
obstruction. 
 
- Completely intact 
acellular sling. 
- Well define fibrous 
capsule.  
- Chronic inflammatory 
response. 
Wiedemann et 
al. 2004 (323) 
Biopsies taken from the 
implantation site of the 
SIS band under the 
vaginal mucosa from 3 
patients during 
reoperation, at a mean of 
12.7 months, after 
pubourethral sling 
procedures due to 
recurrent urinary stress 
incontinence. 
 
- Focal residues of SIS 
implant. 
- No evidence of a specific 
tissue reaction that might 
point to a foreign body 
reaction. 
- No evidence of any 
significant immunological 
reaction and in particular no 
evidence of any chronic 
inflammatory reaction.  
Konstantinovic Abdominal wall defect Significant increase of - Moderate acute 
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et al. 2005 
(313) 
repaired with SIS in 24 
Wistar rats randomized 
into 4 survival groups (7, 
14, 30 and 90 days). 
biomechanical properties 
after 90 days implantation. 
inflammatory response at 
day 7, decreased to minimal 
after 90 days. 
- Moderate 
neovascularization. 
- Abundant collagen 
deposition well organized 
after 90 days. 
Macleod et al. 
2005 (308) 
SIS and porcine dermis 
(Permacol®) implanted 
subcutaneously on the 
anterior rectus fascia of 
18 rats each randomized 
into 5 survival groups (1, 
2, 4, 10, and 20 weeks). 
 
For both grafts: 
- Absent acute 
inflammatory response. 
- From moderate chronic 
inflammation after 1 week 
implantation to minimal 
after 20 weeks. 
- Absent eosinophilic 
infiltration and stromal 
fibroblastic reaction over 
the entire implantation. 
- From moderate fibrosis 
and vascularity around the 
grafts after 1 week 
implantation to minimal 
after 20 weeks. 
Puolose et al. 
2005 (314) 
Perforated vs. 
nonperforated SIS 
implanted on the 
peritoneal surface of the 
abdominal wall of 12 
pigs randomized into 2 
survival groups (2 and 8 
weeks). 
 
- Both type of SIS 
contracted 50% from their 
original surface area. 
- Sever and moderate 
collagen deposition and 
neovascularization, 
respectively, which was 
slightly higher for 
perforated SIS. 
Thiel et al. 
2005 (319) 
SIS implanted 
subcutaneously on the 
abdominal wall of 30 rats 
randomized into 3 
survival groups (7, 30 
and 90 days). 
 
- Moderate inflammatory 
reaction increased to severe 
after 90 days. 
- 86% of the graft replaced 
by new collagen fibres. 
Krambeck et al. 
2006 (304) 
SIS and porcine dermis 
implanted 
subcutaneously on the 
anterior rectus fascia of 
10 rabbits randomized 
into 2 survival groups (6 
and 12 weeks). 
 
- Procine dermis presented 
moderate fibrosis which 
was minimal for SIS. 
- Minimal degree of scar for 
both grafts and high degree 
of inflammatory infiltrate. 
Ko et al. 2006 
(315) 
Abdominal wall defect 
repaired with 8-layer SIS 
in 20 domestic pigs 
randomized into 2 
survival groups (1 and 4 
months). 
No significant changes of 
biomechanical properties 
after 4 months 
implantation. 
- Dense fibrous connective 
tissue ingrowth. 
- Minimal to mild 
mononuclear inflammatory 
cell infiltrate throughout the 
connective tissue. 
Hilger et al. 
2006 (293) 
Porcine dermis implanted 
in 20 rabbits randomized 
into 2 survival groups (6 
and 12 weeks). Half 
implanted on the rectus 
fascia and half on the 
posterior vagina fascia. 
Very significant decrease 
of biomechanical 
properties after 12 weeks 
implantation. 
- 2 missing or fragmented 
materials 12 weeks after 
being implanted on the 
vagina. 
- Moderate to strong 
inflammatory response. 
- Minimal collagen 
ingrowth without 
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significant cell infiltration. 
- Minimal 
neovascularization. 
Rauth et al. 
2007 (316) 
SIS implanted on the 
peritoneal surface of the 
abdominal wall of 6 pigs 
sacrificed 8 weeks after 
implantation. 
 
- 80% of contraction from 
original surface area. 
- Moderate 
neovascularization. 
- Densely populated by host 
cells with moderate 
amounts of new 
disorganized collagen 
deposition.   
Woodruff et al. 
2008 (283) 
Porcine dermis slings 
explanted after revision 
from 4 women, due to 
different complications, 
between 2-65 months 
after implantation. 
 
- Severe encapsulation. 
- None degradation. 
- None fibroblasts 
infiltration and 
neovascularization.    
Sandor et al. 
2008 (310) 
Abdominal wall defect 
repaired with SIS and 
porcine dermis 
(Permacol®) in 33 
primates randomized into 
3 survival groups (1, 3 
and 6 months). 
No changes of healing 
strength from 1 to 6 
months. High variation for 
SIS samples after 6 months 
implantation indicating 
scarring. 
- Considerable contraction 
after 1 month for both 
materials, but not 
significant change over the 
next 5 months. 
- Better integration of both 
materials at late stage by 
scar formation. 
- Inflammatory cells 
infiltration 3 months after 
implantation for SIS and 
associated to formation of 
few blood vessels.  
- Acellular porcine dermis 
over the entire course 
implantation with 
substantial inflammation 
surrounding their perimeter.  
- Partial resorption for both 
materials after 6 months.   
Price et al. 
2009 (285) 
Cross-linked porcine 
dermis implanted on the 
abdominal wall and 
posterior vagina of 18 
rabbits sacrificed 9 
months after 
implantation. 
11 grafts remained intact 
without significant changes 
of biomechanical 
properties compared to the 
baseline values. They just 
were thicker and tolerated 
less elongation at failure. 7 
grafts were partially 
degraded but thicker again 
and with significant 
decrease of all 
biomechanical properties. 
 - Host connective tissue 
incorporation between 
fibres. 
- Intense foreign body 
reaction in degraded grafts 
which may be expedited in 
vaginal environment. 
Price et al. 
2009 (309) 
Cross-linked porcine 
dermis implanted on the 
abdominal wall and 
posterior vagina of 22 
rabbits sacrificed 9 
months after 
implantation. 
 
- Samples from vagina 
presented moderate 
inflammation, mild 
neovascularization and 
minimal fibroblast 
proliferation. 
- Samples from abdomen 
presented mild 
inflammation, minimal 
neovascularization and mild 
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fibroblast proliferation.   
- 37% of abdominal 
implants partly degraded or 
missing, and 70% of the 
vaginal implants. While few 
grafts were encapsulated 
without host cell 
infiltration, degraded grafts 
were replaced by host 
collagen.    
VandeVord et 
al. 2010 (305) 
SIS and porcine dermis 
implanted in 16 rats, 
respectively, and both 
randomized into 4 
survival groups (2, 4, 8, 
12 weeks). Implantation 
around the bladder neck, 
anchored to the 
surrounding tissues. 
 
- Thin fibrous capsule 
formation. 
- Moderate cell infiltration 
and angiogenesis for SIS 
and minimal for porcine 
dermis. 
Rice et al. 2010 
(302) 
Abdominal wall defect 
repair with SIS 
(Surgisis®) in 18 rats 
randomized into 2 
survival groups (30 and 
60 days). 
Increase of tensile strength 
after 30 days and, again, 
increase of tensile strength 
after 60 days respectively 
to 30 days. 
 
- Moderate amounts of 
collagen deposition well 
organized. 
- Abundant 
revascularization. 
Deprest et al. 
2010 (324) 
13 patients underwent 
secondary 
sacrocolpopexy because 
of failure or vaginal 
revision because of a 
graft related complication 
after the initial 
sacrocolpopexy with 
porcine dermal collagen 
(Pelvicol®) (9) or SIS 
(Surgisis®) (4). 
 
- Pelvicol presented high 
degradation rates associated 
with no body foreign 
reaction. 
- Pelvicol remnants were 
integrated into collagen rich 
connective tissue with 
limited neovascularization 
(scar host tissue). 
- No significant body 
foreign reaction to Surgisis 
grafts. 
- Surgisis no longer 
recognizable replaced by 
irregularly organized 
connective tissue and fat 
tissue.    
Liu et al. 2011 
(317) 
Abdominal wall defect 
repaired with SIS and 
acellular porcine dermal 
matrix in 50 Sprague 
Dawley rats randomized 
into 5 survival groups (1, 
2, 4, 8 and 12 weeks). 
After initial decrease of 
biomechanical properties at 
week 2, these were 
increased over the next 10 
weeks reaching similar 
values from week 1. 
- Pronounced inflammatory 
response 1 to 4 weeks after 
implantation for SIS 
compared with porcine 
dermal, but fell to similar 
negligible values for both 
after 12 weeks. 
- Large neovascularization 
and collagen deposition, 
which was higher for SIS 
group. 
- SIS implants degraded 
more quickly and were 
almost totally replaced by 
organized collagenous 
tissues.   
- Contraction at first weeks 
leading to significant lower 
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surface area in both 
materials.   
Jenkins et al. 
2011 (579) 
Abdominal wall defect 
repaired with porcine 
dermal matrix in 24 
Yucatan minipigs 
randomized into 2 
survival groups (1 and 6 
months). 
Significantly greater 
incorporation strengths 
after 6 months compared 
with 1 month. 
- Moderate cell infiltration. 
- Moderate extracellular 
matrix deposition. 
- Moderate 
neovascularisation. 
- Partial degradation and 
from widely to mild fibrous 
encapsulation. 
Suckow et al. 
2012 (320) 
Abdominal wall defect 
repaired with SIS in 12 
rats sacrificed 1 month 
after implantation. 
 
- Small amount of residual 
SIS remained were 
surrounded by mild to 
moderate chronic 
inflammation.  
 
Kolb et al. 2012 
(303) 
Cross-linked porcine 
dermis (Permacol®) 
implanted 
subcutaneously in 5 pigs 
randomized into 4 
survival groups (7, 21, 90 
and 180 days). 
 
- Mild inflammatory 
response decreased to 
minimal from day 7 to day 
180 after implantation.  
- None to minimal 
neovascularization after 180 
days.  
- Moderate levels of 
encapsulation. 
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Table 7 Engineered tissues for pelvic floor repair: 
Author Engineered construct Model Implantation Improvements 
De 
Filippo et 
al. 2003 
(334) 
Vaginal 
epithelial and 
smooth muscle 
cells seeded on 
polyglycolic acid 
scaffolds 
Nude mice Implanted subcutaneously 
Multilayered tissue strips 
of both cell types and 
penetrating native 
vasculature after 1 week. 
Increased organization of 
the smooth muscle and 
epithelial tissue by 4 
weeks. Contractile 
properties of the tissue-
engineered vaginal 
constructs similar to those 
of normal vaginal tissue 
Cannon 
et al. 
2005 
(338) 
MDSC seeded 
on small 
intestinal 
submucosa (SIS) 
Rats with bilateral 
proximal sciatic 
nerve transaction 
Implanted 
suburethrally and 
sutured to the 
pubic bone 
Improved leak point 
pressure, but not 
significant differences 
were showed with only 
the SIS sling implantation 
Atala et 
al. 2006 
(326) 
Autologous 
urothelial and 
muscle cells 
seeded and 
cultured in 
composites of 
collagen or 
polyglycolic acid 
scaffolds 
Seven patients with 
myelomeningocele 
(aged 4-19 years) 
Constructs 
implanted as 
cystoplasty for 
bladder 
reconstruction 
46 months post-
operatively, the mean 
bladder leak point 
pressure decreased at 
capacity, and the volume 
and compliance increased. 
Recovery of bowel 
function  
Bhargava 
et al. 
2008 
(384) 
Autologous 
buccal 
keratinocytes 
and fibroblasts 
seeded and 
cultured in 
acellular donor 
de-epidermised 
dermis 
5 patients with 
urethral stricture 
secondary to lichen 
sclerosus 
Uretroplasty 
After 3 years follow-up, 
one patient had complete 
excision of the grafted 
urethra and one required 
partial graft excision, for 
fibrosis and 
hyperproliferation of 
tissue, respectively. Three 
patients have a patent 
urethra with the 
engineered tissue in situ. 
Drewa et 
al. 2008 
(329) 
Rat hair follicle 
stem cell seeded 
onto bladder 
acellular 
matrices cultured 
for one week 
Rats with surgically 
created defect within 
the anterior bladder 
wall 
Cell-seeded group 
and matrices 
group were 
implanted on the 
defect of the 
anterior bladder 
wall 
Two animals died in the 
acellular group, the other 
develop stone disease. 
Muscle layer regeneration 
was better in the cell-
seeded group 
Jack et al. 
2009 
(327) 
Human-ADSCs 
cultured in 85:15 
poly-lactic-
glycolic acid 
scaffolds and 
under smooth 
muscle inductive 
medium 
Nude rats underwent 
removal of half their 
bladders 
Bladder repair by 
augmentation 
with the ADSCs 
engineered 
construct, with 
acellular 
composite or by 
suture closure 
After 12 weeks, only the 
engineered construct 
group maintained bladder 
capacity and compliance, 
and increased smooth 
muscle mass and its 
contraction 
Ho et al. 
2009 
(335) 
MDSCs cultured 
in small 
intestinal 
submucosa 
Rats with 
hysterectomy and 
partial vaginectomy 
Vaginal 
implantation 
Stimulated vaginal tissue 
repair, including keratin-5 
positive epithelium 
formation and prevented 
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(acellular 
matrix) 
fibrosis at 4 and 8 weeks 
Hung et 
al 2010 
(336) 
Human vaginal 
fibroblasts 
cultured in 
biodegradable 
poly-DL-lactic-
glycolic 
acid mesh coated 
with collagen 
Nude mice Subcutaneous implantation 
A well-organized neo-
fascia formation was 
traced up to 12 weeks, 
without rejection or 
inflammatory reaction 
Zou et al. 
2010 
(339) 
Bone marrow 
derived 
mesenchymal 
stem cell seeded 
degradable silk 
scaffold 
Sprague-Dawley rats 
with bilateral 
proximal sciatic 
nerve transaction 
leading to confirmed 
SUI 
Implanted via 
trans-abdominal 
and sutured to 
abdominal wall 
Same leak point pressure 
improvement compare 
with sling implantation 
without cells. However, 
sling plus cells showed 
higher collagen 
production and ultimate 
tensile strength, as 
ligament-like tissue 
formation was 
determined, suggesting 
long-term retention 
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Table 8 Injection of MDSCs for the treatment of SUI: 
Author Cell type Model Implantation Improvements 
 
Chancellor et 
al. 2000 
(580) 
 
Labelled 
myoblasts 
 
Mice 
Injected 
periurethrally and 
into the bladder wall 
After 3-4 days formation of 
myotubes and myofibres in 
the smooth muscle layers of 
the urethra and bladder wall 
Yokoyama et 
al. 2001 
(581) 
Labelled 
MDSCs 
Mice Injected into the 
bladder wall 
After 5, 35, and 70, long 
term survival and 
differentiation into myofibres 
Lee et al. 
2003 (582) 
MDSCs Rats with sciatic 
nerve transected 
Periurethral injection Increased leak point pressure 
after 4 weeks 
 
Cannon et al. 
2003 (583) 
 
MDSCs 
6-week-old 
Sprague-Dawley 
rats sciatic nerve 
transected 
 
Periurethral injection 
Muscular urethral 
contraction restored after 2 
weeks 
 
Lee et al. 
2004 (584) 
MDSC and 
bovine 
Collagen 
Rats with 
denervation of 
the pudendal 
nerve 
 
Periurethral injection 
Increased leak point pressure 
and closing pressure after 4 
and 12 weeks 
 
Chermansky 
et al. 2004 
(585) 
 
 
MDSCs 
Sprague- 
Dawley rats by 
cauterizing 
tissues lateral to 
the mid-urethra 
 
Intraurethral 
injection 
After 2, 4 and 6 weeks 
increased leak point pressure 
and number of nerves in the 
striated muscle 
 
Tamaki et al. 
2005 (586) 
 
MDSCs 
Severe-damage 
model of mouse 
tibialis anterior 
muscle 
Injection in the 
tibialis anterior 
muscle 
Myogenesis, neurogenesis 
and vasculogenesis in 
striated muscle 
 
Kwon et al. 
2005 (587) 
MDSCs, 
fibroblasts 
and mixture 
of both 
Rat with 
unilateral pelvic 
nerve 
transection 
Injection in the 
sphincteric urethral 
unit 
No differences between cell 
types; only fibroblast 
improved leak point pressure 
because obstruction 
 
 
Mitterberger 
et al. 2007 
(413) 
 
Autologous 
myoblasts 
and 
fibroblasts 
 
 
123 women 
with SUI 
Fibroblast plus small 
amount of collagen 
implanted into the 
urethral submucosa 
and myoblasts 
injected into the 
rhabdosphincter 
 
After 1 year 79% completely 
continent and improvement 
of the thickness and 
contractibility of the 
rhabdosphincter 
 
Strasser et al. 
2007 (588) 
Autologous 
myoblasts, 
fibroblasts 
and 
collagen 
 
63 women with 
SUI 
 
Injection into the 
rhabdosphincter and 
the urethra 
Improvement of the 
rhabdosphincter thickness 
and contractibility after 1 
year 
Carr et al. 
2008 (589) 
Autologous 
MDSCs 
8 women with 
SUI 
Periurethral injection Continent recover in 5 
women after 10 months 
 
Nitta et al. 
2010 (590) 
 
 
MDSCs 
Nude rat with 
damage on the 
bladder branch 
of the pelvic 
plexus 
 
Injection into the 
bladder branch of 
the pelvic plexus 
Differentiation into Schwann 
cells, perineural cells, 
vascular smooth muscle 
cells, pericytes and 
fibroblasts 
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Table 9 Injection of ADSCs for the treatment of SUI: 
Author Cell type Model Implantation site Improvements 
 
Jack et al. 
2005 (591) 
ADSCs from 
human 
lipoaspirate 
Immuno-
competent 
incontinent rat 
model of SUI 
Cells injected into 
the bladder and the 
urethra labelled with 
fluorescent marker 
After 12 weeks, cells were 
positively analyzed for 
smooth muscle morphology 
and alpha-actin phenotype 
 
 
Fu et al. 
2010 (592) 
 
 
Endogenous 
rat ADSCs 
 
Vaginal balloon 
dilatation method 
in female 
Sprague-Dawley 
rats inducing SUI 
Cells injected into 
the posterior urethral 
muscularis in the 
bladder neck after 
myoblastic 
differentiation 
with 5-azacitidine 
After 3 months leak point 
pressure and bladder 
capacity increased, such as 
increased number of 
myoblasts with α-smooth 
muscle actin expression 
under the mucosa 
 
 
Lin et al. 
2010 (593) 
 
Rat ADSCs 
isolated from 
the peri-ovary 
fat 
Rats induced to 
develop SUI by 
postpartum 
vaginal balloon 
dilation and 
bilateral 
ovariectomy 
 
Urethral injection of 
the cells labelled 
with thymidine 
analogue BrdU or 
EdU 
 
 
Normal-voiding with 
significantly higher smooth 
muscle content 
 
Almeida et 
al. 2010 
(414) 
Rabbit 
ADSCs 
isolated from 
inguinal fat 
pad 
 
New Zealand 
adult female 
rabbits 
 
Cells labelled with 
DiI marker and 
injected into the 
urethra wall 
After 2 weeks, cells formed 
a dense nodule in the 
submucosa, but after 4 
weeks, cells dispersed 
uniformly in the whole 
extension of the urethra wall 
 
 
Yamamoto 
et al. 2010 
(594) 
 
 
Human 
ADSCs from 
abdomen 
liposuction 
 
 
2 women with 
moderate SUI 
after radical 
prostatectomy 
 
Cells were 
transurethrally 
injected into the 
rhabdosphincter and 
submucosa of the 
urethra 
During 12 weeks follow-up 
were positively tested for 
24-h pad test, a validated 
patient questionnaire, 
urethral pressure profile, 
transrectal ultrasonography, 
and magnetic resonance 
imaging 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
